Page last updated: 2024-08-23

etoposide and Breast Neoplasms

etoposide has been researched along with Breast Neoplasms in 468 studies

Research

Studies (468)

Timeframe	Studies, this research(%)	All Research%
pre-1990	36 (7.69)	18.7374
1990's	177 (37.82)	18.2507
2000's	130 (27.78)	29.6817
2010's	112 (23.93)	24.3611
2020's	13 (2.78)	2.80

Authors

Authors	Studies
Bisagni, E; Croisy, A; Janin, YL; Riou, JF	1
Carmichael, J; Ellis, MJ; Hagan, DJ; Hammonds, TR; Stanslas, J; Stevens, MF; Turner, C; Ward, W	1
Bastow, KF; Cheng, HH; Ito, J; Lee, KH; Luo, TY; Nakanishi, Y; Tachibana, Y; Wang, HK; Xu, Z	1
Chen, JY; Cheng, KF; Ding, J; Meng, LH; Qin, GW; Yu, BW; Zhou, TX	1
Furbacher, TR; Gunatilaka, AA	1
Cook, JM; Deveau, AM; Dieckhaus, CM; Jain, HD; Johnson, MA; Kakeya, H; Liao, X; Liu, X; Ma, J; Macdonald, TL; Osada, H; Smith, KS; Zhang, C; Zhou, H; Zhou, S	1
Alipour, E; Ardestani, SK; Atash, AF; Emami, S; Foroumadi, A; Jafari-Zavareh, M; Khoshneviszadeh, M; Nakhjiri, M; Safavi, M; Shafiee, A	1
Andricopulo, AD; Beraldo, H; Da Silva, JG; Daghestani, H; Day, BW; Dos Santos, RG; Lessa, JA; Mendes, IC; Pesquero, JL; Rocha, WR; Salum, LB; Soares, MA; Vogt, A	1
Adil, SF; Bhadra, U; Ganesh, R; Kamal, A; Pal-Bhadra, M; Pushpavalli, SN; Ramaiah, MJ; Sarma, P; Tamboli, JR	1
Jeengar, MK; Mallavadhani, UV; Naidu, VG; Vanga, NR	1
Boulay, PL; Bourguet, CB; Claing, A; Lubell, WD	1
Bist, G; Jun, KY; Kadayat, TM; Kwon, Y; Lee, ES; Magar, TB; Na, Y; Park, S; Shrestha, A	1
Islam, MS; Kadi, AA; Kwon, Y; Park, S; Rahman, AF; Song, C	1
Abdel Wahab, AHA; Abdelhameid, MK; Ashmawy, AM; El-Deen, IM; Mohamed, KO; Zaki, I	1
Hwang, SY; Jeon, YH; Jeong, TC; Jo, H; Kadayat, TM; Katila, P; Kim, KS; Kim, SK; Koh, WS; Kwon, Y; Lee, ES; Nepal, MR; Noh, K; Park, S; Shrestha, A; Shrestha, R	1
Jana, K; Manna, T; Misra, AK; Pal, K	1
Chanda, D; Dudi, RK; Fatima, K; Iqbal, H; Khan, F; Kumar, Y; Luqman, S; Mondhe, DM; Negi, AS; Shanker, K; Tabassum, M; Verma, AK	1
Abou Najem, S; Fakhoury, R; Hodroj, MH; Idriss, M; Rizk, S; Younes, M	1
Heo, SH; Lee, CH; Oh, SS; Park, JK; Son, SW	1
Bakar-Ates, F; Ozkan, E	1
Al Tamimi, NS; Belbaraka, R; Bennouna, Y; El Fadli, M	1
Davis, ID; Grimison, P; Kalinowski, P; Martin, A; Maruff, P; Olver, IN; Schembri, A; Stockler, M; Toner, GC; Whitford, HS	1
Chang, DY; Chen, HM; Chen, IC; Chen, TW; Cheng, AL; Jan, IS; Lin, CH; Lu, YS	1
Huang, H; Kou, J; Li, H; Li, W; Liu, Y; Meng, Z; Mi, X; Ren, H; Sun, M; Wei, N; Yang, J; Zhang, H; Zhao, P; Zhao, X	1
Cheng, Q; Gan, L; Li, H; Li, Y; Qi, W; Wang, X	1
Nogalski, MT; Shenk, T	1
Ayadi, M; Bahri, O; Berjeb, KK; Braham, M; Chakroun, N; Chtourou, S; Debbabi, L; Fadhlaoui, A; Hamdoun, M; Hannachi, H; Kacem, K; Zemni, Z; Zhioua, F	1
Borowsky, AD; Castaneda, A; Dahlem, C; Haarmann-Stemmann, T; He, Y; Ishihara, Y; Jugan, J; Kado, SY; La Merrill, MA; Lazennec, G; Mori, H; Rossi, A; Sweeney, C; Vogel, CFA; Vogeley, C	1
Du, Z; Pian, Y; Ren, S; Xu, C	1
Chen, Y; Huang, M; Li, T; Liu, C; Liu, M; Liu, Y; Mo, R; Qu, D; Shen, S; Wang, L	1
Batchelar, D; Crook, J; Fenster, A; Hilts, M; Michael, J; Morton, D	1
Keller, B; McGuffin, M; Merino, T; Pignol, JP	1
Borjihan, G; Cao, X; Fan, L; He, X; Tian, X; Wang, Q; Yan, H; Zhang, L	1
Chen, JL; Dong, LH; Gao, X; Li, GP; Li, YF; Song, YP; Wei, XD	1
Harbeck, N; Hofmann, S; Jeschke, U; Sixou, S; Zhang, X	1
Ajdary, S; Ardestani, SK; Davoodi, J; Foroumadi, A; Safavi, M; Shakeri, R	1
Fei, HR; Li, ZJ; Wang, FZ	1
Genta, S; Ghisoni, E; Giannone, G; Milani, A; Mittica, G; Montemurro, F; Valabrega, G	1
Chen, J; Fan, Y; Hong, R; Ma, F; Ou, K; Sang, D; Wang, J; Xu, B; Yuan, P; Zhai, X; Zhao, C	1
Shi, YJ; Zhao, YL; Zhu, P; Zhu, Y	1
Dong, W; Guo, Q; Liang, J; Liu, S; Liu, Y; Su, W; Wang, Y; Xu, H; Zhang, G; Zhu, J	1
Cabel, L; Carton, M; Cheaib, B; Dalenc, F; Debled, M; Desmoulins, I; Eymard, JC; Ferrero, JM; Gonçalves, A; Jacot, W; Lefeuvre, C; Leheurteur, M; Lerebours, F; Levy, C; Mailliez, A; Mouret-Reynier, MA; Pérol, D; Perrocheau, G; Petit, T; Pierga, JY; Piot, I; Simon, G; Uwer, L	1
Bergstrom, C; Fang, Y; Porembka, J; Sarode, V; Syed, S	1
Chalasani, P; Livingston, RB; Reed, D; Segar, JM; Stopeck, A	1
Kim, EJ; Lee, SH; Um, SJ	1
Angarita, FA; Meek, E; Rodríguez, JL; Sánchez, JO; Tawil, M; Torregrosa, L	1
Amamoto, T; Aramaki, H; Koyachi, K; Matsumoto, K; Nishimura, H; Okamoto, Y; Shindo, M; Takeda, S; Yoshida, K	1
Badinloo, M; Esmaeili-Mahani, S	1
Chang, KJ; Chang, YC; Chen, CL; Huang, CK; Jeng, YM; Kuo, WH; Lee, WH; Ma, C; Shew, JY; Wu, HH; Yang, CY	1
Chou, LC; Chung, CH; Huang, CH; Huang, LJ; Kuo, SC; Lee, FY; Lee, JC; Lien, JC; Way, TD; Wu, JC	1
An, L; Bu, W; Creighton, CJ; Fan, Y; Ge, N; Gray, JW; Hilsenbeck, SG; Leung, E; Li, XN; Lu, YJ; Mao, R; Osborne, CK; Rao, PH; Schiff, R; Sun, W; Vasudevan, S; Wang, X; Yang, J; Zhang, H; Zhao, YJ; Zheng, P	1
Mulchandani, M; Sankaranarayanan, A; Tirupati, S	1
Cao, Y; Chen, X; Chen, Y; Li, X; Ni, D; Shen, K; Tang, J; Wei, Z; Wu, K; Xie, X; Ye, G; Zhang, C; Zheng, H	1
Fan, D; Hu, Y; Li, S; Xiong, D; Yagüe, E; Yan, C; Yang, M; Zhang, Y; Zhou, Y	1
Blower, PJ; Diocou, S; Fruhwirth, GO; Mullen, GE; Ng, T	1
Fuller-Pace, FV; Iyer, RS; Meek, DW; Nicol, SM; Quinlan, PR; Thompson, AM	1
Dolfi, SC; Haffty, BG; Hirshfield, KM; Jäger, AV; Medina, DJ; Yang, JM	1
Chmielarska Masoumi, K; Hellman, U; Helou, K; Karlsson, P; Massoumi, R; Shaw-Hallgren, G; Zarrizi, R	1
Altieri, DC; Bosari, S; Faversani, A; Lopergolo, A; Moro, GP; Rivadeneira, D; Schultz, DC; Tosi, D; Vaira, V	1
Fatma, S; Goswami, DG; Iqbal, Z; Negi, LM; Panda, AK; Talegaonkar, S; Tariq, M	1
Hozumi, Y; Kamiakito, T; Kawata, H; Miyazaki, C; Omoto, Y; Tanaka, A	1
Akahane, K; Fujii, M; Kawada, K; Murata, T; Oda, K; Ohama, T; Yatabe, Y	1
Adachi, S; Endo, I; Ichikawa, Y; Ishikawa, T; Kida, K; Narui, K; Sasaki, T; Satake, T; Shimada, K; Shimizu, D; Sugae, S; Tanabe, M; Yamada, A	1
Dragun, AE; Dunlap, NE; Jain, D; Meena, RA; Quillo, AR; Riley, EC; Shaughnessy, JN	1
Apte, RN; Kogan-Zviagin, I; Peleg, R; Priel, E; Romzova, M	1
Chen, L; Gu, X; Guo, J; Zhang, WH; Zhang, Y	1
Banin, VV; Borisova, LM; Fedotcheva, TA; Kiseleva, MP; Rzheznikov, VM; Semeĭkin, AV; Shimanovskiĭ, NL; Shirokikh, KE; Smirnova, zS; Tolkachev, VN	1
Fox, JL; Storey, A	1
Chao, TC; Chen, BB; Chen, TW; Cheng, AL; Huang, CS; Huang, SM; Lin, CH; Lu, YS; Rau, KM; Shih, TT; Tseng, LM; Wu, PF; Yeh, DC	1
Chen, IC; Cheng, AL; Jan, IS; Lin, CH; Lu, YS	1
Chen, WW; Cheng, AL; Huang, SM; Kuo, CH; Liao, HW; Lin, CH; Lu, YS; Wu, PF; Yeh, DC	1
Cai, J; Dai, H; Di, L; Hong, R; Li, L; Wan, D; Xu, B; Yan, M; Yuan, P; Zhang, X; Zhang, Y; Zhu, Q	1
Angelopoulos, N; Giamas, G; Grothey, A; Nunes, J; Stebbing, J; Xu, Y; Zhang, H	1
McKinnon, E; Xiao, P	1
Abdullah, A; Branick, KA; Freeling, JL; Rezvani, K; Sane, S; Wang, H; Zhang, D	1
Abonante, S; Avino, S; Cirillo, F; De Francesco, EM; De Marco, P; Lappano, R; Maggiolini, M; Pellegrino, M; Rigiracciolo, DC; Santolla, MF; Scarpelli, A; Vivacqua, A	1
Eucker, J; Habbel, P; Kaul, D; Kurreck, A; Neumann, C; Possinger, K; Regierer, AC; Scholz, CW; Schulz, CO	1
Park, MJ	1
Blanchard, A; Han, J; Leygue, E; Ma, X; Myal, Y; Schroedter, I; Wang, N; Zhou, B	1
Baxter, RC; Lin, MZ; Martin, JL; Marzec, KA	2
Dong, L; Du, J; Gao, X; Li, G; Li, Y; Song, Y; Sun, X; Wei, X; Xu, B	1
Bortner, CD; Ehrenshaft, M; Kumar, A; Kumari, A; Mason, RP; Sharma, NK; Sinha, BK; Tokar, EJ; Waalkes, MP; Williams, J	1
Basha, SA; Bhadra, MP; Bhadra, U; Kamal, A; Kavi Kishor, PB; Lavanya, A; Ramaiah, MJ; Srinivas, C; Yerramsetty, S	1
Bratta, M; Candeloro, G; D'Orazi, V; Fumagalli, LA; Pasta, V; Rea, S; Recchia, F; Rosselli, M	1
Aguirre-Alvarado, C; García-Pérez, CA; Guerrero-Rodríguez, SL; Hernández-Esquivel, MA; Pérez-Tapia, SM; Rodríguez-Moreno, A; Ruiz-Moreno, AJ; Segura-Cabrera, A; Velasco-Velázquez, MA; Velázquez-Quesada, I	1
Ehrenshaft, M; Kumar, A; Mason, RP; Sinha, BK; Tokar, EJ	1
Chen, BB; Chen, WW; Cheng, AL; Hsu, CY; Lin, CH; Lu, YS; Shih, TT; Wei, SY; Wu, PF; Yu, CW	1
Akbarzadeh, A; Chiani, M; Esmaeilpour, P; Farahnak, M; Farhangi, A; Mehrabi, M; Saffari, Z	1
Belaaloui, G; Jiang, ZZ; Khaled, M; Zhang, LY; Zhu, X	1
Dantzer, F; Karicheva, O; Magroun, N; Martin-Hernandez, K; Rodriguez-Vargas, JM; Schreiber, V; Tissier, A; Vauchelles, R; Wadier, N	1
Chen, Y; He, Q; Zhang, H	1
Antona, AD; Cipolla, C; Ciulla, A; Graceffa, G; Grillo, A; Locurto, P; Martorana, S; Vieni, S	1
Ayas, S; Cetiner, H; Gurbuz, A; Karateke, A	1
Borovskaja, TG; Fomina, TI; Perelmuter, VM; Timina, EA; Vtorushin, SV; Zavjalova, MV	1
Scorilas, A; Thomadaki, H	1
Annereau, JP; Bailly, C; Barret, JM; Brel, V; Delcros, JG; Guilbaud, N; Guminski, Y; Imbert, T; Kruczynski, A; Lansiaux, A; Vispé, S	1
Chauhan, A; Dahiya, P; Gill, M; Singh, H; Verma, S	1
Hou, LA; Hou, MF; Lin, CY; Ma, H; Tsai, LY; Tsai, SM; Wu, SH	1
Caragnano, A; Del Col, L; Maestro, R; Santarosa, M; Tonin, E; Viel, A	1
Han, X; Lv, J; Shi, J; Sun, Y; Wang, S; Xia, W; Xu, S; Zhao, T	1
Avila, DN; Bishop, MR; Bryant, KE; Danforth, DN; Fowler, DH; Gea-Banacloche, J; Gress, RE; Hardy, NM; Krumlauf, MC; Liewehr, DJ; Pavletic, S; Sportès, C; Steinberg, SM	1
Fan, W; Jiang, Z; Shen, J; Sui, M; Wang, L; Xu, C	1
Bacher, A; Benharroch, D; Eisenreich, W; Eisner, N; Golan-Goldhirsh, A; Gopas, J; Ostrozhenkova, E; Ozer, J	1
Arima, N; Hayashi, M; Nishimura, R; Okumura, Y; Osako, T	1
Capasso, I; Comella, G; Comella, P; D'Aiuto, G; D'Aiuto, M; Di Bonito, M; Frasci, G; Iodice, G; Lastoria, S; Montella, M; Oliviero, P; Petrillo, A; Ruffolo, P; Santangelo, M; Siani, C; Vizioli, L	1
Rivera Rosado, LA; Yoshida, T; Zhang, B; Zhang, Y	1
Cho, HT; Huang, K; Li, Y; Liang, Z; Scala, S; Shim, H; Wagar, N; Wu, H; Xia, J; Yoon, Y; Zhang, Y	1
Bhosle, J; Boone, JJ; Hartley, JA; Hochhauser, D; Tilby, MJ	1
Cho, BJ; Hong, SW; Hwang, YI; Jin, DH; Jung, DJ; Kang, JS; Kim, D; Kim, JE; Lee, WJ; Shin, JS	1
Aranda, A; Gronemeyer, H; Jiménez-Lara, AM	1
Arslan, C; Kilickap, S	1
Cho, SJ; Choi, JS; Kim, HY; Lee, SK; Lee, WH; Park, BD; Park, JH; Surh, YJ	1
Bagari, R; Bansal, D; Gulbake, A; Jain, A; Jain, SK; Soni, V	1
Fleming, JM; Ginsburg, E; Meyer, MJ; Miller, TC; Vonderhaar, BK	1
Chen, JY; Li, J; Zhu, X	1
Cho, SG; Choi, HY; Jeon, K; Jeong, HS; Kim, JH; Lee, ER; Lee, HJ	1
Akbulut, H; Demirkazık, A; Icli, F; Onur, H; Senler, FÇ; Yalcin, B	1
Kanomata, N; Kozuka, Y; Kurebayashi, J; Moriya, T; Sonoo, H; Watanabe, M	1
Chae, M; Kang, HS; Kim, HS; Kim, JH; Kim, WK; Kim, YJ; Yoon, S	1
Brandt, BH; Dittmar, T; Haverkampf, S; Meyer-Staeckling, S; Niggemann, B; Reith, G; Schwitalla, S; Seidel, J; Zänker, KS	1
Aldabbagh, K; Fabbro, M; Jacot, W; Pouderoux, S; Poujol, S; Roca, L; Romieu, G	1
Dong, Y; Liu, B; Liu, J; Song, Y; Sun, Z; Tian, B	1
Ben-Ari, A; Braiman, A; Hai, N; Krasnitsky, E; Livneh, E; Maissel, A; Tamarkin, A; Yankelovich, L; Zurgil, U	1
Abrams, SL; Chappell, WH; Drobot, LB; Franklin, RA; Libra, M; Martelli, AM; McCubrey, JA; Nicoletti, F; Sokolosky, ML; Stadelman, KM; Steelman, LS; Stivala, F	1
Farkas, T; Frankel, LB; Høyer-Hansen, M; Jäättelä, M; Krogh, A; Lees, M; Lund, AH; Wen, J	1
Balashova, EE; Dashtiev, MI; Lokhov, PG	1
Cui, SD; Li, LF; Li, WL; Liu, H; Liu, ZZ; Lu, ZD; Yang, H; Zhang, HW	1
Calabretta, B; Casciati, A; Cesi, V; Raschellà, G; Sesti, F; Tanno, B	1
Gündüz, U; Kaplan, E	1
Abolhasani, E; Hashemian, F; Panahi, Y; Saadat, A; Sahebkar, A; Taghikhani, M	1
Antoon, JW; Beckman, BS	1
Balzer, E; Grabias, B; Kontrogianni-Konstantopoulos, A; Mameza, MG; Perry, NA; Shriver, M	1
Fan, Y; Li, Q; Ma, F; Wang, JY; Xu, BH; Yuan, P; Zhang, P	1
Hollingsworth, J; Koh, GY; Liu, Z; Russo, PS; Stout, RW; Zhang, F	1
Arnould, T; De Backer, O; Flamant, L; Hayez, A; Michiels, C; Pierre, M; Poumay, Y; Roegiers, E; Sterpin, C	1
Hao, J; Liu, GY; Wang, DH; Xu, YF; Yu, J; Yuan, BB	1
Andreou, K; Demonacos, C; Krstic-Demonacos, M; Rajendran, R	1
Bates, S; Borsa, A; Dean, M; Huang, da W; Im, K; Lempicki, RA; Limpert, K; Moitra, K; Robey, R; Savan, R; Sawitzke, J; Yuhki, N	1
Buschmann, MD; Gal, S; Jean, M; Li, Z; Liao, S; Merzouki, A; Slilaty, SN; Young, RS	1
Choudhuri, T; Das, D; Kundu, CN; Mohapatra, P; Preet, R; Satapathy, SR; Wyatt, MD	1
Frazier, C; Habicht, KL; Moaddel, R; Shimmo, R; Singh, N; Wainer, IW	1
Obuchi, W; Ohmine, K; Ohtsuki, S; Terasaki, T; Uchida, Y; Yamori, T	1
Deng, Y; He, H; Li, L; Sun, J; Tian, W; Xu, D	1
Busch, FW; Busse, D; Eichelbaum, M; Fromm, MF; Hempel, G; Hinske, C; Kroemer, HK; Würthwein, G	1
Alam, J; Beckman, BS; Burow, ME; Butler, NN; Clayton, JL; Elliott, S; Jaffe, BM; McLachlan, JA; Melnik, LI; Rolfe, KW; Scandurro, AB; Weldon, CB	1
Fenner, MH; Possinger, K	1
Boldt, S; Kolch, W; Weidle, UH	1
Clark, AS; Dennis, PA; Streicher, S; West, K	1
Aydingöz, U; Ayhan, A; Erman, M; Güler, N; Karaoğlu, A; Oksüzoğlu, B	1
Chiu, SM; Oleinick, NL; Xue, LY	1
Depatie, C; Hayakawa, J; Mercola, D; Ohmichi, M	1
Kessinger, A; Murphy, B; Reed, E; Sharp, JG; Tarantolo, S; Traystman, M	1
Kamata, J; Kitoh, K; Kotake, Y; Koyanagi, N; Nagasu, T; Nakamura, K; Niijima, J; Okada, T; Sugumi, H; Taniguchi, T; Uenaka, T; Yamaguchi, A; Yoshimatsu, K; Yoshino, H	1
Cook, JL; Iklé, DN; Lewis, AM; Miura, TA; Routes, JM	1
Anderson, JS; Daniel, KG; Dou, QP; Gupta, P; Kazi, A; Zhong, Q	1
Jänicke, RU; Schulze-Osthoff, K; Totzke, G	1
Asim, M; Chen, X; Shankar, S; Singh, TR; Srivastava, RK	1
Adam, PJ; Berry, J; Craggs, G; De Belin, J; Harris, AL; Herath, A; Loader, JA; O'Hare, MJ; Pezzella, F; Sachsenmeir, KF; Sim, E; Smith, P; Stamps, AC; Steers, G; Terrett, JA; Tyson, KL	1
Carty, M; Gilmore, PM; Harkin, DP; Johnston, PG; Kennedy, RD; Mullan, PB; Quinn, JE	1
Braybrooke, JP; Davis, T; Harris, AL; Joel, S; Levitt, NC; Madhusudan, S; Talbot, DC; Turley, H; Wilner, S	1
Chin, K; Furuta, N; Hatake, K; Itoh, Y; Mishima, Y; Mizunuma, N; Nagasaki, E; Shinozaki, E; Takahashi, S; Terui, Y; Tokutome, N; Usui, N	1
La Mura, N; Lombardi, D; Sorio, R; Spazzapan, S; Tabaro, G; Veronesi, A	1
Baek, JH; Blake, M; Carrier, F; Kim, MS; Kohlhagen, G; Pommier, Y	1
Carlson, RW; Grekowicz, A; Hartman, AR; Lum, BL; Schurman, C; Shapiro, R; Sikic, BI; Stockdale, FE	1
Amodeo, R; Anghel, G; De Rosa, L; Majolino, I; Pandolfi, A; Riccardi, M	1
Guimarães, JE; Lima, RT; Martins, LM; Sambade, C; Vasconcelos, MH	1
Conticello, C; De Maria, R; Messina, A; Patti, M; Pedini, F; Peschle, C; Stassi, G; Zerilli, M; Zeuner, A	1
Becker, KF; Brunner, I; Busch, R; Fricke, E; Fuchs, M; Hermannstädter, C; Höfler, H; Keller, G; Luber, B	1
Avalos, B; Bechtel, T; Copelan, E; Elder, P; Ezzone, S; Farag, S; Hoshaw-Woodard, S; Lemeshow, S; Lin, T; Marcucci, G; Penza, S; Scholl, MD	1
Diedrich, K; Ortmann, O; Treeck, O; Zhou, R	1
Hoadley, KA; Parker, JS; Perou, CM; Troester, MA	1
Drobchenko, EA; Levina, VV; Shabalina, EV	1
Hausmaninger, H; Heilmann, V; Huebner, G; Nitsch, T; Possinger, K; Schippinger, W; Schmid, P; Schultze, W; Wischnewsky, M	1
Akbulut, H; Altinbas, M; Baltali, E; Boruban, C; Büyükcelik, A; Coşkun, S; Demirkazik, A; Erkisi, M; Icli, F; Komurcu, S; Onur, H; Sak, SD; Sencan, O; Senler, FC; Uner, A; Yalcin, B; Zengin, N	1
Atienza, JM; Denissenko, MF; Ekblom, J; Kammerer, S; Rehbock, J; Rosette, C; Roth, RB; Smylie, KJ	1
Abdach, L; Gershuny, A; Quigley, MM; Stein, ME	1
Allen, K; Barth, NM; Beutel, LD; Chico, S; Dillman, RO; VanderMolen, LA	1
Scorilas, A; Thomadaki, H; Tsiapalis, CM	1
Brown, JG; Gibson, SB; Graham, BA; Harding, G; Hu, X; Paul, JT; Shetty, S; Vegh-Yarema, N	1
Berchtold, C; Chang, PY; Miyamoto, S; Wuerzberger-Davis, SM	1
Bates, SE; Baumeister, P; Costa, F; Dong, D; Ko, B; Lee, AS; Markland, F; Patterson, JB; Stiles, C; Swenson, S	1
Decatris, MP; O'Byrne, KJ; Sundar, S	1
Dagher, MC; Shacter, E; Zhang, B; Zhang, Y	1
Bockbrader, KM; Sun, Y; Tan, M	1
Cheng, AL; Chu, YC; Huang, CJ; Whang-Peng, J; Yang, CH; Yang, CS; Yang, PC	1
Asano, T; Fukunaga, Y; Kleinerman, ES; Zhou, Z; Zwelling, LA	1
Miyahara, S; Mizutani, M; Murabayashi, K; Ogawa, T; Yabana, T	1
Blandino, G; Bossi, G; Lapi, E; Rinaldo, C; Sacchi, A; Strano, S	1
Endo, H; Hamanaka, Y; Inoue, M; Koga, T; Kusama, T; Mukai, M; Tatsuta, M	1
Emberley, ED; Gorski, JJ; Harkin, DP; James, CR; Johnston, PG; Kennedy, RD; Lioe, TF; Moore, S; Morrison, PJ; Mullan, PB; Mulligan, K; Quinn, JE; Reid, G; Stewart, GE; Watson, PH	1
Asanuma, H; Hirata, K; Hirohashi, Y; Kamiguchi, K; Ohmura, T; Sato, M; Sato, N; Torigoe, T	1
Alevizopoulos, K; Demetzos, C; Dimas, K; Hatziantoniou, S; Pantazis, P; Papadaki, M; Tsimplouli, C	1
Booser, DJ; Broglio, K; Buzdar, AU; Champlin, RE; Frye, D; Gajewski, JL; Hanrahan, EO; Hortobagyi, GN; Singletary, SE; Strom, EA; Theriault, RL; Valero, V	1
Eeles, R; Garrett, MD; Mantoni, TS; Sodha, N; Tavtigian, SV	1
Bode, AM; Choi, BY; Choi, HS; Dong, Z; Ermakova, SP; Kang, BS; Ma, WY; Schuster, TF	1
Abiri, SO; Apostolov, EO; Basnakian, AG; Shah, SV; Singh, AB; Stewart, AG; Yin, X	1
Lupu, R; Menendez, JA; Vellon, L	1
Boudrias, M; Fortin, D; Garant, MP; Gendron, C	1
Ling, MT; Wang, X; Wong, YC; Zhang, X	1
Kenna, T; Mattarollo, SR; Nicol, AJ; Nieda, M	1
Coley, HM; Hughes, MP; Labeed, FH; Thomas, H	1
Liu, KL; Lu, YS; Shih, IL; Wang, HP	1
Allen, WL; Galligan, L; Johnston, PG; Longley, DB; Rogers, KM; Sakai, H; Thomas, M; Wilson, TR	1
Antoccia, A; Casadei, M; Faso, C; Federico, R; Leone, S; Marcocci, L; Mondovì, B; Stano, P; Tavladoraki, P	1
Dinter, H; Lalehzadeh, G; Meisner, R; Ruderman, DL; Tedesco, D; Trinh, L; Yamaguchi, KD; Zajchowski, DA; Zhang, J	1
Baxter, RC; Christopherson, RI; Leong, S	1
Fu, J; Liang, M; Su, DM; Zhang, P	1
Atzori, F; Catino, AM; Contu, A; Farris, A; Ionta, MT; Massidda, B; Minerba, L; Palmeri, S; Scanu, A	1
Ghafourifar, P; Parihar, A; Parihar, MS	1
Louie, JC; Sit, WH; Wan, JM	1
Fu, JM; Li, H; Xie, JS; Zhou, J	1
Hirose, S; Hojo, T; Ikeuchi, S; Isobe, Y; Kinoshita, T; Kubochi, K; Matsumoto, S; Sadako, AT; Shien, T; Terada, K	1
Schwarz, MA; Snyder, RD	1
Kennedy, BJ; Raghavan, D; Vogelzang, NJ	1
Aisner, J; Konits, PH; Morris, D; Van Echo, DA; Wiernik, PH	1
Alburquerque Carbuccia, H; Madrigal Alonso, PL; Perez Manga, G	1
Cirera, L; Doncel, F; Estapé, J; Millá, A	1
Alburquerque Carbuccia, H; Madrigal Alonso, P; Perez Manga, G	1
Demitrish, M; Duffin, H; Enochs, K; Groshko, G; Lockhard, C; Maniscalco-Greb, E; Vaughn, CB	1
Brunner, KW; Cavalli, F; Jungi, WF	1
Esparza, L; Hortobagyi, GN; Issell, B; Schell, FC; Yap, HY	1
Höffken, K	1
Ahmann, DL; Decker, DA; Eagan, RT; Hahn, RG; Ingle, JN; Rubin, J	1
Csoka, K; Larsson, R; Liliemark, J; Nygren, P	1
Akard, L; Chang, Q; English, D; Hanks, S; Harvey, K; Jansen, J; Thompson, J	1
Balmanno, K; Chapman, F; Charlton, CJ; Gumbrell, L; Lind, MJ; Matthews, JP; Millward, MJ; Newell, DR; Proctor, M; Yuen, K	1
Ahn, C; Akman, SA; Doroshow, JH; Forman, SJ; Leong, LA; Margolin, KA; Morgan, RJ; Nagasawa, S; Raschko, JW; Somlo, G	1
Bender, JG; Coon, J; George, S; Ghalie, R; Kaizer, H; Lee, W; Lum, L; McLeod, B; Unverzagt, KL; Van Epps, D	1
Ciaccia, D; Corey, GR; Peters, W; Thel, MC; Vredenburgh, JJ	1
Mukaiyama, T; Ogawa, M	1
Berenson, RJ; Brugger, W; Heimfeld, S; Henschler, R; Kanz, L; Mertelsmann, R	1
Chiang, Y; Cowan, KH; Dunbar, CE; Goldspiel, B; Kohler, D; McDonagh, KT; Nienhuis, AW; O'Shaughnessy, JA; Sorrentino, BP; Wilson, W	1
Fichtner, I; Goan, SR; Herrmann, F; Just, U; Karawajew, L; Krause, KP; Schultze, W; von Harsdorf, S; von Schilling, C	1
Dejbakhsh-Jones, S; Ginzton, N; Greenberg, P; Kusnierz-Glaz, CR; Negrin, RS; Schriber, JR; Still, B; Strober, S	1
Arneson, M; Blumenschein, G; Dicke, JA; Dicke, KA; Fulbright, L; Hanks, S; Hood, DL; Vaughan, M	1
Bezwoda, WR; Dansey, RD; Seymour, L	1
Meisenberg, BR	1
Elfenbein, GJ; Fields, KK; Perkins, JB	1
Asbury, RF; Boros, L; Chang, AY; Garrow, GC	1
Crown, J; Hamilton, N; Kritz, A; Norton, L; Raptis, G; Vahdat, L	1
Broun, ER; Cornetta, K; Einhorn, LH; Hanna, M; Hromas, R; Kneebone, PH; Loesch, D; Sledge, GW; Sridhara, R	1
Bontenbal, M; de Wit, R; Klijn, JG; Kruit, WH; Planting, AS; Stoter, G; Verweij, J	1
Bontenbal, M; Kok, TC; Planting, AS; Splinter, TA; van der Gaast, A	1
Hamburger, AW; Mishra, S	1
Boccadoro, M; Bondesan, P; Bregni, M; Caracciolo, D; Frieri, R; Gianni, AM; Omedé, P; Pileri, A; Siena, S; Tarella, C	1
Crown, J; Gilewski, T; Hamilton, N; Harrison, M; Hudis, C; Kritz, A; Moore, M; Reich, L; Schneider, J; Vahdat, L	1
Ballestrero, A; Basta, P; Brema, F; Ferrando, F; Ghio, R; Gobbi, M; Moraglio, L; Patrone, F; Sessarego, M; Valbonesi, M	1
Cowan, KH; Schneider, E; Sinha, BK; Yamazaki, H	1
Duba, D; Fan, S; Fornace, AJ; Kohn, KW; O'Connor, PM; Rivet, DJ; Smith, ML; Zhan, Q	1
Ahn, DC; Doroshow, JH; Forman, SJ; Hwang, L; Leong, LA; Lev-Ran, A; Margolin, KA; Morgan, RJ; Raschko, JW; Somlo, G	1
Cowan, KH; Schneider, E; Sokolova, IA	1
Dive, C; Hickman, JA; Morris, ID; Wakeling, AE; Wilson, JW	1
Carlomagno, C; De Laurentiis, M; De Placido, S; Lauria, R; Marinelli, A; Morabito, A; Pagliarulo, C; Perrone, F; Petrella, G; Varriale, E	1
Biakhov, MIu; Buianov, SS; Dobrovol'skaia, NIu; Voznyĭ, EK	1
Ballester, OF; Cooper, BW; Creger, RJ; Elfenbein, GJ; Fields, KK; Hiemenz, JH; Janssen, WE; Lazarus, HM; Perkins, JB; Zorsky, PE	1
Elfenbein, GJ; Fields, KK; Hiemenz, JW; Janssen, WE; Kronish, LE; Machak, MC; Perkins, JP; Zorsky, PE	1
Cowan, KH; Horton, JK; Nakagawa, M; Schneider, E; Yang, CH	1
Ahn, C; Akman, SA; Doroshow, JH; Forman, SJ; Leong, LA; Margolin, KA; Morgan, RJ; Raschko, JW; Sniecinski, I; Somlo, G	1
Bader, GR; Costa, MA; Lamarca, JE	1
Meisenberg, B	1
Heath, R; Hoen, H; Jackson, DV; McCulloch, J; McFarland, J; Muss, HB; Pavy, M; Ramseur, W; Thomas, GW	1
Adler, SS; Feingold, JM; Ghalie, R; Kaizer, H; Korenblit, AD; Manson, S; Pruett, J; Reynolds, J; Valentino, LA	1
Aggarwal, S; Fisk, B; Glisson, BS; Ioannides, CG; O'Brian, CA; Restifo, N; Wharton, JT	1
Crown, JP; Hamilton, N; Heelan, RT; Heller, G; Kritz, A; Moore, MP; Motzer, RJ; Reich, LM; Schneider, JG; Yao, TJ	1
Cottler-Fox, M; Cowan, K; Dunbar, CE; Goodman, S; Leitman, S; Nienhuis, AW; O'Shaughnessy, J; Quesenberry, P; Sorrentino, BP; Stewart, FM	1
Cook, J; Fisher, J; Goldspiel, B; Hahn, SM; Kaufman, D; Liebmann, JE; Mitchell, JB; Venzon, D	1
Greco, FA; Hainsworth, JD; Johnson, DH; Lamar, RE; Murphy, PB	1
Daniels, M; Estapé, J; Grau, JJ; Mañé, JM; Mellado, B; Palombo, H; Viñolas, N	1
Buzdar, AU; Dicke, KA; Dunphy, FR; Fornoff, JE; Hortobagyi, GN; Huan, SD; Spitzer, G; Yau, JC	1
Adrover, E; Azagra, P; Casado, A; García-Conde, J; Lluch, A; López-Martín, JA; Martín, M; Rodriguez-Lescure, A; Santabárbara, P; Valverde, JJ	1
Fountzilas, G; Giannakakis, T; Skarlos, D; Stathopoulos, G; Theoharis, D	1
Ballester, OF; Elfenbein, GJ; Fields, KK; Foody, MC; Hiemenz, JW; Janssen, WE; Kronish, LE; Perkins, JB; Zorsky, PE	1
Calvert, AH; Cantwell, BM; Chapman, F; Charlton, C; Gumbrell, L; Lind, MJ; Millward, MM; Proctor, M; Robinson, A; Simmons, D	1
Adrover, E; Casado, A; Diaz-Rubio, E; García-Conde, J; Lluch, A; Martín, M	1
Dive, C; Hickman, JA; Morris, ID; Oberhammer, F; Sikorska, M; Wakeling, AE; Walker, PR; Wilson, JW	1
Fukunaga, M; Fukunaga, T; Iba, T; Kidokoro, A; Mishima, S; Yagi, Y	1
Barker, LJ; Jones, SE; Mennel, RG; Savin, MA	1
Bryant, G; Cowan, KH; Dunbar, C; Goldspiel, B; Gress, R; Nienhuis, AW; O'Shaughnessy, JA; Sorrentino, B; Stewart, FM; Wilson, W	1
Beuzeboc, P; Dorval, T; Garcia-Giralt, E; Jouve, M; Livartowski, A; Mosseri, V; Palangie, T; Pouillart, P; Scholl, S	1
Crown, J; Currie, V; Gilewski, T; Hakes, T; Hudis, C; Lebwohl, D; Reichman, B; Seidman, A; Surbone, A; Yao, TJ	1
de Vries, EG; Dolsma, WV; Mulder, NH; Mulder, PO; Sleijfer, DT; van der Ploeg, E; Willemse, PH	1
Adams, GE; Jones, AM; Kalra, R; Kirk, J; Stratford, IJ	1
Elfenbein, GJ; Fields, KK; Moscinski, LC; Perkins, JB	1
Christiansen, NP; Davis, MP; Fay, JW; Herzig, GP; Herzig, RH; Lynch, J	1
Haynes, FA; Holcenberg, J; Mayernik, DG; Neidhart, JA; Nemunaitis, J; Oette, DH; Quick, DP; Triozzi, P; Verma, S; Yau, JC	1
Bromberg, C; Chmura, M; DeConti, RC; Harper, GR; Healey, B; Hilstro, J; Horton, J; Remick, SC; Ruckdeschel, JC; Sporn, J	1
Ball, ED; Bloom, EJ; deMagalhaes-Silverman, M; Lembersky, B; Lister, J; Pincus, SM; Rybka, WB; Voloshin, M; Wilson, J	1
Atienza, DM; Swain, SM; Trock, B; Vogel, CL	1
Blume, KG; Chao, NJ; Hoyle, CF; Kusnierz-Glaz, CR; Long, GD; Negrin, RS; Schriber, JR	1
Bender, JG; Blake, M; Carreon, J; Lee, WJ; Oldham, F; Schilling, M; Smith, S; Swinney, P; Van Epps, D; Williams, DE; Williams, SF; Zimmerman, T	1
Andrews, F; Bolwell, B; Collins, R; Fay, J; LeFever, A; Levitt, D; List, A; Nemunaitis, J; Pallansch, P; Resta, D; Rosenfeld, CS; Schuster, MW; Taylor, R	1
Elfenbein, GJ; Fields, KK; Janssen, WE; Moscinski, LC; Perkins, JB; Trudeau, WL	1
Anderson, NR; Lokich, JJ; Moore, CL	1
Effenbein, GJ; Fields, KK; Perkins, JB	1
Asbury, RF; Boros, L; Chang, AY; Garrow, GC; Hui, L	1
Cowan, KH; Gudas, JM; Li, T; Nguyen, H; Robey, R; Sadzewicz, L; Wosikowski, K	1
Ogretmen, B; Safa, AR	1
Akard, LP; Hanks, S; Jansen, J; Lynn, K; Swinney, M; Thompson, JM; Wiemann, M	1
An, T; Asano, T; Fojo, AT; Kleinerman, ES; Takano, H; Zwelling, LA	1
Fujii, M; Iwai, S; Kochi, M; Otsuka, Y; Tsuneda, Y; Wakabayashi, K; Yamagata, M	1
Bosnjak, SM; Mitrović, LB; Nesković-Konstantinović, ZB; Radulović, SS	1
Arvizu, C; Conzen, SD; Kaufman, PA; LeMarbre, P; Maurer, LH; Mills, LE; Mott, LA	1
Hagel, E; Hering, M; Krieger, G; Zwicker, C	1
Bargou, R; Dörken, B; Hildebrandt, M; Körner, IJ; Krahl, D; Mapara, MY; Reichardt, P	1
Belón, J; Blanco, E; Espinosa, E; Feliu, J; Garcia Alfonso, P; Garcia Girón, C; Garrido, P; González Barón, M; Jara, C; Ruiz, A; Vincent, JM; Zamora, P	1
Anderson, E; Anderson, T; Cameron, DA; Chetty, U; Craig, J; Dixon, M; Gabra, H; Hawkins, A; Jack, W; Kunkler, I; Lee, L; Leonard, R; Leonard, RC; MacKay, J; Matheson, L; Miller, W; Parker, AC	1
Bachier, C; Bird, RE; Chang, A; Cheng, S; Claxton, D; Cote, R; Deisseroth, AB; Ellerson, D; Fu, SQ; Giles, RE; Hanania, EG; Hester, J; Holmes, F; Holzmayer, T; Hortobagyi, G; Kavanagh, J; Korbling, M; Kudelka, A; Ostrove, JM; Rahman, Z; Seong, D; Su, Y; Thall, P; Wang, T; Zu, Z	1
Avalos, BR; Bechtel, TP; Ceselski, SK; Copelan, EA; Elder, PJ; Ezzone, SA; Hehmeyer, DM; Klein, JL; Lasky, LC; Marshall, DD; Penza, SL; Risley, GL; Scholl, MD	1
Lock, RB; Stribinskiene, L; Sullivan, DM; Thompson, BS	1
Berenson, RJ; Chow, W; Doroshow, JH; Forman, SJ; Hamasaki, V; Leong, L; Margolin, K; Molina, A; Morgan, R; Nowicki, B; Odom-Maryon, T; Raschko, J; Shibata, S; Sniecinski, I; Somlo, G; Tetef, M	1
Andreeff, M; Doyle, LA; Ling, YH; Neamati, N; Perez-Soler, R; Priebe, W; Schneider, E; Zou, Y	1
Benedetti Panici, P; Caracussi, U; Foddai, ML; Leone, G; Mancuso, S; Maneschi, F; Menichella, G; Pierelli, L; Salerno, MG; Scambia, G; Serafini, R; Vittori, M	1
Chen, WD; Coxon, AB; Kaye, FJ; Khleif, SN; Lipkowitz, S; Otterson, GA	1
De Filippis, S; Lalli, A; Nuzzo, A; Recchia, F; Torchio, P	1
Katschinski, DM; Mentzel, M; Mulkerin, DL; Robins, HI; Touhidi, R; Wiedemann, GJ	1
Bates, SE; Dickstein, B; Fojo, AT; Gamelin, E; Regis, J; Sandor, VA; Wilson, W; Zhan, Z	1
Ballestrero, A; Brema, F; Ferrando, F; Patrone, F; Puglisi, M; Stura, P	1
Ascensao, JL; Fontelonga, A; Hall, S; Kelly, AJ; MacKintosh, FR; Monroe, P; Ruthven, A; Shaft, D; Wilson, GS	1
Arese, P; Camanni, M; Deltetto, F; Durando, A; Massobrio, M; Pesola, D; Sberveglieri, M	1
Forman, SJ; Margolin, KA; Wright, C	1
Chow, W; Doroshow, JH; Forman, SJ; Hamasaki, V; Lee, J; Leong, L; Margolin, K; Molina, A; Morgan, R; Odom-Maryon, T; Raschko, J; Shibata, S; Simpson, J; Somlo, G; Tetef, M; Yen, Y	1
Goldberg, SL; Klumpp, TR; Magdalinski, AJ; Mangan, KF	1
Hou, Y; Liu, QY; Ribecco, M; Sikorska, M; Walker, PR	1
Hagiwara, A; Hakomori, S; Igarashi, Y; Imanishi, T; Ogaki, M; Ohyama, T; Sakakura, C; Sawai, K; Shirahama, T; Sweeney, EA; Takahashi, T; Tsujimoto, H; Yamaguchi, T; Yamazaki, J	1
Beeker, T; Birch, R; Buckner, CD; Foster, J; Geier, L; Greco, FA; Hainsworth, J; Hazelton, B; Price, H; Rhinehart, S; Schwartzberg, LS; Weaver, CH; West, J	1
Oblon, DJ; Paul, S; Yankee, R	1
Fojo, T; Matsumoto, Y; Takano, H	1
Bernstein, SH; Christiansen, N; Devos, A; Eaves, CJ; Ericson, S; Fay, J; Hawkins, K; Herzig, GP; Herzig, R; Kovalsky, M; Lynch, J; Phillips, GL; Rasmussen, H; Reece, D; Stephan, M	1
Denny, TN; Fenig, E; Maloof, P; Nichols, G; Stein, D; Wang, H; Wang, Q; Wieder, R; Yahalom, J	1
Benderra, Z; Manfait, M; Morjani, H; Trussardi, A	1
Bilkay, BC; Burgut, R; Erkisi, M; Hazar, B; Seyrek, E	1
Benjamin, CW; Hiebsch, RR; Jones, DA	1
Buckwalter, CA; Perez, EA	1
Harris, LN; Lupu, R; Tang, C; Yang, D; Yang, L	1
Idezuki, Y; Inokuma, S; Ishizuka, N; Kobayashi, M; Maeda, H; Miura, T; Murata, N; Suwata, J; Takada, S	1
Ballester, OF; Elfenbein, GJ; Fields, KK; Goldstein, SC; Heimenz, JW; Kronish, LA; Partyka, JS; Perkins, JB; Saez, RA; Sullivan, DM	1
Cesano, A; Miller, EJ; Santoli, D; Torosian, MH; Visonneau, S	1
Beeker, T; Birch, R; Buckner, CD; Greco, T; Hainsworth, J; Leff, R; MacAneny, B; Manner, C; Morgan-Ihrig, C; Murphy, MN; Schwartzberg, LS; Schwerkoske, J; Smith, R; Tauer, K; Weaver, CH	1
Baker, WJ; Burrell, LM; Lee, N; Perry, JJ; Vukelja, SJ	1
Adachi, M; Horiike, S; Huang, CL; Ieki, Y; Konaka, Y; Miyake, M; Onishi, R; Taki, T; Yagita, M	1
Adachi, I; Inaji, H; Kanda, K; Kikkawa, N; Koyama, H; Miura, S; Nakao, K; Shiba, E; Tajima, T; Takai, S; Tamura, K; Toge, T; Yoshida, M	1
Fukuda, H; Kunitoh, H; Saijo, N; Sekine, I	1
Hortobagyi, GN; Pusztai, L; Theriault, RL; Valero, V; Walters, RS	1
Horton, JK; Reuss, L; Vanoye, CG	1
Bernstein, SH; Christiansen, NP; Fay, JP; Herzig, GP; Pinero, L; Shah, D; Stephan, M	1
Bianco, C; Ciardiello, F; Damiano, V; Davies, SL; di Isernia, G; Harris, AL; Hickson, ID; North, P; Pepe, S; Tortora, G	1
Budman, DR; Calabro, A; Kreis, W	1
Idezuki, Y; Ishizuka, N; Kobayashi, M; Murata, N; Suwata, J; Takada, S	1
Bar-Am, A; Inbar, MJ; Kraminsky, N; Ron, IG; Vishne, TH	1
Hochman, A; Kessler-Icekson, G; Koren, R; Liberman, UA; Machlenkin, A; Ravid, A; Rocker, D; Rotem, C	1
Iwata, T; Kanematsu, T	1
Boni, C; Carlini, P; Cocconi, G; Di Costanzo, F; Di Sarra, S; Fosser, V; Franciosi, V; Michiara, M; Tonato, M	1
Ashby, M; Bhatia, R; Chow, W; Doroshow, JH; Forman, S; Fyfe, G; Hellmann, S; Jones, D; Knutson, G; Leong, L; Longmate, J; Margolin, K; Morgan, R; Raschko, J; Shibata, S; Sniecinski, I; Somlo, G; ter Veer, A; Tetef, M; Vuk-Pavlovic, S; Yen, Y	1
Baly, D; Beryt, M; Coombs, D; Hsu, S; Kabbinavar, F; Lewis, G; Pegram, M; Pietras, R; Slamon, D; Sliwkowski, M	1
Burns, LJ; Gingrich, RD; Hohl, R; Joyce, J; Lee, CK; Scott, S; Tamaki, K; Wen, BC	1
Daskalakis, A; Lange, W; Musahl, V; von Lintig, F; Waller, CF	1
Fleming, DR; Goldsmith, GC; Herzig, RH; Stevens, DA	1
Nieder, C	1
Leung, LK; Wang, TT	1
Ericson, SG; Fortney, J; Gibson, LF; Landreth, KS; Lynch, JP; Magro, G	1
Belt, R; Coon, J; Cord, M; Dix, S; Geller, R; Howard, S	1
An, T; Herzog, C; Kawakami, Y; Kleinerman, ES; Kobayashi, K; Zhou, Z; Zwelling, LA	1
Akutsu, M; Kano, Y; Mori, K; Suzuki, K; Tsunoda, S; Yazawa, Y	1
Bisagni, G; Boni, C; Ceci, G; Cocconi, G; De Lisi, V; Di Blasio, B; Morandi, P; Passalacqua, R; Savoldi, L; Zadro, A	1
Denny, TN; Fenig, E; Maloof, P; Stein, D; Wang, H; Wang, Q; Wieder, R; Yahalom, J	1
Akard, LP; Dugan, MJ; Greenspan, A; Hanks, S; Jansen, J; Nyhuis, A; Swinney, M; Thompson, JM; Wiemann, M	1
Acito, L; Anastasi, P; Bella, M; Bisagni, G; Borrini, A; Buzzi, P; Carpi, A; Cocconi, G; Di Costanzo, F; Frassoldati, A; Mosconi, A	1
Asbury, R; Boros, L; Chang, AY; Garrow, G; Hui, L; Rubins, J	1
Fried, G; Haim, N; Stein, ME	1
Bilgrami, S; Bona, RD; Clive, J; Edwards, RL; Feingold, JM; Kazierad, D; Khan, AM; Khan, IA; Rodriguez-Pinero, F; Tutschka, PJ	1
Appella, E; Connell, T; Gao, C; Moul, JW; Nagaich, AK; Saito, S; Seth, P; Srivastava, S; Zou, Z	1
Bianco, AR; Caputo, R; Ciardiello, F; De Laurentiis, M; De Placido, S; Pomatico, G; Tortora, G	1
Benderra, Z; Doglia, SM; Manfait, M; Morjani, H; Trussardi, A; Villa, AM	1
Bashey, A; Corringham, RE; Corringham, S; Garrett, J; Gilpin, EA; Ho, AD; Lane, TA; Law, P	1
Lash, LH; Mathieu, P; Okafor, C; Putt, DA; Reiners, JJ	1
Ahmed, T; Ali, MF; Bar, M; Chun, HG; Durrani, H; Farley, T; Goldberg, R; Kancherla, R; Lake, D; Lipshutz, M; Mannancheril, A; Mittelman, A; Preti, R; Puccio, C; Qureshi, Z; Seiter, K	1
Bello-Reuss, E; Ernest, S; Hellmich, MR; Holland, OB	1
Falkson, CI; Pandya, KJ; Robert, NJ; Saphner, T; Stewart, J; Tormey, DC; Weller, EA	1
Aref, IM; Cross, PW; Gertler, SZ; Grimard, LJ; Hanson, J; Huan, SD; Malik, ST; St Cyr, DA; Stewart, DJ; Tomiak, EM; Verma, S; Yau, JC	1
Amoroso, D; Ballestrero, A; Boccardo, F; Ferrando, F; Garuti, A; Gonella, R; Patrone, F; Sessarego, M; Stura, P	1
Jeng, J; Wang, TT	1
Clowes, C; Duarte, R; Pu, QQ; Wang, X	2
Bláha, M; Filip, S; Vanásek, J; Vávrová, J; Vokurková, D	1
Andrews, DF; Gilmore, GL; Lister, J; Shadduck, RK; Zeigler, ZR	1
Belka, C; Berg, C; Engels, IH; Gregor, M; Jänicke, RU; Lauber, K; Porter, AG; Schulze-Osthoff, K; Schwenzer, R; Stepczynska, A; Stroh, C; Wajant, H; Wesselborg, S	1
Ames, F; Asmar, L; Booser, DJ; Brito, RA; Buzdar, AU; Frye, D; Hortobagyi, GN; Kau, SW; McNeese, M; Ross, M; Singletary, SE; Strom, E; Theriault, RL; Valero, V	1
Butler, BR; Froelich, CJ; Liu, X; Sladek, TL; Thor, AD; Yang, XH	1
Chen, F; Cryns, VL; Kamradt, MC	1
Cervek, J; Cufer, T; Jagodic, M; Zakotnik, B	1
Colvin, OM; Harris, LN; Hsieh, TS; Iglehart, JD; Liotcheva, V; Pauli, S; Yang, L	1
Brugarolas, A; García-Rayo, S; Inogés, S; Martín-Algarra, S; Martínez-Aguillo, M; Ordóñez, JM; Pérez-Calvo, J; Ramón y Cajal, T; Santisteban, M; Subirá, ML	1
Fojo, T; Kunishio, K; Matsumoto, Y; Nagao, S; Takano, H	3
Akbulut, H; Cam, R; Cay, F; Demirci, S; Demirkazik, A; Dinçol, D; Erekul, S; Içli, F; Onur, H; Uner, A	1
Dunkern, T; Engels, IH; Jänicke, RU; Kaina, B; Porter, AG; Schulze-Osthoff, K	1
Azinovic, I; Brugarolas, A; Fernández-Hidalgo, O; García-Rayo, S; Martín-Algarra, S; Martínez-Aguillo, M; Martínez-Monge, R; Pérez-Calvo, J; Rebollo, J; Subirá, L	1
Gralow, JR; Livingston, RB	1
Fojo, T; Matsumoto, Y; Nagao, S; Takano, H	1
Fujise, K; Li, F; Zhang, D	1
Basso, B; Boiocchi, M; Colussi, AM; Corona, G; Robieux, I; Sorio, R; Toffoli, G	1
Amir, G; Cohen, Y; Polliack, A; Rachmilewitz, EA	1
Clarke, P; Geraci, MW; Johnson, GL; Jotte, RM; Scheinman, RI; Spalding, AC; Tyler, KL	1
Mao, Y; Mehl, IR; Muller, MT	1
Aiba, K; Akaza, H; Blackledge, G; Boku, N; Ikeda, T; Isonishi, S; Kato, M; Kawai, K; Mikami, O; Ohashi, Y; Saeki, T; Saijo, N; Sone, S; Stribling, D; Tsukagoshi, S; Tsuruo, T	1
Martín, M	1
Bergauer, F; Dimpfl, T; Janni, W; Kaestner, R; Linka, F; Rack, B; Rjosk, D; Schindlbeck, C; Sommer, H; Strobl, B	1
Cummings, J; Jardine, L; Joel, SP; Okorokov, AL; te Poele, RH	1
Bushell, M; Clemens, MJ; Jeffrey, IW; Morley, S; Tilleray, VJ	1
Behr, W; Brockmeyer, C; Ehnle, S; Hempel, P; Müller, P; Oruzio, D; Riethmüller, R; Schlimok, G; Wochner, M	1
Badve, S; Khan, SA	1
Ahmann, DL; Bisel, HF; Eagan, RT	1
Ahmann, DL; Bisel, HF; Eagan, RT; Edmonson, JH; Frytak, S; Hahn, RG; O'Connell, MJ	1
Lafleur, MV; Lankelma, J; Mans, DR; Pinedo, HM; Retèl, J; Schuurhuis, GJ; Treskes, M	1
Cowan, KH; Dixon, KH; Horton, J; Kelley, K; Morrow, C; Nakagawa, M; Schneider, E	1
Fay, JW; Harden, EA; Herzig, GP; Herzig, RH; Heye, MM; Meagher, RC; Montes, VM; Stevens, DA	1
Nichols, CR	1
Daniels, M; Estapé, J; Grau, JJ; Palombo, H; Solá, C; Viñolas, N	1
Ariad, S; Bezwoda, WR; Seymour, L	1
Cold, S; Pfeiffer, P; Rose, C	1
Demirkazik, A; Dinçol, D; Günel, N; Içli, F; Karaoğuz, H	1
Armitage, JO; Bierman, PJ; Glenn, LD; Kessinger, A; Reed, EC; Vaughan, WP	1
Fujita, M; Honda, I; Kawabe, T; Kawakami, Y; Matsushita, K; Ryu, M; Watanabe, K; Watanabe, S; Yoshida, M	1
Dunphy, FR; Spitzer, G	1
Buzdar, AU; Esparza, L; Fraschini, G; Holmes, FA; Hortobagyi, GN; Theriault, RL	1
Ohtagaki, S; Toge, T; Toi, M; Yagi, M; Yoshinaka, K	1
Anderson, N; Bern, M; Lokich, J; Moore, C	1
Hill, BT; Hinds, MD; Hosking, LK; Mayes, J; Shellard, SA; Whelan, RD; Zwelling, LA	1
Albertini, M; Saphner, T; Tormey, DC	1
Sinha, BK; Usui, N	1
Arnold, ST; Felsted, RL; Politi, PM; Sinha, BK	1
Sledge, GW	1
Bacchi, M; Bartolucci, R; Bisagni, G; Boni, C; Ceci, G; Cocconi, G; Colozza, MA; De Lisi, V; Lottici, R; Mosconi, AM	1
Bickel, J; Drings, P; Kaufmann, M; Manegold, C; Schmid, H; Worst, P	1
Buzdar, A; Dunphy, F; Ewer, M; Holmes, F; Hortobagyi, G; Huan, S; Spitzer, G; Theriault, R; Wallerstein, R; Yau, J	1
Hirano, A; Horikoshi, N; Inoue, K; Matsumura, T; Matsuoka, A; Mizunuma, N; Mukaiyama, T; Ogawa, M	1
Eliot, HM; Kerrigan, D; Politi, PM; Pommier, Y; Sinha, BK	1
Beattie, M; Kingston, JE; Malpas, JS; Norton, AJ	1
Bacchi, M; Bassi, P; Belsanti, V; Bisagni, G; Boni, C; Cocconi, G; Lottici, R; Passalacqua, R; Tonato, M	1
Ellison, NM; Kardinal, CG; Krook, JE; Loprinzi, CL; Mailliard, JA; Nelimark, RA; Pfeifle, DM; Reuter, NF; Schaid, DJ	1
Bonardi, G; Calciati, A; Donadio, M; Giaccone, G; Testore, F	1
Daniels, M; Estape, J; Gardella, S; Grau, JJ; Santabarbara, P; Viñolas, N	1
Buzdar, AU; Dunphy, FR; Holmes, F; Hortobagyi, GN; Horwitz, LJ; Jagannath, S; Spinolo, JA; Spitzer, G; Wallerstein, RO; Yau, JC	1
Epstein, RJ; Smith, PJ; Watson, JV	1
Cellerino, R; Menichetti, ET; Miseria, S; Silva, RR; Torresi, U; Tummarello, D	1
Epstein, RJ; Smith, PJ	2
Burton, GV; Cox, EB; Hart, LL; Iglehart, JD; Leight, GS; McCarty, KS	1
Bleehen, NM; Epstein, RJ; Smith, PJ; Waters, C; Watson, JV	1
Politi, PM; Sinha, BK	1
Ajani, JA; Baker, FL; Blaauw, AA; Dicke, KA; Spitzer, G; Thielvoldt, D; Tomasovic, B; Umbach, G; Zander, AR	1
Burton, GV; Cox, EB; Olsen, GA; Vugrin, D	1
Cowan, KH; Hill, BT; Hosking, LK; Townsend, AJ; Whelan, RD	1
Achterrath, W; Meyer, D; Nagel, GA; Rauschning, W; Wander, HE	1
Eliot, HM; Kalayanaraman, B; Sinha, BK	1
Creagan, ET; Kovach, JS; Richardson, RL	1
Dusre, L; Haim, N; Kerrigan, D; Pommier, Y; Sinha, BK	1
Kobayasi, S; Nakagawa, M; Sasamoto, H; Seki, T; Tsuruta, A; Yamaji, T	1
Peters, W; Souhami, R	1
Fletcher, WS; Green, JB; Green, SJ; Grozea, PN; Metch, B; O'Bryan, R; Oishi, N; Reed, M; Vaughn, CB	1
Fujii, T; Kurihara, T; Owada, S; Teshigawara, O	1
Buzdar, AU; Fraschini, G; Holmes, FA; Hortobagyi, GN; Hug, V; Jabboury, K; Kau, SW; Theriault, RL	1
Calciati, A; Donadio, M; Ferrati, P; Giaccone, G	1
Bleehen, NM; Epstein, RJ; Smith, PJ; Watson, JV	1
Athanassiades, P; Bacoyiannes, H; Kontoyiannes, D	1
Belsanti, V; Bisagni, G; Buzzi, F; Ceci, G; Cocconi, G; Di Costanzo, F; Tonato, M	1

Reviews

19 review(s) available for etoposide and Breast Neoplasms

Article	Year
Metastatic Small Cell Carcinoma of a Male Breast: A Case Report and Review of the Literature. The Gulf journal of oncology, 2023, Volume: 1, Issue:42 Topics: Breast Neoplasms; Carcinoma, Neuroendocrine; Carcinoma, Small Cell; Etoposide; Humans; Male; Middle Aged; Prognosis	2023
Metaplastic carcinoma of the breast. Archives of pathology & laboratory medicine, 2015, Volume: 139, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast; Breast Neoplasms; Chemoradiotherapy; Etoposide; Female; Humans; Ifosfamide; Metaplasia; Prognosis	2015
Durable Response of Leptomeningeal Metastasis of Breast Cancer to Salvage Intrathecal Etoposide After Methotrexate: A Case Report and Literature Review. The American journal of case reports, 2015, Aug-10, Volume: 16 Topics: Adult; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Ductal, Breast; Etoposide; Female; Humans; Injections, Spinal; Meningeal Neoplasms; Methotrexate; Salvage Therapy	2015
[Primary breast diffuse large B-cell lymphoma-report of 21 cases from China with literatures review]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2015, Volume: 36, Issue:10 Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; China; Cisplatin; Cyclophosphamide; Dexamethasone; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Neoplasm Recurrence, Local; Prednisone; Prognosis; Retrospective Studies; Rituximab; Vincristine	2015
Primary neuroendocrine carcinoma of the breast A single Center experience and review of the literature. Annali italiani di chirurgia, 2016, Nov-28, Volume: 87 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Neuroendocrine; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Estrogens; Etoposide; Female; Humans; Mastectomy; Middle Aged; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Progesterone; Radiotherapy, Adjuvant; Radiotherapy, High-Energy; Receptors, Steroid; Retrospective Studies; Sentinel Lymph Node Biopsy; Tamoxifen	2016
Chemotherapy for breast cancer brain metastases. Onkologie, 2002, Volume: 25, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Etoposide; Female; Fluorouracil; Humans; Methotrexate; Survival Rate; Treatment Outcome	2002
Ifosfamide in advanced/disseminated breast cancer. Oncology, 2003, Volume: 65 Suppl 2 Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Etoposide; Female; Humans; Ifosfamide; Neoplasm Staging; Paclitaxel; Treatment Outcome; Vinblastine; Vinorelbine	2003
[Treatment strategy to obtain cure for recurrent advanced breast cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21 Suppl 2 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Carboplatin; Carmustine; Chemotherapy, Adjuvant; Cyclophosphamide; Drug Administration Schedule; Epirubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Neoplasm Recurrence, Local; Thiotepa	1994
High dose versus standard dose chemotherapy for the treatment of breast cancer. A review of current concepts. Annals of the New York Academy of Sciences, 1995, Dec-29, Volume: 770 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Busulfan; Carboplatin; Cyclophosphamide; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Middle Aged; Mitoxantrone; Neoplasm Metastasis; Paclitaxel; Taxoids; Thiotepa	1995
Phase II study of oral etoposide for patients with advanced breast cancer. Cancer, 1995, Dec-15, Volume: 76, Issue:12 Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Disease Progression; Etoposide; Female; Humans; Middle Aged; Treatment Outcome	1995
Defining the role of novel high-dose chemotherapy regimens for the treatment of high-risk breast cancer. Seminars in oncology, 1998, Volume: 25, Issue:2 Suppl 4 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Clinical Trials as Topic; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Mitoxantrone; Neoplasm Staging; Paclitaxel; Taxoids; Thiotepa	1998
Cancer chemotherapy in the elderly. Japanese journal of clinical oncology, 1998, Volume: 28, Issue:8 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aging; Anthraquinones; Antineoplastic Agents; Breast Neoplasms; Busulfan; Daunorubicin; Doxorubicin; Etoposide; Female; Fluorouracil; Heart; Hematologic Neoplasms; Humans; Lung; Male; Middle Aged; Neoplasms; Pyrazoles	1998
21-day oral etoposide for metastatic breast cancer: a phase II study and review of the literature. American journal of clinical oncology, 2000, Volume: 23, Issue:3 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Etoposide; Female; Humans; Middle Aged	2000
Platinum compounds in the treatment of advanced breast cancer. Clinical breast cancer, 2001, Volume: 2, Issue:3 Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Female; Fluorouracil; Humans; Mastectomy; Neoadjuvant Therapy; Neoplasm Metastasis; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Preoperative Care; Severity of Illness Index; Treatment Outcome; Vinblastine; Vinorelbine	2001
Phyllodes tumors of the breast. Current treatment options in oncology, 2001, Volume: 2, Issue:2 Topics: Antineoplastic Agents; Breast Neoplasms; Cisplatin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Mastectomy; Mastectomy, Segmental; Phyllodes Tumor; Practice Guidelines as Topic; Prognosis	2001
Role of etoposide in treatment of breast cancer. Seminars in oncology, 1992, Volume: 19, Issue:6 Suppl 13 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Etoposide; Humans	1992
Cytotoxic treatment of metastatic breast cancer. Which drugs and drug combinations to use? Acta oncologica (Stockholm, Sweden), 1992, Volume: 31, Issue:2 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Epirubicin; Etoposide; Female; Fluorouracil; Humans; Melphalan; Methotrexate; Mitomycin; Mitoxantrone; Neoplasm Metastasis; Vincristine	1992
Etoposide in the management of metastatic breast cancer. Cancer, 1991, Jan-01, Volume: 67, Issue:1 Suppl Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Evaluation; Etoposide; Humans	1991
High dose chemotherapy in solid tumours in adults. Clinics in haematology, 1986, Volume: 15, Issue:1 Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Transplantation; Breast Neoplasms; Carcinoma, Small Cell; Carmustine; Cell Separation; Cisplatin; Colonic Neoplasms; Cyclophosphamide; Etoposide; Glioma; Humans; Lung Neoplasms; Male; Melanoma; Melphalan; Neoplasms; Testicular Neoplasms; Whole-Body Irradiation	1986

Trials

111 trial(s) available for etoposide and Breast Neoplasms

Article	Year
A Phase II Study of Irinotecan and Etoposide as Treatment for Refractory Metastatic Breast Cancer. The oncologist, 2019, Volume: 24, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Etoposide; Female; Humans; Irinotecan; Middle Aged; Neoplasm Metastasis; Topoisomerase I Inhibitors	2019
Superior outcome after neoadjuvant chemotherapy with docetaxel, anthracycline, and cyclophosphamide versus docetaxel plus cyclophosphamide: results from the NATT trial in triple negative or HER2 positive breast cancer. Breast cancer research and treatment, 2013, Volume: 142, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Docetaxel; Etoposide; Female; Humans; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Receptor, ErbB-2; Taxoids; Treatment Outcome; Triple Negative Breast Neoplasms	2013
Bevacizumab preconditioning followed by Etoposide and Cisplatin is highly effective in treating brain metastases of breast cancer progressing from whole-brain radiotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research, 2015, Apr-15, Volume: 21, Issue:8 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Biomarkers, Tumor; Brain Neoplasms; Breast Neoplasms; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Female; Humans; Middle Aged; Radiotherapy; Treatment Outcome	2015
A pilot study of bevacizumab combined with etoposide and cisplatin in breast cancer patients with leptomeningeal carcinomatosis. BMC cancer, 2015, Apr-17, Volume: 15 Topics: Adult; Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Breast Neoplasms; Cisplatin; Etoposide; Female; Humans; Meningeal Carcinomatosis; Mice; Middle Aged; Neoplasm Staging	2015
Efficacy of oral Etoposide in pretreated metastatic breast cancer: a multicenter phase 2 study. Medicine, 2015, Volume: 94, Issue:17 Topics: Administration, Oral; Adult; Aged; Anthracyclines; Breast Neoplasms; China; Disease Progression; Etoposide; Female; Humans; Middle Aged; Salvage Therapy; Survival Rate; Taxoids; Treatment Outcome	2015
A pilot study to determine the timing and effect of bevacizumab on vascular normalization of metastatic brain tumors in breast cancer. BMC cancer, 2016, 07-13, Volume: 16 Topics: Adult; Aged; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Brain Neoplasms; Breast Neoplasms; Cisplatin; Contrast Media; Drug Administration Schedule; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Pilot Projects; Prospective Studies; Time Factors; Treatment Outcome	2016
Strategies to improve long-term outcome in stage IIIB inflammatory breast cancer: multimodality treatment including dose-intensive induction and high-dose chemotherapy. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2009, Volume: 15, Issue:8 Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Combined Modality Therapy; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Inflammation; Melphalan; Middle Aged; Remission Induction; Survival Analysis; Treatment Outcome	2009
Preoperative weekly cisplatin, epirubicin, and paclitaxel (PET) improves prognosis in locally advanced breast cancer patients: an update of the Southern Italy Cooperative Oncology Group (SICOG) randomised trial 9908. Annals of oncology : official journal of the European Society for Medical Oncology, 2010, Volume: 21, Issue:4 Topics: Adult; Aged; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Cisplatin; Combined Modality Therapy; Disease Progression; Drug Administration Schedule; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Italy; Middle Aged; Paclitaxel; Preoperative Care; Taxoids	2010
Effect of ginger on acute and delayed chemotherapy-induced nausea and vomiting: a pilot, randomized, open-label clinical trial. Integrative cancer therapies, 2012, Volume: 11, Issue:3 Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dexamethasone; Drug Therapy, Combination; Etoposide; Female; Granisetron; Humans; Middle Aged; Nausea; Pilot Projects; Prevalence; Severity of Illness Index; Taxoids; Time Factors; Vomiting; Zingiber officinale	2012
Oral etoposide monotherapy is effective for metastatic breast cancer with heavy prior therapy. Chinese medical journal, 2012, Volume: 125, Issue:5 Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Breast Neoplasms; Drug Administration Schedule; Etoposide; Female; Humans; Middle Aged; Young Adult	2012
Pharmacokinetics of intravenous etoposide in patients with breast cancer: influence of dose escalation and cyclophosphamide and doxorubicin coadministration. Naunyn-Schmiedeberg's archives of pharmacology, 2002, Volume: 366, Issue:3 Topics: Adult; Antineoplastic Agents; Area Under Curve; Breast Neoplasms; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Drug Interactions; Etoposide; Female; Humans; Injections, Intravenous; Middle Aged	2002
Phase I trial of uracil-ftorafur, leucovorin, and etoposide: an active all-oral regimen for metastatic breast cancer. Breast cancer research and treatment, 2003, Volume: 82, Issue:1 Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cohort Studies; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Leucovorin; Maximum Tolerated Dose; Middle Aged; Tegafur; Uracil	2003
Therapy-related myelodysplasia and leukemia occur infrequently following VP-16 priming and autotransplantation without total body irradiation. Bone marrow transplantation, 2004, Volume: 34, Issue:1 Topics: Adolescent; Adult; Aged; Breast Neoplasms; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Humans; Incidence; Leukemia; Lymphoma; Male; Middle Aged; Neoplasms, Second Primary; Neural Tube Defects; Peripheral Blood Stem Cell Transplantation; Probability; Transplantation, Autologous	2004
Up-front tandem high-dose chemotherapy compared with standard chemotherapy with doxorubicin and paclitaxel in metastatic breast cancer: results of a randomized trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Jan-20, Volume: 23, Issue:3 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Disease Progression; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Humans; Infusions, Intravenous; Middle Aged; Mitoxantrone; Paclitaxel; Peripheral Blood Stem Cell Transplantation; Quality of Life; Survival Analysis; Treatment Outcome	2005
Cisplatin plus oral etoposide (EoP) combination is more effective than paclitaxel in patients with advanced breast cancer pretreated with anthracyclines: a randomised phase III trial of Turkish Oncology Group. British journal of cancer, 2005, Feb-28, Volume: 92, Issue:4 Topics: Administration, Oral; Adult; Aged; Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Humans; Infusions, Intravenous; Middle Aged; Paclitaxel; Survival Analysis; Treatment Outcome; Turkey	2005
High-dose chemotherapy and autologous stem cell rescue for metastatic breast cancer: superior survival for tandem compared with single transplants. American journal of clinical oncology, 2005, Volume: 28, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carboplatin; Cohort Studies; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Liver Neoplasms; Lung Neoplasms; Middle Aged; Mitoxantrone; Organ Specificity; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Survival Analysis; Thiotepa; Transplantation, Autologous; Treatment Outcome	2005
Randomized trial of high-dose chemotherapy and autologous hematopoietic stem cell support for high-risk primary breast carcinoma: follow-up at 12 years. Cancer, 2006, Jun-01, Volume: 106, Issue:11 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Middle Aged; Neoadjuvant Therapy; Survival Rate; Transplantation, Autologous; Treatment Outcome	2006
Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in the treatment of cerebral metastasis. Cancer, 2007, Feb-15, Volume: 109, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Brain Neoplasms; Breast Neoplasms; Carboplatin; Cyclophosphamide; Etoposide; Female; Humans; Infusions, Intra-Arterial; Lung Neoplasms; Lymphoma; Male; Methotrexate; Middle Aged; Osmosis; Ovarian Neoplasms; Prospective Studies; Survival Rate	2007
Dose-dense primary chemotherapy, as part of multidisciplinary treatment, for inoperable stage III B breast cancer--long-term results of a phase II trial. Oncology, 2007, Volume: 72, Issue:1-2 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Combined Modality Therapy; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Mastectomy; Mastectomy, Segmental; Middle Aged; Treatment Outcome	2007
VP-16-213 (etoposide): the mandrake root from Issyk-Kul. The American journal of medicine, 1982, Volume: 72, Issue:1 Topics: Animals; Breast Neoplasms; Carcinoma, Small Cell; Cell Cycle; Chemical Phenomena; Chemistry; Clinical Trials as Topic; Dysgerminoma; Etoposide; Female; Humans; Leukemia; Lung Neoplasms; Lymphoma; Mice; Podophyllotoxin	1982
Doxorubicin plus VP-16-213 for the treatment of refractory breast carcinoma. American journal of clinical oncology, 1982, Volume: 5, Issue:5 Topics: Adult; Aged; Breast Neoplasms; Clinical Trials as Topic; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Humans; Infusions, Parenteral; Leukopenia; Middle Aged; Podophyllotoxin; Thrombocytopenia	1982
[Randomized phase II study with VP-16-213 (etoposide) in the treatment of advanced breast cancer]. Onkologie, 1981, Volume: 4, Issue:2 Topics: Administration, Oral; Breast Neoplasms; Drug Evaluation; Etoposide; Female; Humans; Injections, Intravenous; Middle Aged; Podophyllotoxin; Prognosis; Random Allocation	1981
An evaluation of two schedules of VP-16 and adriamycin in patients with advanced breast cancer. Oncology, 1980, Volume: 37, Issue:3 Topics: Bone Marrow; Breast Neoplasms; Cardiomyopathies; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Etoposide; Female; Humans; Male; Podophyllotoxin; Remission, Spontaneous; Time Factors	1980
Maturation of mobilized peripheral blood progenitor cells: preclinical and phase I clinical studies. Journal of hematotherapy, 1995, Volume: 4, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Cell Differentiation; Cell Division; Colony-Forming Units Assay; Cryopreservation; Culture Techniques; Cyclophosphamide; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Growth Substances; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Interleukin-3; Leukapheresis; Neoplasms; Neutropenia; Thiotepa	1995
Pharmacokinetics and pharmacodynamics of prolonged oral etoposide in women with metastatic breast cancer. Cancer chemotherapy and pharmacology, 1995, Volume: 37, Issue:1-2 Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents, Phytogenic; Bone Marrow; Breast Neoplasms; Etoposide; Female; Humans; Middle Aged; Neoplasm Metastasis	1995
High-dose doxorubicin, etoposide, and cyclophosphamide with stem cell reinfusion in patients with metastatic or high-risk primary breast cancer. City of Hope Bone Marrow Oncology Team. Cancer, 1994, Mar-15, Volume: 73, Issue:6 Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Cyclophosphamide; Diarrhea; Doxorubicin; Etoposide; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Middle Aged; Remission Induction; Risk Factors; Sepsis; Stem Cell Transplantation; Stroke Volume; Survival Rate; Transplantation, Autologous	1994
Positively selected autologous blood CD34+ cells and unseparated peripheral blood progenitor cells mediate identical hematopoietic engraftment after high-dose VP16, ifosfamide, carboplatin, and epirubicin. Blood, 1994, Sep-01, Volume: 84, Issue:5 Topics: Adult; Antigens, CD; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bleomycin; Blood Transfusion, Autologous; Breast Neoplasms; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Epirubicin; Etoposide; Feasibility Studies; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neoplasms; Predictive Value of Tests; Vincristine	1994
High-dose chemotherapy with hematopoietic rescue as primary treatment for metastatic breast cancer: a randomized trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:10 Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Bone Neoplasms; Breast Neoplasms; Combined Modality Therapy; Confidence Intervals; Cyclophosphamide; Drug Administration Schedule; Etoposide; Female; Heart Diseases; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Length of Stay; Mitoxantrone; Neutropenia; Pilot Projects; Platelet Count; Remission Induction; Survival Rate; Vincristine	1995
Ifosfamide/carboplatin/etoposide chemotherapy for metastatic breast cancer with or without autologous hematopoietic stem cell transplantation: evaluation of dose-response relationships. Seminars in oncology, 1995, Volume: 22, Issue:3 Suppl 7 Topics: Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Combined Modality Therapy; Dose-Response Relationship, Drug; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Neoplasm Metastasis; Neoplasm Recurrence, Local; Survival Analysis	1995
Phase I study of escalating doses of paclitaxel (Taxol) with fixed doses of ifosfamide, carboplatin, and etoposide. Seminars in oncology, 1995, Volume: 22, Issue:3 Suppl 7 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Carcinoma, Adenoid Cystic; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Remission Induction; Sarcoma	1995
Tandem autotransplantation for the treatment of metastatic breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:8 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Diarrhea; Disease-Free Survival; Etoposide; Feasibility Studies; Female; Humans; Middle Aged; Mouth Mucosa; Neoplasm Metastasis; Remission Induction; Stomatitis; Transplantation, Autologous	1995
Second-line chemotherapy with long-term low-dose oral etoposide in patients with advanced breast cancer. Breast cancer research and treatment, 1995, Volume: 34, Issue:2 Topics: Administration, Oral; Adult; Aged; Breast Neoplasms; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Humans; Middle Aged; Neoplasm Metastasis	1995
Phase II study of carboplatin and etoposide as a first line regimen in patients with metastatic breast cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 1994, Volume: 5, Issue:9 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Disease-Free Survival; Etoposide; Female; Humans; Middle Aged; Neoplasm Metastasis; Survival Rate; Treatment Outcome	1994
Four-step high-dose sequential chemotherapy with double hematopoietic progenitor-cell rescue for metastatic breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:4 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Feasibility Studies; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Melphalan; Methotrexate; Middle Aged; Mitoxantrone; Neoplasm Metastasis; Neutropenia; Remission Induction; Thrombocytopenia; Vincristine	1995
Effect of low-dose prophylactic dopamine on high-dose cisplatin-induced electrolyte wasting, ototoxicity, and epidermal growth factor excretion: a randomized, placebo-controlled, double-blind trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:5 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Creatinine; Cyclophosphamide; Dopamine; Double-Blind Method; Electrolytes; Epidermal Growth Factor; Etoposide; Female; Hearing Loss; Humans; Kidney Diseases; Male; Middle Aged; Prospective Studies; Sarcoma; Soft Tissue Neoplasms; Water-Electrolyte Imbalance	1995
CMF vs alternating CMF/EV in the adjuvant treatment of operable breast cancer. A single centre randomised clinical trial (Naples GUN-3 study). British journal of cancer, 1995, Volume: 71, Issue:6 Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Multivariate Analysis; Neoplasm Staging; Survival Rate; Vindesine	1995
Maximum-tolerated doses of ifosfamide, carboplatin, and etoposide given over 6 days followed by autologous stem-cell rescue: toxicity profile. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:2 Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Drug Tolerance; Etoposide; Female; Germinoma; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Ifosfamide; Leukemia; Lymphoma, Non-Hodgkin; Male; Middle Aged; Ovarian Neoplasms; Prognosis; Sarcoma; Testicular Neoplasms; Transplantation, Autologous	1995
Intensive dose ifosfamide, carboplatin, and etoposide followed by autologous stem cell rescue: results of a phase I/II study in breast cancer patients. Surgical oncology, 1993, Volume: 2, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Carboplatin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Middle Aged; Neoplasm Staging; Nervous System Diseases; Remission Induction; Survival Rate; Treatment Outcome	1993
Phase II study of 4-epirubicin, etoposide and cisplatin as neoadjuvant chemotherapy in locally advanced breast cancer. European journal of cancer (Oxford, England : 1990), 1994, Volume: 30A, Issue:6 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Epirubicin; Etoposide; Female; Humans; Mastectomy; Middle Aged	1994
Vincristine with high-dose etoposide in advanced breast cancer: a phase II trial of the Piedmont Oncology Association. Cancer chemotherapy and pharmacology, 1994, Volume: 35, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Middle Aged; Vincristine	1994
Beneficial impact of peripheral blood progenitor cells in patients with metastatic breast cancer treated with high-dose chemotherapy plus granulocyte-macrophage colony-stimulating factor. A randomized trial. Cancer, 1993, Apr-15, Volume: 71, Issue:8 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Middle Aged; Neutropenia; Thrombocytopenia	1993
Chronic oral etoposide in advanced breast cancer. Cancer chemotherapy and pharmacology, 1994, Volume: 33, Issue:6 Topics: Administration, Oral; Adult; Aged; Breast Neoplasms; Drug Administration Schedule; Etoposide; Female; Humans; Middle Aged	1994
Factors predicting long-term survival for metastatic breast cancer patients treated with high-dose chemotherapy and bone marrow support. Cancer, 1994, Apr-15, Volume: 73, Issue:8 Topics: Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Etoposide; Female; Follow-Up Studies; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Neoplasms, Hormone-Dependent; Prognosis; Proportional Hazards Models; Receptors, Estrogen; Risk Factors	1994
Clinical activity of chronic oral etoposide in previously treated metastatic breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1994, Volume: 12, Issue:5 Topics: Administration, Oral; Adult; Aged; Breast Neoplasms; Drug Administration Schedule; Etoposide; Female; Humans; Middle Aged; Neoplasm Metastasis	1994
Two novel high-dose treatment regimens for metastatic breast cancer--ifosfamide, carboplatin, plus etoposide and mitoxantrone plus thiotepa: outcomes and toxicities. Seminars in oncology, 1993, Volume: 20, Issue:5 Suppl 6 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Immunotherapy; Middle Aged; Mitoxantrone; Neoplasm Metastasis; Stem Cell Transplantation; Survival Analysis; Thiotepa	1993
Long-term oral etoposide in metastatic breast cancer: clinical and pharmacokinetic results. Cancer treatment reviews, 1993, Volume: 19 Suppl C Topics: Administration, Oral; Adult; Aged; Breast Neoplasms; Etoposide; Female; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local	1993
Preliminary results of a phase II trial of chronic oral etoposide in breast cancer. Cancer treatment reviews, 1993, Volume: 19 Suppl C Topics: Administration, Oral; Adult; Aged; Breast Neoplasms; Etoposide; Female; Humans; Middle Aged; Neoplasm Metastasis	1993
Phase II evaluation of carboplatin and VP-16 for patients with metastatic breast cancer and only one prior chemotherapy regimen. Cancer, 1993, Aug-01, Volume: 72, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Etoposide; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Salvage Therapy; Thoracic Neoplasms; Treatment Outcome	1993
Pilot study of high dose ICE (ifosfamide, carboplatin, etoposide) chemotherapy and autologous bone marrow transplant (ABMT) with neoR-transduced bone marrow and peripheral blood stem cells in patients with metastatic breast cancer. Human gene therapy, 1993, Volume: 4, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Cisplatin; Clinical Protocols; Combined Modality Therapy; Drug Resistance; Etoposide; Genetic Therapy; Genetic Vectors; Humans; Ifosfamide; Neomycin; Pilot Projects; Retroviridae; Stem Cell Transplantation; Transduction, Genetic; Transplantation, Autologous	1993
A phase II study of etoposide, cisplatin plus methotrexate in patients with advanced refractory breast cancer. European journal of cancer (Oxford, England : 1990), 1993, Volume: 29A, Issue:9 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Etoposide; Female; Humans; Methotrexate; Middle Aged; Salvage Therapy	1993
Phase II trial of carboplatin and etoposide in metastatic breast cancer. Cancer, 1993, Feb-15, Volume: 71, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carboplatin; Etoposide; Female; Humans; Injections, Intravenous; Liver; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Remission Induction; Survival Rate	1993
Randomized placebo-controlled trial of granulocyte-macrophage colony-stimulating-factor support for dose-intensive cyclophosphamide, etoposide, and cisplatin. American journal of hematology, 1996, Volume: 51, Issue:4 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Blood Transfusion; Breast Neoplasms; Cisplatin; Cyclophosphamide; Double-Blind Method; Etoposide; Female; Gastrointestinal Diseases; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Immunologic Factors; Length of Stay; Leukocyte Count; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia; Platelet Count; Thrombocytopenia; Treatment Outcome	1996
Concurrent 72-hour continuous infusion of etoposide and cisplatin in metastatic breast cancer. American journal of clinical oncology, 1996, Volume: 19, Issue:2 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Confidence Intervals; Etoposide; Female; Humans; Infusions, Intravenous; Middle Aged; Nausea; Neutropenia; Remission Induction; Survival Rate; Thrombocytopenia; Vomiting	1996
Phase II study of oral etoposide for patients with advanced breast cancer. Cancer, 1995, Dec-15, Volume: 76, Issue:12 Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Disease Progression; Etoposide; Female; Humans; Middle Aged; Treatment Outcome	1995
Selection and expansion of peripheral blood CD34+ cells in autologous stem cell transplantation for breast cancer. Blood, 1996, Mar-01, Volume: 87, Issue:5 Topics: Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Cell Culture Techniques; Cells, Cultured; Combined Modality Therapy; Culture Media; Cyclophosphamide; Doxorubicin; Etoposide; Feasibility Studies; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Immunomagnetic Separation; Leukapheresis; Lewis X Antigen; Melphalan; Middle Aged; Neutropenia; Tamoxifen; Thiotepa; Thrombocytopenia	1996
Comparison of four cytokine regimens for mobilization of peripheral blood stem cells: IL-3 alone and combined with GM-CSF or G-CSF. Bone marrow transplantation, 1996, Volume: 17, Issue:2 Topics: Adult; Bone Marrow; Breast Neoplasms; Busulfan; Carboplatin; Carmustine; Cyclophosphamide; Drug Administration Schedule; Drug Synergism; Etoposide; Female; Graft Survival; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Interleukin-3; Leukapheresis; Leukemia; Leukocyte Count; Lymphoma; Male; Middle Aged; Neutrophils; Prospective Studies; Thiotepa; Whole-Body Irradiation	1996
Analysis of dose-response relationships in the setting of high-dose ifosfamide, carboplatin, and etoposide and autologous hematopoietic stem cell transplantation: implications for the treatment of patients with advanced breast cancer. Seminars in oncology, 1996, Volume: 23, Issue:3 Suppl 6 Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Carboplatin; Carcinoma; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Retrospective Studies; Survival Rate; Transplantation, Autologous	1996
Impaired stem cell collection by consecutive courses of high-dose mobilizing chemotherapy using cyclophosphamide, etoposide, and G-CSF. Journal of hematotherapy, 1996, Volume: 5, Issue:3 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Middle Aged; Stem Cells; Transplantation Conditioning	1996
Daily oral etoposide in metastatic breast cancer. Anti-cancer drugs, 1996, Volume: 7, Issue:5 Topics: Adult; Aged; Agranulocytosis; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Etoposide; Female; Humans; Middle Aged; Neoplasm Metastasis	1996
Phase II trial of tamoxifen, etoposide, mitoxantrone, and cisplatin in patients with metastatic breast carcinoma. Cancer, 1996, Nov-01, Volume: 78, Issue:9 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Etoposide; Female; Humans; Middle Aged; Mitoxantrone; Tamoxifen	1996
Experience of Oncopaz Cooperative Group with oral fluoropyrimidines in tumors of the stomach, lung, head and neck, and breast. Oncology, 1997, Volume: 54 Suppl 1 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Drug Combinations; Etoposide; Head and Neck Neoplasms; Humans; Leucovorin; Lung Neoplasms; Middle Aged; Stomach Neoplasms; Tegafur; Uracil	1997
High-dose chemotherapy supported by peripheral blood progenitor cells in poor prognosis metastatic breast cancer--phase I/II study. Edinburgh Breast Group. British journal of cancer, 1996, Volume: 74, Issue:12 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Central Nervous System Neoplasms; Chi-Square Distribution; Confidence Intervals; Diarrhea; Disease-Free Survival; Etoposide; Female; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Herpes Zoster; Humans; Liver Neoplasms; Lung Neoplasms; Melphalan; Middle Aged; Neoplasm Staging; Survival Rate; Thiotepa; Treatment Outcome	1996
Results of MDR-1 vector modification trial indicate that granulocyte/macrophage colony-forming unit cells do not contribute to posttransplant hematopoietic recovery following intensive systemic therapy. Proceedings of the National Academy of Sciences of the United States of America, 1996, Dec-24, Volume: 93, Issue:26 Topics: Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Base Sequence; Bone Marrow; Bone Marrow Transplantation; Breast Neoplasms; Colony-Forming Units Assay; Cyclophosphamide; DNA Primers; Etoposide; Female; Genetic Therapy; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Ovarian Neoplasms; Polymerase Chain Reaction	1996
High-dose carboplatin, etoposide and melphalan (CEM) with peripheral blood progenitor cell support as late intensification for high-risk cancer: non-haematological, haematological toxicities and role of growth factor administration. British journal of cancer, 1997, Volume: 75, Issue:8 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Erythropoietin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Hematopoietic System; Humans; Length of Stay; Melphalan; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Recombinant Proteins; Survival Rate	1997
Activity of standard-dose carboplatin, cyclophosphamide, and etoposide in patients with metastatic breast cancer with previous exposure to anthracyclines. American journal of clinical oncology, 1997, Volume: 20, Issue:2 Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Carcinoma, Ductal, Breast; Cyclophosphamide; Etoposide; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Retreatment; Survival Rate	1997
Optimization of chemotherapy administration for clinical 41.8 degrees C whole body hyperthermia. Cancer letters, 1997, May-19, Volume: 115, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Body Temperature; Breast Neoplasms; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Cross-Over Studies; Drug Administration Schedule; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Hyperthermia, Induced; Ifosfamide; Lung Neoplasms; Male; Neutropenia; Platelet Count; Sarcoma	1997
Standard-dose recombinant human granulocyte colony-stimulating factor (rhG-CSF) allows safe and repeated administration of high-dose cyclophosphamide, etoposide, and cisplatin (CEP). American journal of clinical oncology, 1997, Volume: 20, Issue:3 Topics: Adjuvants, Immunologic; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Cyclophosphamide; Drug Administration Schedule; Etoposide; Feasibility Studies; Female; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Mediastinal Neoplasms; Middle Aged; Recombinant Proteins; Remission Induction	1997
A novel high-dose chemotherapy protocol with autologous hematopoietic rescue in patients with metastatic breast cancer or recurrent non-Hodgkin's lymphoma. Bone marrow transplantation, 1997, Volume: 19, Issue:10 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Carboplatin; Cyclophosphamide; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Recurrence; Thiotepa; Transplantation, Autologous	1997
Carboplatin plus etoposide regimen in advanced breast cancer. A phase II study. European journal of gynaecological oncology, 1997, Volume: 18, Issue:3 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Drug Administration Schedule; Etoposide; Female; Humans; Injections, Intravenous; Lymphatic Metastasis; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Survival Rate; Treatment Outcome	1997
Phase II study of high-dose cyclophosphamide, etoposide, and carboplatin (CEC) followed by autologous hematopoietic stem cell rescue in women with metastatic or high-risk non-metastatic breast cancer: multivariate analysis of factors affecting survival an Bone marrow transplantation, 1997, Volume: 20, Issue:4 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Breast Neoplasms; Carboplatin; Cyclophosphamide; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Middle Aged; Multivariate Analysis; Neoplasm Metastasis; Survival Rate; Transplantation, Autologous	1997
Collection of peripheral blood progenitor cells after the administration of cyclophosphamide, etoposide, and granulocyte-colony-stimulating factor: an analysis of 497 patients. Transfusion, 1997, Volume: 37, Issue:9 Topics: Adolescent; Adult; Aged; Antigens, CD34; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Blood Component Removal; Breast Neoplasms; Cyclophosphamide; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cells; Humans; Male; Middle Aged; Multivariate Analysis; Specimen Handling	1997
A randomized phase II study of BB-10010: a variant of human macrophage inflammatory protein-1alpha for patients receiving high-dose etoposide and cyclophosphamide for malignant lymphoma and breast cancer. British journal of haematology, 1997, Volume: 99, Issue:4 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemokine CCL3; Chemokine CCL4; Cyclophosphamide; Etoposide; Female; Growth Inhibitors; Hematopoiesis; Hematopoietic Stem Cells; Humans; Lymphoma, Non-Hodgkin; Macrophage Inflammatory Proteins; Male; Middle Aged; Platelet Count; Stomatitis	1997
Refractory breast cancer: a comparison of two different chemotherapy regimens. Journal of chemotherapy (Florence, Italy), 1997, Volume: 9, Issue:6 Topics: Administration, Oral; Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Etoposide; Female; Fluorouracil; Humans; Injections, Intravenous; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Remission Induction; Turkey	1997
A randomized trial of two doses of cyclophosphamide with etoposide and G-CSF for mobilization of peripheral blood stem cells in 318 patients with stage II-III breast cancer. Journal of hematotherapy, 1998, Volume: 7, Issue:2 Topics: Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dose-Response Relationship, Drug; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Humans; Leukocytes, Mononuclear; Middle Aged; Neoplasm Staging; Prospective Studies; Treatment Outcome	1998
[Results of clinical study with epirubicin hydrochloride injectable solution and cyclophosphamide in breast cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:11 Topics: Administration, Oral; Adult; Aged; Alopecia; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Drug Administration Schedule; Etoposide; Female; Humans; Infusions, Intravenous; Middle Aged; Nausea; Receptors, Estrogen; Vomiting	1998
Daily oral etoposide in patients with heavily pretreated metastatic breast cancer. American journal of clinical oncology, 1998, Volume: 21, Issue:5 Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Drug Administration Schedule; Etoposide; Female; Humans; Middle Aged; Neoplasm Metastasis; Salvage Therapy	1998
Sequential interleukin-3 and granulocyte-colony stimulating factor prior to and following high-dose etoposide and cyclophosphamide: a phase I/II trial. Clinical cancer research : an official journal of the American Association for Cancer Research, 1997, Volume: 3, Issue:9 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Breast Neoplasms; Cyclophosphamide; Drug Administration Schedule; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cells; Hodgkin Disease; Humans; Interleukin-3; Leukocyte Count; Life Tables; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia; Platelet Count; Premedication; Safety; Thrombocytopenia; Treatment Outcome	1997
[CBDCA, etoposide and epirubicin high-dose combination chemotherapy supported by peripheral blood stem cell transplantation (PBSCT) in metastatic breast cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1999, Volume: 26, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Breast Neoplasms; Carboplatin; Combined Modality Therapy; Drug Administration Schedule; Epirubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lung Neoplasms; Middle Aged; Neoplasm Recurrence, Local	1999
Phase II study of carboplatin and etoposide as salvage treatment for patients with metastatic breast cancer. American journal of clinical oncology, 1999, Volume: 22, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Carcinoma, Ductal, Breast; Etoposide; Female; Humans; Middle Aged; Salvage Therapy; Survival Analysis	1999
Front-line chemotherapy with cisplatin and etoposide for patients with brain metastases from breast carcinoma, nonsmall cell lung carcinoma, or malignant melanoma: a prospective study. Cancer, 1999, Apr-01, Volume: 85, Issue:7 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide; Female; Humans; Lung Neoplasms; Melanoma; Middle Aged; Prospective Studies; Survival Rate	1999
Recombinant human thrombopoietin in combination with granulocyte colony-stimulating factor enhances mobilization of peripheral blood progenitor cells, increases peripheral blood platelet concentration, and accelerates hematopoietic recovery following high Blood, 1999, May-01, Volume: 93, Issue:9 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blood Component Removal; Blood Platelets; Breast Neoplasms; Cisplatin; Cyclophosphamide; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoiesis; Hematopoietic Stem Cells; Humans; Middle Aged; Neoplasm Staging; Platelet Count; Recombinant Proteins; Thrombopoietin	1999
A novel four-drug ablative regimen with hemopoietic stem cell rescue for patients with breast cancer: a phase II study. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 1999, Volume: 5, Issue:2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Middle Aged; Thiotepa; Transplantation, Autologous; Treatment Outcome	1999
Mobilization of peripheral blood progenitor cells in patients with breast cancer: a prospective randomized trial comparing rhG-CSF with the combination of rhG-CSF plus rhEpo after VIP-E chemotherapy. Bone marrow transplantation, 1999, Volume: 24, Issue:1 Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Cyclophosphamide; Epirubicin; Erythropoietin; Etoposide; Female; Fluorouracil; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Methotrexate; Middle Aged; Prospective Studies; Recombinant Proteins; Transplantation Conditioning; Transplantation, Autologous	1999
Three new active cisplatin-containing combinations in the neoadjuvant treatment of locally advanced and locally recurrent breast carcinoma: a randomized phase II trial. Breast cancer research and treatment, 1999, Volume: 56, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Epirubicin; Etoposide; Female; Humans; Leucovorin; Methotrexate; Middle Aged; Mitomycin; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Vincristine	1999
Matched-pair analysis of hematopoietic progenitor cell mobilization using G-CSF vs. cyclophosphamide, etoposide, and G-CSF: enhanced CD34+ cell collections are not necessarily cost-effective. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 1999, Volume: 5, Issue:6 Topics: Adult; Antigens, CD34; Breast Neoplasms; Cost-Benefit Analysis; Cyclophosphamide; Erythrocyte Transfusion; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hospitalization; Humans; Leukapheresis; Matched-Pair Analysis; Middle Aged; Platelet Transfusion	1999
Comparison of CMF (cyclophosphamide, methotrexate, and 5-fluorouracil) with a rotational crossing and a sequential intensification regimen in advanced breast cancer: a prospective randomized study. American journal of clinical oncology, 1999, Volume: 22, Issue:6 Topics: Adenocarcinoma; Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Prospective Studies; Remission Induction; Survival Rate; Treatment Outcome	1999
Ifosfamide, carboplatin and etoposide (ICE) in metastatic and refractory breast cancer. Cancer chemotherapy and pharmacology, 1999, Volume: 44 Suppl Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Ifosfamide; Middle Aged; Neoplasm Metastasis; Safety; Salvage Therapy	1999
Clinical activity of cisplatin and prolonged oral administration of etoposide in previously treated, anthracycline-resistant, metastatic breast cancer patients: a phase II study. Medical and pediatric oncology, 2000, Volume: 34, Issue:1 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Drug Administration Schedule; Drug Resistance; Etoposide; Female; Humans; Middle Aged; Nausea; Neoplasm Metastasis; Nervous System Diseases; Remission Induction; Stomatitis; Time Factors; Treatment Outcome; Vomiting	2000
Dose-intense paclitaxel, etoposide and cyclophosphamide: a safe and active regimen for tumor cytoreduction and stem cell mobilization in metastatic breast cancer. Bone marrow transplantation, 2000, Volume: 25, Issue:2 Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Middle Aged; Multivariate Analysis; Neoplasm Metastasis; Paclitaxel; Remission Induction; Taxoids; Treatment Outcome	2000
A phase II study of two cycles of high-dose chemotherapy with autologous stem cell support in patients with metastatic breast cancer who meet eligibility criteria for a single cycle. Bone marrow transplantation, 2000, Volume: 25, Issue:5 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carboplatin; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Female; Graft Survival; Hematopoietic Stem Cell Transplantation; Humans; Liver Neoplasms; Middle Aged; Mitoxantrone; Platelet Count; Soft Tissue Neoplasms; Survival Rate; Tamoxifen; Thiotepa; Transplantation, Autologous	2000
A phase III study of high-dose intensification without hematopoietic progenitor cells support for patients with high-risk primary breast carcinoma. American journal of clinical oncology, 2000, Volume: 23, Issue:3 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Breast Neoplasms, Male; Carcinoma; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Male; Middle Aged; Risk Factors; Survival Analysis	2000
Effects of three cytokine regimens on hematologic recovery and progenitor cell mobilization after high-dose cyclophosphamide, etoposide, and cisplatin. Oncology, 2000, Volume: 59, Issue:1 Topics: Adenocarcinoma; Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Cyclophosphamide; Cytokines; Drug Administration Schedule; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cells; Humans; Interleukin-3; Leukocyte Count; Middle Aged; Neutropenia; Thrombocytopenia	2000
Long-term results of combined-modality therapy for locally advanced breast cancer with ipsilateral supraclavicular metastases: The University of Texas M.D. Anderson Cancer Center experience. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Feb-01, Volume: 19, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Fluorouracil; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Prednisone; Prospective Studies; Radiography; Survival Analysis; Tamoxifen; Treatment Outcome; Vincristine	2001
Factors determining the actual received dose intensity in a program of multicyclic dose-intensive alternating chemotherapy with sequential stem cell support. Acta haematologica, 2001, Volume: 105, Issue:3 Topics: Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Count; Cisplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Immunomagnetic Separation; Middle Aged; Models, Biological; Ovarian Neoplasms; Paclitaxel; Stem Cells; Time Factors; Transplantation, Autologous; Treatment Outcome	2001
A randomized trial of four cycles of adjuvant AC (adriamycin + cyclophosphamide) +/- two cycles of EP (etoposide + cisplatin) in node positive patients with breast cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 2001, Volume: 12, Issue:7 Topics: Adult; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Lymphatic Metastasis; Middle Aged; Premenopause; Survival Analysis; Treatment Outcome	2001
Multiple cycles of dose-intensive chemotherapy with repeated stem cell support as induction treatment in metastatic breast cancer: a feasibility study. Bone marrow transplantation, 2001, Volume: 28, Issue:3 Topics: Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Feasibility Studies; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Infections; Middle Aged; Neutropenia; Paclitaxel; Remission Induction; Survival Analysis; Treatment Outcome	2001
Population pharmacokinetics and pharmacodynamics of oral etoposide. British journal of clinical pharmacology, 2001, Volume: 52, Issue:5 Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Area Under Curve; Biological Availability; Breast Neoplasms; Creatinine; Cross-Over Studies; Etoposide; Female; Humans; Injections, Intravenous; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Models, Biological; Software; Stomach Neoplasms	2001
Combination of high-dose chemotherapy and monoclonal antibody in breast-cancer patients: a pilot trial to monitor treatment effects on disseminated tumor cells. Cytotherapy, 2000, Volume: 2, Issue:4 Topics: Adult; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Breast Neoplasms; Cisplatin; Creatine Kinase; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Immunotherapy; Middle Aged; Neoplasm Staging; Pilot Projects; Radiotherapy, Adjuvant; Survival Rate	2000
Evaluation of VP-16 and the combination of adriamycin and vincristine in advanced breast cancer. Oncology, 1976, Volume: 33, Issue:3 Topics: Adenocarcinoma; Breast Neoplasms; Cell Division; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Humans; Neoplasm Metastasis; Podophyllotoxin; Remission, Spontaneous; Vincristine	1976
Phase II evaluation of VP-16-213 (NSC-141540) and cytembena (NSC-104801) in patients with advanced breast cancer. Cancer treatment reports, 1976, Volume: 60, Issue:5 Topics: Acrylates; Breast Neoplasms; Drug Therapy, Combination; Etoposide; Female; Humans; Podophyllotoxin	1976
Phase II trial of carboplatin and etoposide activity in pretreated breast cancer patients. American journal of clinical oncology, 1992, Volume: 15, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Drug Evaluation; Etoposide; Female; Humans; Middle Aged	1992
High-dose etoposide in treatment of metastatic breast cancer. Oncology, 1992, Volume: 49, Issue:2 Topics: Breast Neoplasms; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Neoplasm Metastasis	1992
Cisplatin plus VP-16 combination chemotherapy in advanced refractory breast cancer. Journal of surgical oncology, 1992, Volume: 50, Issue:4 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Evaluation; Drug Synergism; Etoposide; Female; Fluorouracil; Humans; Lung Neoplasms; Lymphatic Metastasis; Methotrexate; Middle Aged; Mitomycin; Skin Neoplasms; Time Factors	1992
Use of very-high-dose chemotherapy with autologous bone marrow transplantation in treatment of breast cancer. Journal of the National Cancer Institute, 1992, Jan-15, Volume: 84, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Humans; Transplantation, Autologous	1992
Phase I-II study of high-dose etoposide in patients with refractory breast cancer. Investigational new drugs, 1991, Volume: 9, Issue:4 Topics: Breast Neoplasms; Drug Evaluation; Etoposide; Female; Humans	1991
Continuous infusion 5-fluorouracil with escalating doses of intermittent cisplatin and etoposide. A phase I study. Cancer, 1991, Dec-01, Volume: 68, Issue:11 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Fluorouracil; Gastrointestinal Diseases; Hematologic Diseases; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Stomatitis	1991
Cisplatin and etoposide as first-line chemotherapy for metastatic breast carcinoma: a prospective randomized trial of the Italian Oncology Group for Clinical Research. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1991, Volume: 9, Issue:4 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Cyclophosphamide; Etoposide; Female; Fluorouracil; Humans; Methotrexate; Middle Aged	1991
Treatment of estrogen receptor-negative or hormonally refractory breast cancer with double high-dose chemotherapy intensification and bone marrow support. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1990, Volume: 8, Issue:7 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Drug Administration Schedule; Etoposide; Female; Humans; Middle Aged; Neoplasm Staging; Prognosis; Random Allocation; Receptors, Estrogen	1990
Cisplatin and etoposide: an effective treatment for refractory breast carcinoma. American journal of clinical oncology, 1989, Volume: 12, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Clinical Trials as Topic; Drug Administration Schedule; Etoposide; Female; Humans; Middle Aged; Neoplasm Metastasis	1989
VP-16 + adriamycin vs. adriamycin alone in advanced adenocarcinoma of the breast, phase II, a randomized trial: a Southwest Oncology Group Study. Medical and pediatric oncology, 1988, Volume: 16, Issue:5 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Doxorubicin; Drug Evaluation; Etoposide; Humans; Middle Aged; Random Allocation; Receptors, Estrogen	1988
Etoposide (VP-16-213) and cis-dichlorodiammineplatinum (DDP) in advanced breast carcinoma resistant to previous chemotherapy. Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1986, Volume: 5, Issue:2 Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Etoposide; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Neoplasm Metastasis; Podophyllotoxin; Vincristine	1986

Other Studies

339 other study(ies) available for etoposide and Breast Neoplasms

Article	Year
Synthesis and evaluation of new 6-amino-substituted benzo[c]phenanthridine derivatives. Journal of medicinal chemistry, 1993, Nov-12, Volume: 36, Issue:23 Topics: Adenocarcinoma; Alkaloids; Animals; Antineoplastic Agents; Benzophenanthridines; Breast Neoplasms; Humans; Leukemia L1210; Leukemia P388; Mice; Molecular Structure; Phenanthridines; Structure-Activity Relationship; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Tumor Cells, Cultured	1993
Antitumor polycyclic acridines. 7. Synthesis and biological properties of DNA affinic tetra- and pentacyclic acridines. Journal of medicinal chemistry, 2000, Apr-20, Volume: 43, Issue:8 Topics: Acridines; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Humans; Indoles; Inhibitory Concentration 50; Lung Neoplasms; Microscopy, Fluorescence; Structure-Activity Relationship; Topoisomerase II Inhibitors; Tumor Cells, Cultured	2000
Cytotoxic pheophorbide-related compounds from Clerodendrum calamitosum and C. cyrtophyllum. Journal of natural products, 2001, Volume: 64, Issue:7 Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Camptothecin; Cell Survival; Chlorophyll; Dose-Response Relationship, Drug; Drug Resistance; Etoposide; Female; Humans; Ileal Neoplasms; KB Cells; Kidney Neoplasms; Lung Neoplasms; Magnetic Resonance Spectroscopy; Melanoma; Molecular Structure; Ovarian Neoplasms; Plant Leaves; Plant Stems; Plants, Medicinal; Stereoisomerism; Structure-Activity Relationship; Taiwan; Tumor Cells, Cultured; Vincristine	2001
Cytotoxic oxoisoaporphine alkaloids from Menispermum dauricum. Journal of natural products, 2001, Volume: 64, Issue:7 Topics: Adenocarcinoma; Alkaloids; Animals; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cytochrome P-450 Enzyme Inhibitors; Drugs, Chinese Herbal; Enzyme Inhibitors; Female; Humans; Leukemia; Lung Neoplasms; Magnetic Resonance Spectroscopy; Mass Spectrometry; Mice; Molecular Structure; Plant Roots; Plants, Medicinal; Porphyrins; Tumor Cells, Cultured	2001
Catalytic inhibition of topoisomerase IIalpha by demethylzeylasterone, a 6-oxophenolic triterpenoid from Kokoona zeylanica. Journal of natural products, 2001, Volume: 64, Issue:10 Topics: Antigens, Neoplasm; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Catalysis; DNA; DNA Topoisomerases, Type II; DNA-Binding Proteins; Electrophoresis, Agar Gel; Electrophoretic Mobility Shift Assay; Enzyme Inhibitors; Female; Glioma; Humans; Inhibitory Concentration 50; Lung Neoplasms; Methyl Green; Molecular Structure; Plants, Medicinal; Saccharomyces cerevisiae; Structure-Activity Relationship; Topoisomerase II Inhibitors; Triterpenes; Tumor Cells, Cultured	2001
Synthesis and structure-activity relationship studies on tryprostatin A, an inhibitor of breast cancer resistance protein. Bioorganic & medicinal chemistry, 2008, Apr-15, Volume: 16, Issue:8 Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; DNA Topoisomerases, Type II; Drug Resistance, Neoplasm; Enzyme Inhibitors; Humans; Indole Alkaloids; Molecular Structure; Piperazines; Structure-Activity Relationship; Topoisomerase II Inhibitors; Tubulin	2008
Asymmetrical 2,6-bis(benzylidene)cyclohexanones: Synthesis, cytotoxic activity and QSAR study. European journal of medicinal chemistry, 2012, Volume: 50 Topics: Antineoplastic Agents; Apoptosis; Benzylidene Compounds; Breast Neoplasms; Cell Proliferation; Cyclohexanones; Drug Screening Assays, Antitumor; Female; Humans; Molecular Structure; Neuroblastoma; Quantitative Structure-Activity Relationship; Structure-Activity Relationship; Tumor Cells, Cultured	2012
N⁴-Phenyl-substituted 2-acetylpyridine thiosemicarbazones: cytotoxicity against human tumor cells, structure-activity relationship studies and investigation on the mechanism of action. Bioorganic & medicinal chemistry, 2012, Jun-01, Volume: 20, Issue:11 Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Death; Cell Line, Tumor; Central Nervous System Neoplasms; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Etoposide; Female; Glioblastoma; Glioma; Humans; Inhibitory Concentration 50; Microtubules; Molecular Structure; Structure-Activity Relationship; Thiosemicarbazones; Tubulin; Tumor Suppressor Protein p53	2012
Quinazolino linked 4β-amidopodophyllotoxin conjugates regulate angiogenic pathway and control breast cancer cell proliferation. Bioorganic & medicinal chemistry, 2013, Nov-01, Volume: 21, Issue:21 Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Female; G2 Phase Cell Cycle Checkpoints; Human Umbilical Vein Endothelial Cells; Humans; M Phase Cell Cycle Checkpoints; MCF-7 Cells; Membrane Potential, Mitochondrial; Neovascularization, Physiologic; Podophyllotoxin; Quinazolinones; Signal Transduction	2013
Synthesis of novel ring-A fused hybrids of oleanolic acid with capabilities to arrest cell cycle and induce apoptosis in breast cancer cells. European journal of medicinal chemistry, 2014, Mar-03, Volume: 74 Topics: Apoptosis; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Humans; Magnetic Resonance Spectroscopy; Male; Mass Spectrometry; Oleanolic Acid	2014
Design and synthesis of novel azapeptide activators of apoptosis mediated by caspase-9 in cancer cells. Bioorganic & medicinal chemistry letters, 2014, Aug-01, Volume: 24, Issue:15 Topics: Antineoplastic Agents; Apoptosis; Aza Compounds; Breast Neoplasms; Caspase 9; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Oligopeptides; Structure-Activity Relationship	2014
Effect of chlorine substituent on cytotoxic activities: Design and synthesis of systematically modified 2,4-diphenyl-5H-indeno[1,2-b]pyridines. Bioorganic & medicinal chemistry letters, 2016, Apr-01, Volume: 26, Issue:7 Topics: Antineoplastic Agents; Biphenyl Compounds; Breast; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Drug Design; Female; Halogenation; HeLa Cells; Humans; Indenes; Pyridines; Structure-Activity Relationship; Topoisomerase Inhibitors	2016
Fluorescein hydrazones: A series of novel non-intercalative topoisomerase IIα catalytic inhibitors induce G1 arrest and apoptosis in breast and colon cancer cells. European journal of medicinal chemistry, 2017, Jan-05, Volume: 125 Topics: Animals; Antigens, Neoplasm; Apoptosis; Apoptosis Regulatory Proteins; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; DNA-Binding Proteins; Dose-Response Relationship, Drug; Female; Fluorescein; G1 Phase Cell Cycle Checkpoints; Humans; Hydrazones; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors	2017
Design, synthesis and screening of 1, 2, 4-triazinone derivatives as potential antitumor agents with apoptosis inducing activity on MCF-7 breast cancer cell line. European journal of medicinal chemistry, 2018, Aug-05, Volume: 156 Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Drug Design; Female; Humans; MCF-7 Cells; Topoisomerase II Inhibitors; Triazines; Tubulin; Tubulin Modulators	2018
Discovery and Biological Evaluations of Halogenated 2,4-Diphenyl Indeno[1,2- Journal of medicinal chemistry, 2019, 09-12, Volume: 62, Issue:17 Topics: Animals; Antineoplastic Agents; Biphenyl Compounds; Breast Neoplasms; Cell Proliferation; Cell Survival; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Drug Discovery; Drug Screening Assays, Antitumor; Female; Humans; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred ICR; Microwaves; Molecular Structure; Pyridines; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Topoisomerase II Inhibitors; Tumor Cells, Cultured	2019
Anti-cancer potential of novel glycosylated 1,4-substituted triazolylchalcone derivatives. Bioorganic & medicinal chemistry letters, 2019, 10-01, Volume: 29, Issue:19 Topics: Antineoplastic Agents; Breast Neoplasms; Cell Proliferation; Chalcone; Click Chemistry; Cycloaddition Reaction; Drug Screening Assays, Antitumor; Female; Glycosylation; Humans; Molecular Structure; Structure-Activity Relationship; Triazoles	2019
Antiproliferative activity of diarylnaphthylpyrrolidine derivative via dual target inhibition. European journal of medicinal chemistry, 2020, Feb-15, Volume: 188 Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Drug Screening Assays, Antitumor; Female; G2 Phase Cell Cycle Checkpoints; Humans; Male; Mice; Molecular Docking Simulation; Naphthalenes; Pyrrolidines; Topoisomerase II Inhibitors; Tubulin Modulators	2020
Gamma-Tocotrienol Synergistically Promotes the Anti-proliferative and Pro-apoptotic Effects of Etoposide on Breast Cancer Cell Lines. Current molecular pharmacology, 2022, Volume: 15, Issue:7 Topics: Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Chromans; Etoposide; Female; Humans; MCF-7 Cells; Vitamin E	2022
Etoposide-induced MicroRNA-205-5p Suppresses Proliferation and Migration by Targeting ERBB4 in MCF-7 Cells. Anticancer research, 2022, Volume: 42, Issue:9 Topics: Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Etoposide; Female; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; MicroRNAs; Receptor, ErbB-4	2022
Etoposide in combination with erastin synergistically altered iron homeostasis and induced ferroptotic cell death through regulating IREB2/FPN1 expression in estrogen receptor positive-breast cancer cells. Life sciences, 2023, Jan-01, Volume: 312 Topics: Breast Neoplasms; Cell Death; Etoposide; Female; Glutathione Peroxidase; Homeostasis; Humans; Iron; Lipid Peroxidation; Receptors, Estrogen	2023
The impact of chemotherapy on cognitive function: a multicentre prospective cohort study in testicular cancer. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2020, Volume: 28, Issue:7 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast Neoplasms; Carboplatin; Cisplatin; Cognition; Cognitive Dysfunction; Etoposide; Female; Humans; Male; Middle Aged; Prospective Studies; Testicular Neoplasms	2020
Systemic treatment of breast cancer with leptomeningeal metastases using bevacizumab, etoposide and cisplatin (BEEP regimen) significantly improves overall survival. Journal of neuro-oncology, 2020, Volume: 148, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Breast Neoplasms; Cisplatin; Etoposide; Female; Humans; Kaplan-Meier Estimate; Meningeal Neoplasms; Middle Aged; Prospective Studies; Treatment Outcome	2020
TRAF4, a new substrate of SIAH1, participates in chemotherapy resistance of breast cancer cell by counteracting SIAH1-mediated downregulation of β-catenin. Breast cancer research and treatment, 2020, Volume: 183, Issue:2 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; beta Catenin; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Nuclear Proteins; TNF Receptor-Associated Factor 4; Ubiquitin-Protein Ligases	2020
The effect of reduced RDI of chemotherapy on the outcome of breast cancer patients. Scientific reports, 2020, 08-06, Volume: 10, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Middle Aged; Neoplasm Staging; Retrospective Studies; Survival Analysis; Taxoids; Treatment Outcome	2020
HSATII RNA is induced via a noncanonical ATM-regulated DNA damage response pathway and promotes tumor cell proliferation and movement. Proceedings of the National Academy of Sciences of the United States of America, 2020, 12-15, Volume: 117, Issue:50 Topics: Ataxia Telangiectasia Mutated Proteins; Bleomycin; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cytomegalovirus Infections; Disease Progression; DNA Damage; DNA Repair; DNA, Satellite; Etoposide; Female; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Genetic Fitness; Humans; Repetitive Sequences, Nucleic Acid; RNA-Seq; RNA, Untranslated; Transcriptional Activation	2020
Evaluation of ovarian reserve before and after chemotherapy. Journal of gynecology obstetrics and human reproduction, 2021, Volume: 50, Issue:5 Topics: Adolescent; Adult; Anti-Mullerian Hormone; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast Neoplasms; Cyclophosphamide; Dacarbazine; Docetaxel; Doxorubicin; Epirubicin; Etoposide; Female; Fertility Preservation; Fluorouracil; Hodgkin Disease; Humans; Longitudinal Studies; Luminescent Measurements; Ovarian Reserve; Prednisone; Procarbazine; Vinblastine; Vincristine; Young Adult	2021
Targeting the Aryl Hydrocarbon Receptor Signaling Pathway in Breast Cancer Development. Frontiers in immunology, 2021, Volume: 12 Topics: Animals; Animals, Genetically Modified; Antigens, Polyomavirus Transforming; Antineoplastic Agents; Apoptosis; Basic Helix-Loop-Helix Transcription Factors; Breast Neoplasms; Cell Proliferation; Cell Transformation, Neoplastic; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Female; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; Mice, Inbred C57BL; Receptors, Aryl Hydrocarbon; Repressor Proteins; Signal Transduction; Time Factors; Tumor Burden; Tumor Cells, Cultured	2021
Downregulation of GSK3B by miR-132-3p Enhances Etoposide-Induced Breast Cancer Cell Apoptosis. Annals of clinical and laboratory science, 2021, Volume: 51, Issue:3 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Biomarkers, Tumor; Breast Neoplasms; Cell Proliferation; Etoposide; Female; Gene Expression Regulation, Neoplastic; Glycogen Synthase Kinase 3 beta; Humans; MicroRNAs; Neoplasms; Prognosis; Survival Rate; Tumor Cells, Cultured	2021
Oral Nanomedicine Based on Multicomponent Microemulsions for Drug-Resistant Breast Cancer Treatment. Biomacromolecules, 2017, 04-10, Volume: 18, Issue:4 Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Breast Neoplasms; Caco-2 Cells; Coix; Drug Liberation; Drug Resistance, Neoplasm; Drug Synergism; Emulsions; Etoposide; Excipients; Female; Ginsenosides; Humans; Mammary Neoplasms, Experimental; MCF-7 Cells; Mice, Inbred ICR; Mice, Nude; Nanostructures; Plant Oils; Rats, Sprague-Dawley; Seeds; Xenograft Model Antitumor Assays	2017
Reply to: Who Should Bear the Cost of Convenience? A Cost-effectiveness Analysis Comparing External Beam and Brachytherapy Radiotherapy Techniques for Early Stage Breast Cancer. Clinical oncology (Royal College of Radiologists (Great Britain)), 2017, Volume: 29, Issue:6 Topics: Brachytherapy; Breast Neoplasms; Cost-Benefit Analysis; Etoposide; Humans	2017
Response to: 'Reply to: Who Should Bear the Cost of Convenience? A Cost-effectiveness Analysis Comparing External Beam and Brachytherapy Radiotherapy Techniques for Early Stage Breast Cancer'. Clinical oncology (Royal College of Radiologists (Great Britain)), 2017, Volume: 29, Issue:6 Topics: Brachytherapy; Breast Neoplasms; Cost-Benefit Analysis; Etoposide; Humans	2017
The synthetic antihyperlipidemic drug potassium piperate selectively kills breast cancer cells through inhibiting G1-S-phase transition and inducing apoptosis. Oncotarget, 2017, Jul-18, Volume: 8, Issue:29 Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cisplatin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Etoposide; Female; G1 Phase Cell Cycle Checkpoints; Humans; Hypolipidemic Agents; MCF-7 Cells; Mice; Piperidines; Reactive Oxygen Species; Stress, Physiological; Xenograft Model Antitumor Assays	2017
[Clinical Efficacy of EPOCH±R Followed by DICE±R Regimen for Primary Breast Diffuse Large B-Cell Lymphoma]. Zhongguo shi yan xue ye xue za zhi, 2017, Volume: 25, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma, Large B-Cell, Diffuse; Prednisone; Rituximab; Treatment Outcome; Vincristine	2017
Impact of Etoposide on BRCA1 Expression in Various Breast Cancer Cell Lines. Drugs in R&D, 2017, Volume: 17, Issue:4 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; BRCA1 Protein; Breast Neoplasms; Cell Culture Techniques; Cell Line, Tumor; Cell Nucleus; Cell Survival; Cytoplasm; DNA Damage; Etoposide; Female; Humans; MCF-7 Cells; Phosphorylation	2017
Caspase-dependent apoptosis induced by two synthetic halogenated flavanones, 3',7-dichloroflavanone and 3',6-dichloroflavanone, on human breast and prostate cancer cells. In vitro cellular & developmental biology. Animal, 2018, Volume: 54, Issue:2 Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Caspase 3; Caspase 8; Caspase 9; Cell Line, Tumor; Cell Survival; Etoposide; Female; Flavanones; Humans; Male; Poly (ADP-Ribose) Polymerase-1; Prostatic Neoplasms	2018
HBXIP regulates etoposide-induced cell cycle checkpoints and apoptosis in MCF-7 human breast carcinoma cells. Gene, 2018, Mar-20, Volume: 647 Topics: Adaptor Proteins, Signal Transducing; Apoptosis; Breast Neoplasms; Caspase 9; Cell Cycle Checkpoints; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; Etoposide; Female; Humans; MAP Kinase Signaling System; MCF-7 Cells; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-akt; Tumor Suppressor Protein p53; Up-Regulation	2018
Oral etoposide in heavily pre-treated metastatic breast cancer: A retrospective series. Breast (Edinburgh, Scotland), 2018, Volume: 38 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Administration Schedule; Etoposide; Female; Humans; Kaplan-Meier Estimate; Middle Aged; Neoplasm Metastasis; Retrospective Studies; Treatment Outcome	2018
Analysis of the activity and safety of weekly low-dose bevacizumab-based regimens in heavily pretreated patients with metastatic breast cancer. Thoracic cancer, 2018, Volume: 9, Issue:5 Topics: Adult; Aged; Albumins; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Breast Neoplasms; Dose-Response Relationship, Drug; Drug-Related Side Effects and Adverse Reactions; Etoposide; Female; Humans; Irinotecan; Methotrexate; Middle Aged; Neoplasm Metastasis; Paclitaxel; Pemetrexed; Progression-Free Survival; Treatment Outcome	2018
[Topoisomerase inhibitor upregulates MICA/B expression in breast cancer cells through ATM/ATR and NF-κB pathway]. Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences, 2018, Apr-18, Volume: 50, Issue:2 Topics: Antineoplastic Agents; Ataxia Telangiectasia Mutated Proteins; Breast Neoplasms; Cell Line, Tumor; Doxorubicin; Etoposide; Histocompatibility Antigens Class I; Humans; I-kappa B Proteins; NF-kappa B; RNA, Messenger; Topoisomerase Inhibitors; Up-Regulation	2018
Upregulation of EID3 sensitizes breast cancer cells to ionizing radiation-induced cellular senescence. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2018, Volume: 107 Topics: Breast Neoplasms; Carrier Proteins; Cellular Senescence; Cyclin-Dependent Kinase Inhibitor Proteins; DNA Damage; DNA Repair; Etoposide; Female; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; HEK293 Cells; Humans; Imidazoles; MCF-7 Cells; Quinoxalines; Radiation-Sensitizing Agents; Radiation, Ionizing; Time Factors; Up-Regulation	2018
Oral etoposide in heavily pre-treated metastatic breast cancer: results from the ESME cohort and comparison with other chemotherapy regimens. Breast cancer research and treatment, 2019, Volume: 173, Issue:2 Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Etoposide; Female; Follow-Up Studies; Humans; Middle Aged; Progression-Free Survival; Receptor, ErbB-2; Retrospective Studies; Topoisomerase II Inhibitors	2019
Primary neuroendocrine carcinoma of the breast. The breast journal, 2019, Volume: 25, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Neuroendocrine; Cisplatin; Contrast Media; Etoposide; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Receptors, Estrogen; Receptors, Progesterone; Ultrasonography, Mammary	2019
CBX8 suppresses Sirtinol-induced premature senescence in human breast cancer cells via cooperation with SIRT1. Cancer letters, 2013, Jul-28, Volume: 335, Issue:2 Topics: Acetylation; Aging, Premature; Antineoplastic Agents, Phytogenic; Benzamides; Breast Neoplasms; Cell Line, Tumor; Cellular Senescence; Cyclin-Dependent Kinase Inhibitor p21; Etoposide; Female; Humans; Naphthols; Polycomb Repressive Complex 1; Promoter Regions, Genetic; RNA Interference; RNA, Small Interfering; Sirtuin 1; Sirtuins; Tumor Suppressor Protein p53	2013
Locally-advanced primary neuroendocrine carcinoma of the breast: case report and review of the literature. World journal of surgical oncology, 2013, Jun-05, Volume: 11 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carboplatin; Carcinoma, Ductal, Breast; Carcinoma, Neuroendocrine; Cisplatin; Combined Modality Therapy; Diagnosis, Differential; Etoposide; Female; Humans; Liver Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging; Mastectomy; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Prognosis; Review Literature as Topic	2013
(-)-Xanthatin induces the prolonged expression of c-Fos through an N-acetyl-L-cysteine (NAC)-sensitive mechanism in human breast cancer MDA-MB-231 cells. The Journal of toxicological sciences, 2013, Volume: 38, Issue:4 Topics: Acetylcysteine; Antigens, Neoplasm; Antineoplastic Agents; Breast Neoplasms; Cell Division; DNA Topoisomerases, Type II; DNA-Binding Proteins; Etoposide; Female; Free Radical Scavengers; Furans; GADD45 Proteins; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Humans; Intracellular Signaling Peptides and Proteins; Proto-Oncogene Proteins c-fos; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; Tumor Cells, Cultured; Up-Regulation	2013
Phosphatidylinositol 3-kinases inhibitor LY294002 potentiates the cytotoxic effects of doxorubicin, vincristine, and etoposide in a panel of cancer cell lines. Fundamental & clinical pharmacology, 2014, Volume: 28, Issue:4 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Breast Neoplasms; Caspase 3; Cell Line, Tumor; Cell Survival; Chromones; Doxorubicin; Drug Synergism; Enzyme Inhibitors; Etoposide; Female; Humans; Lung Neoplasms; Morpholines; Ovarian Neoplasms; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Vincristine	2014
Autocrine/paracrine mechanism of interleukin-17B receptor promotes breast tumorigenesis through NF-κB-mediated antiapoptotic pathway. Oncogene, 2014, Jun-05, Volume: 33, Issue:23 Topics: Animals; Apoptosis; Autocrine Communication; Breast Neoplasms; Carcinogenesis; Cell Line, Tumor; Etoposide; Female; Gene Expression Regulation, Neoplastic; Humans; Interleukin-17; Mammary Neoplasms, Experimental; MCF-7 Cells; Mice; Mice, Inbred NOD; Mice, SCID; NF-kappa B; Paracrine Communication; Receptor, ErbB-2; Receptors, Interleukin-17; Signal Transduction; Xenograft Model Antitumor Assays	2014
CLC604 preferentially inhibits the growth of HER2-overexpressing cancer cells and sensitizes these cells to the inhibitory effect of Taxol in vitro and in vivo. Oncology reports, 2013, Volume: 30, Issue:4 Topics: Animals; Antibiotics, Antineoplastic; Antibodies, Monoclonal, Humanized; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Doxorubicin; Etoposide; Female; Furans; HSP90 Heat-Shock Proteins; Humans; Indazoles; Mice; Mice, SCID; Neoplasm Transplantation; Ovarian Neoplasms; Paclitaxel; Pyrazoles; Receptor, ErbB-2; Trastuzumab; Xenograft Model Antitumor Assays	2013
Amplification and over-expression of MAP3K3 gene in human breast cancer promotes formation and survival of breast cancer cells. The Journal of pathology, 2014, Volume: 232, Issue:1 Topics: Animals; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colony-Forming Units Assay; Computational Biology; Doxorubicin; Epithelial Cells; Etoposide; Female; Fibroblasts; Fluorouracil; Gene Amplification; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; In Situ Hybridization, Fluorescence; MAP Kinase Kinase Kinase 3; Mice; Phosphorylation; TNF-Related Apoptosis-Inducing Ligand; Tumor Necrosis Factor-alpha	2014
Clozapine, cancer chemotherapy and neutropenia - dilemmas in management. Psychiatria Danubina, 2013, Volume: 25, Issue:4 Topics: Adult; Antineoplastic Agents; Antipsychotic Agents; Bleomycin; Breast Neoplasms; Carcinoma; Cisplatin; Clozapine; Etoposide; Female; Humans; Intestinal Neoplasms; Male; Middle Aged; Neoplasms; Neutropenia; Schizophrenia; Seminoma; Testicular Neoplasms	2013
Sorcin silencing inhibits epithelial-to-mesenchymal transition and suppresses breast cancer metastasis in vivo. Breast cancer research and treatment, 2014, Volume: 143, Issue:2 Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aldehyde Dehydrogenase 1 Family; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Calcium-Binding Proteins; CD24 Antigen; Cell Movement; Cell Proliferation; Doxorubicin; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Etoposide; Female; Fibrosarcoma; Gene Expression Regulation, Neoplastic; Humans; Hyaluronan Receptors; Isoenzymes; Lung Neoplasms; MCF-7 Cells; Mice; Mice, Nude; Neoplasm Invasiveness; Neovascularization, Pathologic; Retinal Dehydrogenase; RNA Interference; RNA, Small Interfering; Spheroids, Cellular; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A	2014
A whole-body dual-modality radionuclide optical strategy for preclinical imaging of metastasis and heterogeneous treatment response in different microenvironments. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2014, Volume: 55, Issue:4 Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; DNA Damage; Environment; Etoposide; Female; Fluorescence; Humans; Lymph Nodes; Microscopy, Confocal; Neoadjuvant Therapy; Neoplasm Metastasis; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sodium Pertechnetate Tc 99m; Symporters; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Whole Body Imaging	2014
The RNA helicase/transcriptional co-regulator, p68 (DDX5), stimulates expression of oncogenic protein kinase, Polo-like kinase-1 (PLK1), and is associated with elevated PLK1 levels in human breast cancers. Cell cycle (Georgetown, Tex.), 2014, Volume: 13, Issue:9 Topics: Adenosine Triphosphatases; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Cycle Proteins; Cell Line, Tumor; Cohort Studies; DEAD-box RNA Helicases; Etoposide; Female; Humans; Middle Aged; Polo-Like Kinase 1; Promoter Regions, Genetic; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Tumor Suppressor Protein p53	2014
Fulvestrant treatment alters MDM2 protein turnover and sensitivity of human breast carcinoma cells to chemotherapeutic drugs. Cancer letters, 2014, Aug-01, Volume: 350, Issue:1-2 Topics: Antineoplastic Agents, Hormonal; Apoptosis; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cellular Senescence; Cyclin-Dependent Kinase Inhibitor p21; Down-Regulation; Doxorubicin; Drug Resistance, Neoplasm; Estradiol; Estrogen Antagonists; Etoposide; Female; Fulvestrant; Humans; MCF-7 Cells; Paclitaxel; Proto-Oncogene Proteins c-mdm2; Receptors, Estrogen; RNA, Messenger; Tumor Suppressor Protein p53	2014
Association of nuclear-localized Nemo-like kinase with heat-shock protein 27 inhibits apoptosis in human breast cancer cells. PloS one, 2014, Volume: 9, Issue:5 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Breast Neoplasms; Cell Line; Cell Line, Tumor; Cell Nucleus; Cytoplasm; Down-Regulation; Etoposide; Female; Heat-Shock Proteins; HSP27 Heat-Shock Proteins; Humans; Immunohistochemistry; Intracellular Signaling Peptides and Proteins; MCF-7 Cells; Microscopy, Confocal; Molecular Chaperones; Mutation; Phosphorylation; Protein Binding; Protein Serine-Threonine Kinases; RNA Interference; Tumor Necrosis Factor-alpha	2014
Survivin family proteins as novel molecular determinants of doxorubicin resistance in organotypic human breast tumors. Breast cancer research : BCR, 2014, May-30, Volume: 16, Issue:3 Topics: Alternative Splicing; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Breast Neoplasms; Camptothecin; Cell Line, Tumor; Cell Proliferation; Cell Survival; DNA Damage; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Female; High-Throughput Screening Assays; Humans; Imidazoles; Inhibitor of Apoptosis Proteins; MCF-7 Cells; Naphthoquinones; Paclitaxel; Receptor, ErbB-2; Survivin; Tumor Suppressor Protein p53	2014
Novel flavonoid-based biodegradable nanoparticles for effective oral delivery of etoposide by P-glycoprotein modulation: an in vitro, ex vivo and in vivo investigations. Drug delivery, 2016, Volume: 23, Issue:2 Topics: Administration, Oral; Animals; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B; Biological Availability; Breast Neoplasms; Cell Separation; Cell Survival; Dose-Response Relationship, Drug; Drug Carriers; Drug Compounding; Etoposide; Female; Flow Cytometry; Fluorescent Dyes; Humans; Inhibitory Concentration 50; Intestinal Absorption; Lactic Acid; Male; MCF-7 Cells; Microscopy, Confocal; Nanoparticles; Nanotechnology; Permeability; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polyvinyl Alcohol; Quercetin; Rats, Wistar; Rhodamines; Solubility; Sonication; Technology, Pharmaceutical	2016
RhoC upregulation is correlated with reduced E-cadherin in human breast cancer specimens after chemotherapy and in human breast cancer MCF-7 cells. Hormones & cancer, 2014, Volume: 5, Issue:6 Topics: Actin Cytoskeleton; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Biomarkers, Tumor; Breast Neoplasms; Cadherins; Down-Regulation; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Etoposide; Female; Fibronectins; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; Middle Aged; Neoplasm Staging; rho GTP-Binding Proteins; rhoC GTP-Binding Protein; Up-Regulation	2014
Multidisciplinary management of small cell carcinoma of the breast: a case report. Nagoya journal of medical science, 2014, Volume: 76, Issue:1-2 Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Breast Neoplasms; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Epirubicin; Etoposide; Female; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Mastectomy, Modified Radical; Middle Aged; Neoadjuvant Therapy; Radiotherapy, Adjuvant; Time Factors; Treatment Outcome; Ultrasonography, Mammary	2014
Outcomes of immediate perforator flap reconstruction after skin-sparing mastectomy following neoadjuvant chemotherapy. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2015, Volume: 41, Issue:1 Topics: Adult; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Lobular; Chemotherapy, Adjuvant; Cohort Studies; Cyclophosphamide; Docetaxel; Epirubicin; Etoposide; Female; Fluorouracil; Humans; Mammaplasty; Mastectomy, Subcutaneous; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Perforator Flap; Retrospective Studies; Taxoids; Trastuzumab; Treatment Outcome; Young Adult	2015
Efficacy of concurrent chemoradiotherapy for patients with locally recurrent or advanced inoperable breast cancer. Clinical breast cancer, 2015, Volume: 15, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Capecitabine; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Etoposide; Female; Humans; Kaplan-Meier Estimate; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Salvage Therapy	2015
Modification of topoisomerases in mammospheres derived from breast cancer cell line: clinical implications for combined treatments with tyrosine kinase inhibitors. BMC cancer, 2014, Dec-03, Volume: 14 Topics: Animals; Antigens, Surface; Breast Neoplasms; Camptothecin; Cell Line, Tumor; Cell Survival; DNA Topoisomerases; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Drug Synergism; Enzyme Activation; Etoposide; Female; Gefitinib; Humans; Immunophenotyping; MCF-7 Cells; Mice; Neoplastic Stem Cells; Quinazolines; Spheroids, Cellular; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Tumor Cells, Cultured	2014
Efficacy of neo-adjuvant chemotherapy with TEC regimen on breast cancer. Cancer chemotherapy and pharmacology, 2015, Volume: 75, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Cyclophosphamide; Etoposide; Female; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm Metastasis; Receptor, ErbB-2; Taxoids; Treatment Outcome	2015
[Antitumor and antiproliferative action of the steroidal cytostatic antiestrogen cytestrol acetate on hormone-dependent tumor models]. Eksperimental'naia i klinicheskaia farmakologiia, 2014, Volume: 77, Issue:10 Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cell Line, Tumor; Cytostatic Agents; Doxorubicin; Drug Administration Schedule; Drug Synergism; Estrogen Antagonists; Ethinyl Estradiol; Etoposide; Female; Humans; Inhibitory Concentration 50; Injections, Subcutaneous; Mice; Rats; Tamoxifen; Tumor Burden; Xenograft Model Antitumor Assays	2014
BMX Negatively Regulates BAK Function, Thereby Increasing Apoptotic Resistance to Chemotherapeutic Drugs. Cancer research, 2015, Apr-01, Volume: 75, Issue:7 Topics: Antineoplastic Agents; Apoptosis; bcl-2 Homologous Antagonist-Killer Protein; Breast Neoplasms; Camptothecin; Cell Line, Tumor; Colorectal Neoplasms; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Male; Phosphorylation; Prostatic Neoplasms; Protein Processing, Post-Translational; Protein Tyrosine Phosphatases, Non-Receptor; Protein-Tyrosine Kinases	2015
Bevacizumab might potentiate the chemotherapeutic effect in breast cancer patients with leptomeningeal carcinomatosis. Journal of the Formosan Medical Association = Taiwan yi zhi, 2016, Volume: 115, Issue:4 Topics: Adult; Angiogenesis Inhibitors; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Brain; Breast Neoplasms; Cisplatin; Etoposide; Fatal Outcome; Female; Humans; Magnetic Resonance Imaging; Meningeal Carcinomatosis; Middle Aged; Tomography, X-Ray Computed	2016
Proteomic profile of KSR1-regulated signalling in response to genotoxic agents in breast cancer. Breast cancer research and treatment, 2015, Volume: 151, Issue:3 Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cluster Analysis; Doxorubicin; Etoposide; Female; Gene Expression; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Humans; Mutagens; Prognosis; Protein Kinases; Proteome; Proteomics; Signal Transduction; Survival Analysis	2015
A plant alkaloid, veratridine, potentiates cancer chemosensitivity by UBXN2A-dependent inhibition of an oncoprotein, mortalin-2. Oncotarget, 2015, Sep-15, Volume: 6, Issue:27 Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Colonic Neoplasms; Cytoplasm; Disease Progression; Enhancer Elements, Genetic; Etoposide; Female; Fluorouracil; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Green Fluorescent Proteins; HCT116 Cells; HSP70 Heat-Shock Proteins; Humans; Hyaluronan Receptors; Mice; Mice, Nude; Mitochondrial Proteins; Neoplasm Transplantation; Plant Extracts; Protein Array Analysis; Tumor Suppressor Protein p53; Ubiquitin; Ubiquitins; Veratridine	2015
SIRT1 is involved in oncogenic signaling mediated by GPER in breast cancer. Cell death & disease, 2015, Jul-30, Volume: 6 Topics: Animals; Antineoplastic Agents, Phytogenic; Benzamides; Breast Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cyclopentanes; ErbB Receptors; Estradiol; Etoposide; Female; Fibroblasts; Gene Expression Regulation, Neoplastic; Humans; Mice, Nude; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Naphthols; Primary Cell Culture; Proto-Oncogene Proteins c-fos; Quinolines; Receptors, Estrogen; Receptors, G-Protein-Coupled; Signal Transduction; Sirtuin 1; Transcription Factor AP-1; Xenograft Model Antitumor Assays	2015
Cisplatin Plus Ifosfamide with/without Etoposide as Salvage Treatment in Heavily-pre-treated Patients with Metastatic Breast Cancer. Anticancer research, 2015, Volume: 35, Issue:9 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Salvage Therapy; Treatment Outcome	2015
Claudin 1 promotes migration and increases sensitivity to tamoxifen and anticancer drugs in luminal-like human breast cancer cells MCF7. Cancer investigation, 2015, Volume: 33, Issue:9 Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cisplatin; Claudin-1; Down-Regulation; Etoposide; Female; Gene Expression; Humans; MCF-7 Cells; Tamoxifen; Tight Junctions; Transforming Growth Factor beta	2015
Involvement of p53 in insulin-like growth factor binding protein-3 regulation in the breast cancer cell response to DNA damage. Oncotarget, 2015, Sep-29, Volume: 6, Issue:29 Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Caspase 3; Cell Line, Tumor; DNA Damage; Doxorubicin; Etoposide; Female; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Insulin-Like Growth Factor Binding Protein 3; Membrane Proteins; Mutation; Nerve Tissue Proteins; Real-Time Polymerase Chain Reaction; RNA, Small Interfering; Tumor Suppressor Protein p53	2015
Nitric Oxide Down-Regulates Topoisomerase I and Induces Camptothecin Resistance in Human Breast MCF-7 Tumor Cells. PloS one, 2015, Volume: 10, Issue:11 Topics: Breast Neoplasms; Camptothecin; Cell Survival; DNA Topoisomerases, Type I; Down-Regulation; Drug Resistance, Neoplasm; Etoposide; HT29 Cells; Humans; MCF-7 Cells; Nitric Oxide; Topoisomerase I Inhibitors; Tumor Cells, Cultured; Up-Regulation	2015
Novel Etoposide Analogue Modulates Expression of Angiogenesis Associated microRNAs and Regulates Cell Proliferation by Targeting STAT3 in Breast Cancer. PloS one, 2015, Volume: 10, Issue:11 Topics: Apoptosis; Breast Neoplasms; Caspase 9; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; DNA Damage; Enzyme Activation; Etoposide; Gene Expression Regulation, Neoplastic; Human Umbilical Vein Endothelial Cells; Humans; MCF-7 Cells; MicroRNAs; Models, Molecular; Molecular Docking Simulation; Neovascularization, Pathologic; Podophyllotoxin; Protein Binding; Proto-Oncogene Proteins c-bcl-2; Quinazolines; RNA Interference; RNA, Small Interfering; STAT3 Transcription Factor; Vascular Endothelial Growth Factor A	2015
Adjuvant Ovarian Suppression, High-dose Chemotherapy and Immunotherapy for Premenopausal Patients with High-risk Breast Cancer. Anticancer research, 2015, Volume: 35, Issue:12 Topics: Adult; Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Bone Marrow Transplantation; Breast Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease-Free Survival; Endpoint Determination; Etoposide; Female; Humans; Ifosfamide; Immunotherapy; Interleukin-2; Isotretinoin; Leuprolide; Nitriles; Premenopause; Receptors, Estrogen; Receptors, Progesterone; Triazoles; Triple Negative Breast Neoplasms	2015
Virtual screening-driven repositioning of etoposide as CD44 antagonist in breast cancer cells. Oncotarget, 2016, Apr-26, Volume: 7, Issue:17 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Biomarkers, Tumor; Breast Neoplasms; CD24 Antigen; Cell Proliferation; Drug Repositioning; Epithelial-Mesenchymal Transition; Etoposide; Female; High-Throughput Screening Assays; Humans; Hyaluronan Receptors; Hyaluronic Acid; Molecular Docking Simulation; Molecular Dynamics Simulation; Signal Transduction; Tumor Cells, Cultured	2016
Nitric oxide inhibits topoisomerase II activity and induces resistance to topoisomerase II-poisons in human tumor cells. Biochimica et biophysica acta, 2016, Volume: 1860, Issue:7 Topics: Breast Neoplasms; Catalysis; Colorectal Neoplasms; DNA; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Enzyme Stability; Etoposide; Female; HT29 Cells; Humans; MCF-7 Cells; Nitric Oxide; Nitric Oxide Donors; Nucleic Acid Conformation; Protein Conformation; Topoisomerase II Inhibitors	2016
Efficacy of pegylated liposomal etoposide nanoparticles on breast cancer cell lines. Turkish journal of medical sciences, 2016, Feb-17, Volume: 46, Issue:2 Topics: Breast Neoplasms; Etoposide; Humans; Liposomes; MCF-7 Cells; Nanoparticles	2016
Antitumor effect of Deoxypodophyllotoxin on human breast cancer xenograft transplanted in BALB/c nude mice model. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2016, Volume: 22, Issue:10 Topics: 2-Hydroxypropyl-beta-cyclodextrin; Administration, Intravenous; Animals; Antineoplastic Agents, Phytogenic; beta-Cyclodextrins; Breast Neoplasms; Cell Line, Tumor; Docetaxel; Drugs, Chinese Herbal; Etoposide; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Podophyllotoxin; Taxoids; Xenograft Model Antitumor Assays	2016
PARP3 controls TGFβ and ROS driven epithelial-to-mesenchymal transition and stemness by stimulating a TG2-Snail-E-cadherin axis. Oncotarget, 2016, Sep-27, Volume: 7, Issue:39 Topics: A549 Cells; Antigens, CD; Breast Neoplasms; Cadherins; CD24 Antigen; Cell Cycle Proteins; Cell Movement; Cell Self Renewal; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Etoposide; Female; Gene Expression Regulation, Neoplastic; GTP-Binding Proteins; Hep G2 Cells; Humans; Hyaluronan Receptors; Mammary Glands, Human; Neoplastic Stem Cells; Octamer Transcription Factor-3; Phenotype; Poly(ADP-ribose) Polymerases; Protein Glutamine gamma Glutamyltransferase 2; Reactive Oxygen Species; RNA Interference; Signal Transduction; Snail Family Transcription Factors; SOXB1 Transcription Factors; Spheroids, Cellular; Time Factors; Topoisomerase II Inhibitors; Transfection; Transforming Growth Factor beta; Transglutaminases	2016
Involvement of bleomycin hydrolase and poly(ADP-ribose) polymerase-1 in Ubc9-mediated resistance to chemotherapy agents. International journal of oncology, 2017, Volume: 50, Issue:1 Topics: Antineoplastic Agents; Bleomycin; Breast Neoplasms; Bridged Bicyclo Compounds, Heterocyclic; Cisplatin; Cysteine Endopeptidases; Deoxycytidine; DNA Damage; Doxorubicin; Drug Resistance, Neoplasm; Enbucrilate; Etoposide; Female; Fluorouracil; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; Poly (ADP-Ribose) Polymerase-1; Ubiquitin; Ubiquitin-Conjugating Enzymes; Vincristine	2017
Placental site trophoblastic tumor with multiple metastases and complete response to salvage BEP regimen: a case report and review of the literature. Medical oncology (Northwood, London, England), 2009, Volume: 26, Issue:1 Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast Neoplasms; Chorionic Gonadotropin; Cisplatin; Cyclophosphamide; Dactinomycin; Digestive System Neoplasms; Endocrine Gland Neoplasms; Etoposide; Female; Humans; Hysterectomy; Kidney Neoplasms; Lung Neoplasms; Lymph Node Excision; Methotrexate; Pelvis; Pregnancy; Trophoblastic Tumor, Placental Site; Uterine Hemorrhage; Uterine Neoplasms; Vincristine; Young Adult	2009
Carcinogenic effect of an antitumor drug etoposide in laboratory animals. Bulletin of experimental biology and medicine, 2007, Volume: 144, Issue:5 Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Etoposide; Female; Injections, Intravenous; Mice; Rats; Rats, Wistar	2007
Molecular profile of breast versus ovarian cancer cells in response to treatment with the anticancer drugs cisplatin, carboplatin, doxorubicin, etoposide and taxol. Biological chemistry, 2008, Volume: 389, Issue:11 Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carboplatin; Cell Line, Tumor; Cisplatin; Doxorubicin; Etoposide; Female; Gene Expression Regulation, Neoplastic; Humans; Ovarian Neoplasms; Paclitaxel; RNA, Messenger	2008
F14512, a potent antitumor agent targeting topoisomerase II vectored into cancer cells via the polyamine transport system. Cancer research, 2008, Dec-01, Volume: 68, Issue:23 Topics: Animals; Binding, Competitive; Biogenic Polyamines; Breast Neoplasms; Cell Line, Tumor; CHO Cells; Cricetinae; Cricetulus; DNA Damage; DNA Topoisomerases, Type II; DNA, Neoplasm; Drug Delivery Systems; Etoposide; Female; Humans; Leukemia L1210; Lung Neoplasms; Mice; Mice, Nude; Neoplasms; Podophyllotoxin; Topoisomerase II Inhibitors; Xenograft Model Antitumor Assays	2008
Isolated breast metastasis from granulosa cell tumor of the ovary. Archives of gynecology and obstetrics, 2009, Volume: 280, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast Neoplasms; Cisplatin; Combined Modality Therapy; Etoposide; Female; Granulosa Cell Tumor; Humans; Hysterectomy; Middle Aged; Ovarian Neoplasms	2009
Side effects after docetaxel treatment in Taiwanese breast cancer patients with CYP3A4, CYP3A5, and ABCB1 gene polymorphisms. Clinica chimica acta; international journal of clinical chemistry, 2009, Jun-27, Volume: 404, Issue:2 Topics: Adult; Alleles; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Cyclophosphamide; Cytochrome P-450 CYP3A; Docetaxel; Etoposide; Female; Genotype; Humans; Middle Aged; Polymorphism, Single Nucleotide; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Taxoids	2009
Premature senescence is a major response to DNA cross-linking agents in BRCA1-defective cells: implication for tailored treatments of BRCA1 mutation carriers. Molecular cancer therapeutics, 2009, Volume: 8, Issue:4 Topics: Aging, Premature; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; BRCA1 Protein; Breast Neoplasms; Cell Line, Transformed; Cells, Cultured; Cellular Senescence; Cisplatin; Colony-Forming Units Assay; Cross-Linking Reagents; Doxorubicin; Etoposide; Humans; Mitomycin	2009
Celecoxib enhanced the sensitivity of cancer cells to anticancer drugs by inhibition of the expression of P-glycoprotein through a COX-2-independent manner. Journal of cellular biochemistry, 2009, Sep-01, Volume: 108, Issue:1 Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Celecoxib; Cell Line, Tumor; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Down-Regulation; Drug Resistance, Neoplasm; Etoposide; Female; Glycoproteins; Humans; Pyrazoles; Sulfonamides; Tamoxifen	2009
The potential biomarkers in predicting pathologic response of breast cancer to three different chemotherapy regimens: a case control study. BMC cancer, 2009, Jul-11, Volume: 9 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Case-Control Studies; Cyclophosphamide; Doxorubicin; Epirubicin; Etoposide; Female; Fluorouracil; Humans; Middle Aged; Receptors, Progesterone; Steroids; Treatment Outcome; Vincristine	2009
Nuphar lutea thioalkaloids inhibit the nuclear factor kappaB pathway, potentiate apoptosis and are synergistic with cisplatin and etoposide. Cancer biology & therapy, 2009, Volume: 8, Issue:19 Topics: Alkaloids; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cisplatin; Drug Synergism; Etoposide; Hodgkin Disease; Humans; Magnetic Resonance Spectroscopy; Methanol; NF-kappa B; Nuphar; Plant Extracts; Sulfhydryl Compounds	2009
Clinical significance of Ki-67 in neoadjuvant chemotherapy for primary breast cancer as a predictor for chemosensitivity and for prognosis. Breast cancer (Tokyo, Japan), 2010, Volume: 17, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Biomarkers; Breast Neoplasms; Cell Proliferation; Cyclophosphamide; Docetaxel; Drug Resistance, Neoplasm; Epirubicin; Etoposide; Female; Fluorouracil; Humans; Ki-67 Antigen; Logistic Models; Middle Aged; Multivariate Analysis; Neoadjuvant Therapy; Prognosis; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies; Survival Analysis; Tamoxifen; Taxoids; Tumor Suppressor Protein p53	2010
Repeated treatment with subtoxic doses of TRAIL induces resistance to apoptosis through its death receptors in MDA-MB-231 breast cancer cells. Molecular cancer research : MCR, 2009, Volume: 7, Issue:11 Topics: Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Down-Regulation; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Etoposide; Female; Gene Expression Regulation, Neoplastic; Humans; Paclitaxel; Receptors, TNF-Related Apoptosis-Inducing Ligand; Receptors, Tumor Necrosis Factor; Recombinant Proteins; STAT5 Transcription Factor; TNF-Related Apoptosis-Inducing Ligand; Transfection	2009
Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1. Biochemical pharmacology, 2010, Mar-15, Volume: 79, Issue:6 Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; MicroRNAs; Multidrug Resistance-Associated Proteins; Oligonucleotide Array Sequence Analysis	2010
Involvement of the HER2 pathway in repair of DNA damage produced by chemotherapeutic agents. Molecular cancer therapeutics, 2009, Volume: 8, Issue:11 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Line, Tumor; Cell Nucleus; Cisplatin; Comet Assay; DNA Damage; DNA Repair; Drug Synergism; Enzyme-Linked Immunosorbent Assay; Etoposide; Female; Humans; Receptor, ErbB-2; Transfection; Trastuzumab	2009
Foxp3 expression in p53-dependent DNA damage responses. The Journal of biological chemistry, 2010, Mar-12, Volume: 285, Issue:11 Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Death; Cell Division; Colonic Neoplasms; DNA Damage; Doxorubicin; Etoposide; Female; Forkhead Transcription Factors; Gene Expression Regulation, Neoplastic; HCT116 Cells; Humans; Imidazoles; Phosphorylation; Piperazines; Proto-Oncogene Proteins c-mdm2; Tumor Suppressor Protein p53	2010
Retinoic acid protects human breast cancer cells against etoposide-induced apoptosis by NF-kappaB-dependent but cIAP2-independent mechanisms. Molecular cancer, 2010, Jan-26, Volume: 9 Topics: Alitretinoin; Antineoplastic Agents; Apoptosis; Baculoviral IAP Repeat-Containing 3 Protein; Breast Neoplasms; Cell Differentiation; Cell Line, Tumor; Cytoprotection; Etoposide; Female; Humans; I-kappa B Proteins; Inhibitor of Apoptosis Proteins; NF-kappa B; NF-KappaB Inhibitor alpha; Promoter Regions, Genetic; Protein Binding; Receptors, Retinoic Acid; Signal Transduction; Transcription Factor RelA; Transcription, Genetic; Tretinoin; Ubiquitin-Protein Ligases	2010
Preoperative weekly cisplatin, epirubicin, and paclitaxel (PET) improves prognosis: how much is it true? Annals of oncology : official journal of the European Society for Medical Oncology, 2010, Volume: 21, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Epirubicin; Etoposide; Female; Humans; Paclitaxel; Preoperative Care; Prognosis; Randomized Controlled Trials as Topic; Taxoids; Treatment Outcome	2010
Potentiation of etoposide-induced apoptosis in HeLa cells by co-treatment with KG-135, a quality-controlled standardized ginsenoside formulation. Cancer letters, 2010, Aug-01, Volume: 294, Issue:1 Topics: Androstadienes; Apoptosis; bcl-2-Associated X Protein; Breast Neoplasms; Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Synergism; Etoposide; Female; Ginsenosides; HeLa Cells; Humans; Korea; Liver Neoplasms; Medicine, East Asian Traditional; Membrane Potentials; Mitochondria; Mycotoxins; Phosphoserine; Stomach Neoplasms; Wortmannin	2010
Chondroitin sulfate functionalized liposomes for solid tumor targeting. Journal of drug targeting, 2011, Volume: 19, Issue:4 Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Chondroitin Sulfates; Drug Carriers; Drug Delivery Systems; Etoposide; Female; Humans; Liposomes; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Tissue Distribution	2011
Local regulation of human breast xenograft models. Journal of cellular physiology, 2010, Volume: 224, Issue:3 Topics: Animals; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; Disease Models, Animal; DNA Methylation; Estrogens; Etoposide; Female; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Promoter Regions, Genetic; Receptors, Estrogen; Receptors, Progesterone; Transplantation, Heterologous	2010
Discovering breast cancer drug candidates from biomedical literature. International journal of data mining and bioinformatics, 2010, Volume: 4, Issue:3 Topics: Antineoplastic Agents; Breast Neoplasms; Data Mining; Doxorubicin; Drug Discovery; Etoposide; Female; Humans; Internet; MEDLINE; Paclitaxel; Publications	2010
Involvement of caspase-9 in autophagy-mediated cell survival pathway. Biochimica et biophysica acta, 2011, Volume: 1813, Issue:1 Topics: Antibiotics, Antineoplastic; Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Autophagy; Blotting, Western; Breast Neoplasms; Caspase 9; Caspase Inhibitors; Cell Proliferation; Cell Survival; Cytoplasm; Doxorubicin; Enzyme Activation; Etoposide; Female; Flow Cytometry; Humans; Isothiocyanates; Mitochondria; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Signal Transduction; Sulfoxides; Thiocyanates; Tumor Cells, Cultured	2011
Adjuvant oral etoposide plus cisplatin (EoP) following sequential doxorubicin/cyclophosphamide (AC) and docetaxel (T) in early breast cancer patients with 4 or more positive lymph nodes (10 years follow-up). Breast (Edinburgh, Scotland), 2011, Volume: 20, Issue:2 Topics: Administration, Oral; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Disease-Free Survival; Docetaxel; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Middle Aged; Pilot Projects; Taxoids	2011
Preferential antitumor effect of the Src inhibitor dasatinib associated with a decreased proportion of aldehyde dehydrogenase 1-positive cells in breast cancer cells of the basal B subtype. BMC cancer, 2010, Oct-20, Volume: 10 Topics: Aldehyde Dehydrogenase; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Dasatinib; DNA Damage; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Etoposide; Humans; Inhibitory Concentration 50; Neoplastic Stem Cells; Pyrimidines; src-Family Kinases; Thiazoles	2010
Salinomycin sensitizes cancer cells to the effects of doxorubicin and etoposide treatment by increasing DNA damage and reducing p21 protein. British journal of pharmacology, 2011, Volume: 162, Issue:3 Topics: Annexin A5; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Comet Assay; Cyclin-Dependent Kinase Inhibitor p21; DNA Damage; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Female; Hep G2 Cells; Humans; In Situ Nick-End Labeling; Proteasome Endopeptidase Complex; Pyrans; Sarcoma; Uterine Neoplasms	2011
Characterization of hybrid cells derived from spontaneous fusion events between breast epithelial cells exhibiting stem-like characteristics and breast cancer cells. Clinical & experimental metastasis, 2011, Volume: 28, Issue:1 Topics: Breast Neoplasms; Cell Fusion; Cell Movement; Cell Survival; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Epithelial Cells; Etoposide; Female; Flow Cytometry; Fluorouracil; Gene Expression Profiling; Humans; Hybrid Cells; Paclitaxel; Reverse Transcriptase Polymerase Chain Reaction; Structure-Activity Relationship; Tumor Cells, Cultured	2011
Etoposide, mitomycin, and methotrexate combination in heavily treated breast cancer: a retrospective study. Breast cancer (Tokyo, Japan), 2012, Volume: 19, Issue:1 Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Disease-Free Survival; Etoposide; Female; Humans; Methotrexate; Middle Aged; Mitomycin; Retrospective Studies; Survival Rate	2012
p53 Suppresses lung resistance-related protein expression through Y-box binding protein 1 in the MCF-7 breast tumor cell line. Journal of cellular physiology, 2011, Volume: 226, Issue:12 Topics: Antineoplastic Agents; Apoptosis; Binding Sites; Breast Neoplasms; Cell Line, Tumor; Chromatin Immunoprecipitation; Cisplatin; Down-Regulation; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Female; Gene Expression Regulation, Neoplastic; Genes, Reporter; Histone Deacetylase 2; Humans; Promoter Regions, Genetic; Response Elements; RNA Interference; RNA, Messenger; Signal Transduction; Time Factors; Transfection; Tumor Suppressor Protein p53; Vault Ribonucleoprotein Particles; Y-Box-Binding Protein 1	2011
DNA damage targets PKCη to the nuclear membrane via its C1b domain. Experimental cell research, 2011, Jun-10, Volume: 317, Issue:10 Topics: Animals; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Nucleus; Cells, Cultured; Chlorocebus aethiops; COS Cells; Cytoplasm; DNA Damage; Etoposide; Flow Cytometry; Fluorescent Antibody Technique; Humans; Nuclear Envelope; Protein Kinase C-delta; Protein Structure, Tertiary; Protein Transport; Subcellular Fractions	2011
Involvement of Akt-1 and mTOR in sensitivity of breast cancer to targeted therapy. Oncotarget, 2011, Volume: 2, Issue:7 Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Molecular Targeted Therapy; Proto-Oncogene Proteins c-akt; Signal Transduction; Sirolimus; Tamoxifen; TOR Serine-Threonine Kinases	2011
microRNA-101 is a potent inhibitor of autophagy. The EMBO journal, 2011, Sep-13, Volume: 30, Issue:22 Topics: Autophagy; Autophagy-Related Proteins; Breast Neoplasms; Cell Line, Tumor; Cysteine Endopeptidases; Etoposide; Female; Gene Expression Profiling; Gene Expression Regulation; Humans; MicroRNAs; Oligonucleotide Array Sequence Analysis; rab5 GTP-Binding Proteins; RNA Interference; RNA, Small Interfering; Sirolimus; Stathmin; Tamoxifen	2011
Proteomic footprinting of drug-treated cancer cells as a measure of cellular vaccine efficacy for the prevention of cancer recurrence. Molecular & cellular proteomics : MCP, 2012, Volume: 11, Issue:2 Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cancer Vaccines; Chromatography, Liquid; Dendritic Cells; Doxorubicin; Etoposide; Female; Hep G2 Cells; Humans; Neoplasm Recurrence, Local; Proteomics; Receptors, Cell Surface; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; T-Lymphocytes, Cytotoxic; Tamoxifen; Tumor Cells, Cultured	2012
[Predictive value of (99)Tc(m)-MIBI scintimammography in evaluation of the efficacy of neoadjuvant chemotherapy in patients with operable breast cancer]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2011, Volume: 33, Issue:7 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Epirubicin; Etoposide; Female; Fluorouracil; Follow-Up Studies; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Remission Induction; Taxoids; Technetium Tc 99m Sestamibi	2011
TGFβ-induced c-Myb affects the expression of EMT-associated genes and promotes invasion of ER+ breast cancer cells. Cell cycle (Georgetown, Tex.), 2011, Dec-01, Volume: 10, Issue:23 Topics: Apoptosis; Biomarkers, Tumor; Breast Neoplasms; Cadherins; Cell Line, Tumor; Cell Proliferation; Cloning, Molecular; Epithelial-Mesenchymal Transition; Estrogen Receptor alpha; Etoposide; Female; Flow Cytometry; Gene Expression Regulation, Neoplastic; Genes, myb; Humans; Lentivirus; MicroRNAs; Mutagenesis, Site-Directed; Neoplasm Invasiveness; Protein Processing, Post-Translational; Protein Stability; Proto-Oncogene Proteins c-myb; Receptors, Transforming Growth Factor beta; RNA, Small Interfering; Transcriptional Activation; Transfection; Transforming Growth Factor beta	2011
Expression analysis of TOP2A, MSH2 and MLH1 genes in MCF7 cells at different levels of etoposide resistance. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2012, Volume: 66, Issue:1 Topics: Adaptor Proteins, Signal Transducing; Analysis of Variance; Antigens, Neoplasm; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; DNA Topoisomerases, Type II; DNA-Binding Proteins; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Etoposide; Female; Humans; MutL Protein Homolog 1; MutS Homolog 2 Protein; Nuclear Proteins; Poly-ADP-Ribose Binding Proteins; Reverse Transcriptase Polymerase Chain Reaction	2012
Anti-proliferative effects of the novel ceramide analog (S)-2-(benzylideneamino)-3-hydroxy-N-tetrade-cylpropanamide in chemoresistant cancer. Bioorganic & medicinal chemistry letters, 2012, Apr-01, Volume: 22, Issue:7 Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Ceramides; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Etoposide; Female; Humans; Ki-67 Antigen; Lysophospholipids; Sphingosine; Stereoisomerism; Structure-Activity Relationship	2012
Loss of giant obscurins promotes breast epithelial cell survival through apoptotic resistance. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2012, Volume: 26, Issue:7 Topics: Apoptosis; Base Sequence; Breast; Breast Neoplasms; Cell Line; Cell Line, Tumor; Cell Nucleus; Cell Survival; Cell Transformation, Neoplastic; Colonic Neoplasms; DNA Damage; Epithelial Cells; Etoposide; Female; Gene Expression; Guanine Nucleotide Exchange Factors; Humans; Muscle Proteins; Protein Isoforms; Protein Serine-Threonine Kinases; Rho Guanine Nucleotide Exchange Factors; RNA, Messenger; RNA, Neoplasm; RNA, Small Interfering; Skin Neoplasms	2012
Reformulation of etoposide with solubility-enhancing rubusoside. International journal of pharmaceutics, 2012, Sep-15, Volume: 434, Issue:1-2 Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; Colonic Neoplasms; Dimethyl Sulfoxide; Diterpenes, Kaurane; Drug Stability; Drug Storage; Etoposide; Excipients; Female; Glucosides; Humans; Light; Male; Microscopy, Electron, Transmission; Nanoparticles; Particle Size; Prostatic Neoplasms; Scattering, Radiation; Solubility; Temperature	2012
TMEM45A is essential for hypoxia-induced chemoresistance in breast and liver cancer cells. BMC cancer, 2012, Sep-06, Volume: 12 Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Breast Neoplasms; Cell Hypoxia; Cell Line, Tumor; Cell Survival; Cells, Cultured; Drug Resistance, Neoplasm; Epirubicin; Etoposide; Female; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Kaplan-Meier Estimate; Keratinocytes; Liver Neoplasms; Membrane Proteins; Oligonucleotide Array Sequence Analysis; Paclitaxel; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Transcriptome	2012
[Sensitivity to chemotherapeutic drugs of polyploid tumor cells induced by a spindle poison nocodazole]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2012, Volume: 34, Issue:6 Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Docetaxel; Down-Regulation; Drug Resistance, Neoplasm; Epirubicin; Etoposide; Female; Fluorouracil; Gene Knockdown Techniques; Humans; Inhibitory Concentration 50; Nocodazole; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Polyploidy; Proto-Oncogene Proteins c-bcl-2; RNA, Messenger; RNA, Small Interfering; Taxoids; Vincristine	2012
Regulation of CXCR4 gene expression in breast cancer cells under diverse stress conditions. International journal of oncology, 2012, Volume: 41, Issue:6 Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Hypoxia; Cell Line, Tumor; Etoposide; Female; Gene Expression Regulation, Neoplastic; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Interleukin-10; MCF-7 Cells; Nuclear Receptor Coactivator 1; Promoter Regions, Genetic; Receptors, CXCR4; RNA, Messenger; Sirtuin 1; Stress, Physiological; Tumor Necrosis Factor-alpha	2012
Differential gene and microRNA expression between etoposide resistant and etoposide sensitive MCF7 breast cancer cell lines. PloS one, 2012, Volume: 7, Issue:9 Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Drug Resistance, Neoplasm; Etoposide; Female; Gene Dosage; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; MicroRNAs; Multidrug Resistance-Associated Proteins; Neoplasm Proteins	2012
Adva-27a, a novel podophyllotoxin derivative found to be effective against multidrug resistant human cancer cells. Anticancer research, 2012, Volume: 32, Issue:10 Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Female; Fluorine Compounds; Glycosides; Humans; Male; Microsomes, Liver; Monosaccharides; Podophyllotoxin; Rats; Rats, Sprague-Dawley; Small Cell Lung Carcinoma; Topoisomerase II Inhibitors	2012
Lycopene synergistically enhances quinacrine action to inhibit Wnt-TCF signaling in breast cancer cells through APC. Carcinogenesis, 2013, Volume: 34, Issue:2 Topics: Adenomatous Polyposis Coli Protein; Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; beta Catenin; Blotting, Western; Breast Neoplasms; Carotenoids; Cell Cycle; Cell Proliferation; Comet Assay; Cyclin D1; Drug Synergism; Etoposide; Female; Flow Cytometry; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Lycopene; Promoter Regions, Genetic; Quinacrine; RNA, Small Interfering; Signal Transduction; T Cell Transcription Factor 1; TCF Transcription Factors; Trans-Activators; Transcription, Genetic; Tumor Cells, Cultured; Tumor Stem Cell Assay; Wnt Proteins	2013
The synthesis and characterization of a nuclear membrane affinity chromatography column for the study of human breast cancer resistant protein (BCRP) using nuclear membranes obtained from the LN-229 cells. Journal of pharmaceutical and biomedical analysis, 2013, Volume: 72 Topics: ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Breast Neoplasms; Cell Line; Cell Membrane; Chromatography, Affinity; Etoposide; Female; Humans; Ligands; Membranes, Artificial; Neoplasm Proteins; Nuclear Envelope; Protein Binding	2013
The role of insulin-like growth factor binding protein-3 in the breast cancer cell response to DNA-damaging agents. Oncogene, 2014, Jan-02, Volume: 33, Issue:1 Topics: Active Transport, Cell Nucleus; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Nucleus; Cell Survival; DNA Damage; DNA Repair; DNA-Activated Protein Kinase; Doxorubicin; ErbB Receptors; Etoposide; Female; Gefitinib; Humans; Insulin-Like Growth Factor Binding Protein 3; Membrane Microdomains; Phosphorylation; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Quinazolines	2014
Identification of transporters associated with Etoposide sensitivity of stomach cancer cell lines and methotrexate sensitivity of breast cancer cell lines by quantitative targeted absolute proteomics. Molecular pharmacology, 2013, Volume: 83, Issue:2 Topics: Biological Transport; Breast Neoplasms; Carrier Proteins; Cell Line, Tumor; Etoposide; Female; Humans; MCF-7 Cells; Membrane Proteins; Membrane Transport Proteins; Methotrexate; Multidrug Resistance-Associated Proteins; Propionates; Proteomics; Quinolines; Replication Protein C; Stomach Neoplasms	2013
Honokiol synergizes chemotherapy drugs in multidrug resistant breast cancer cells via enhanced apoptosis and additional programmed necrotic death. International journal of oncology, 2013, Volume: 42, Issue:2 Topics: Apoptosis; Biphenyl Compounds; Breast Neoplasms; Cyclophilins; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Etoposide; Female; Humans; Lignans; MCF-7 Cells; Peptidyl-Prolyl Isomerase F	2013
Identification of mitogen-activated protein kinase kinase as a chemoresistant pathway in MCF-7 cells by using gene expression microarray. Surgery, 2002, Volume: 132, Issue:2 Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Breast Neoplasms; Carcinogens; Cell Survival; Drug Resistance, Neoplasm; Etoposide; Female; Humans; MAP Kinase Kinase 5; Membrane Glycoproteins; Mitogen-Activated Protein Kinase 7; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Oligonucleotide Array Sequence Analysis; Phorbol Esters; TNF-Related Apoptosis-Inducing Ligand; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha	2002
The role of MAPK pathways in the action of chemotherapeutic drugs. Carcinogenesis, 2002, Volume: 23, Issue:11 Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carcinoma, Squamous Cell; Cell Cycle; Ceramides; Enzyme Activation; Enzyme Inhibitors; Etoposide; Female; Flavonoids; HeLa Cells; Humans; Imidazoles; MAP Kinase Signaling System; Microtubules; Mitogen-Activated Protein Kinases; Neoplasm Proteins; Paclitaxel; Pyridines; Skin Neoplasms; Topoisomerase II Inhibitors; Tumor Cells, Cultured; Tumor Stem Cell Assay	2002
Constitutive and inducible Akt activity promotes resistance to chemotherapy, trastuzumab, or tamoxifen in breast cancer cells. Molecular cancer therapeutics, 2002, Volume: 1, Issue:9 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Breast Neoplasms; Chromones; Doxorubicin; Drug Resistance, Neoplasm; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Etoposide; Flow Cytometry; Humans; Immunoblotting; Morpholines; Paclitaxel; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Tamoxifen; Time Factors; Transfection; Trastuzumab; Tumor Cells, Cultured	2002
Solitary esophageal metastasis of breast cancer after 11 years: a case report. Medical oncology (Northwood, London, England), 2002, Volume: 19, Issue:3 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Cisplatin; Deglutition Disorders; Diagnosis, Differential; Doxorubicin; Esophageal Neoplasms; Etoposide; Female; Humans; Immunohistochemistry; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Radiography; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen	2002
Staurosporine-induced death of MCF-7 human breast cancer cells: a distinction between caspase-3-dependent steps of apoptosis and the critical lethal lesions. Experimental cell research, 2003, Feb-15, Volume: 283, Issue:2 Topics: Apoptosis; Breast Neoplasms; Caspase 3; Caspases; Cell Death; Cell Survival; Clone Cells; Enzyme Inhibitors; Etoposide; Female; Humans; Mitochondria; Nucleic Acid Synthesis Inhibitors; Staurosporine; Tumor Cells, Cultured	2003
The activation of c-Jun NH2-terminal kinase (JNK) by DNA-damaging agents serves to promote drug resistance via activating transcription factor 2 (ATF2)-dependent enhanced DNA repair. The Journal of biological chemistry, 2003, Jun-06, Volume: 278, Issue:23 Topics: Activating Transcription Factor 2; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cisplatin; Cyclic AMP Response Element-Binding Protein; Dactinomycin; DNA Damage; DNA Repair; Drug Resistance, Neoplasm; Enzyme Inhibitors; Etoposide; Gastrointestinal Agents; Humans; JNK Mitogen-Activated Protein Kinases; Mitogen-Activated Protein Kinases; Phenotype; Transcription Factors; Transcriptional Activation; Tumor Cells, Cultured; Vitamin U	2003
Occult tumor cells detected in autologous blood stem cell harvests have no impact on 5 year outcomes for breast cancer patients with 4-9 positive nodes treated with adjuvant high-dose therapy and stem cell transplantation. Bone marrow transplantation, 2003, Volume: 31, Issue:7 Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Blood Component Removal; Breast Neoplasms; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Middle Aged; Survival Rate; Transplantation, Autologous; Treatment Outcome	2003
A novel carbazole topoisomerase II poison, ER-37328: potent tumoricidal activity against human solid tumors in vitro and in vivo. Cancer science, 2003, Volume: 94, Issue:1 Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carbazoles; Colonic Neoplasms; DNA Damage; DNA, Neoplasm; Dose-Response Relationship, Drug; Enzyme Inhibitors; Etoposide; Female; Humans; Lung Neoplasms; Macromolecular Substances; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Proteins; Protein Binding; Pyrimidines; Stomach Neoplasms; Topoisomerase II Inhibitors; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2003
E1A oncogene-induced sensitization of human tumor cells to innate immune defenses and chemotherapy-induced apoptosis in vitro and in vivo. Cancer research, 2003, Jun-15, Volume: 63, Issue:12 Topics: Adenovirus E1A Proteins; Adenoviruses, Human; Animals; Antineoplastic Agents; Apoptosis; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Line; Cytotoxicity, Immunologic; Drug Resistance, Neoplasm; Etoposide; Female; Fibrosarcoma; Genes, p53; Humans; Immunologic Surveillance; Kidney; Killer Cells, Natural; Mice; Mice, Nude; Oncogenes; Osteosarcoma; Rats; Rats, Nude; Time Factors; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays	2003
Association of mitochondrial calpain activation with increased expression and autolysis of calpain small subunit in an early stage of apoptosis. International journal of molecular medicine, 2003, Volume: 12, Issue:2 Topics: Antineoplastic Agents; Apoptosis; Autolysis; Breast Neoplasms; Calpain; Cytochrome c Group; Enzyme Activation; Enzyme Inhibitors; Etoposide; Female; Humans; Imidazoles; Jurkat Cells; Male; Mitochondria; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Prostatic Neoplasms; Protein Subunits; Tamoxifen; Tumor Cells, Cultured	2003
Cyclooxygenase-2 (COX-2) inhibitors sensitize tumor cells specifically to death receptor-induced apoptosis independently of COX-2 inhibition. Oncogene, 2003, Sep-11, Volume: 22, Issue:39 Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Breast Neoplasms; Caspase 3; Caspases; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; fas Receptor; Female; HeLa Cells; Humans; Isoenzymes; Membrane Glycoproteins; Membrane Proteins; Mitochondria; Nitrobenzenes; Prostaglandin-Endoperoxide Synthases; Receptors, Tumor Necrosis Factor; Sulfonamides; TNF-Related Apoptosis-Inducing Ligand; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha	2003
Synergistic interactions of chemotherapeutic drugs and tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand on apoptosis and on regression of breast carcinoma in vivo. Cancer research, 2003, Sep-01, Volume: 63, Issue:17 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Regulatory Proteins; bcl-X Protein; Breast Neoplasms; Camptothecin; Caspases; Doxorubicin; Drug Synergism; Enzyme Activation; Etoposide; Humans; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Mice, Nude; Paclitaxel; Proto-Oncogene Proteins c-bcl-2; Receptors, TNF-Related Apoptosis-Inducing Ligand; Receptors, Tumor Necrosis Factor; TNF-Related Apoptosis-Inducing Ligand; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Vinblastine; Vincristine; Xenograft Model Antitumor Assays	2003
Arylamine N-acetyltransferase-1 is highly expressed in breast cancers and conveys enhanced growth and resistance to etoposide in vitro. Molecular cancer research : MCR, 2003, Volume: 1, Issue:11 Topics: Arylamine N-Acetyltransferase; Breast; Breast Neoplasms; Cell Division; Cell Survival; Drug Resistance, Neoplasm; Etoposide; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Organ Specificity; Proteomics; RNA, Messenger; Tumor Cells, Cultured; Up-Regulation	2003
BRCA1 functions as a differential modulator of chemotherapy-induced apoptosis. Cancer research, 2003, Oct-01, Volume: 63, Issue:19 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Bleomycin; BRCA1 Protein; Breast Neoplasms; Cell Line, Tumor; Cisplatin; DNA Damage; Etoposide; G2 Phase; Humans; Microtubules; Mitosis; Paclitaxel; Vinblastine; Vinorelbine	2003
Pharmacokinetic study of cisplatin and infusional etoposide phosphate in advanced breast cancer with correlation of response to topoisomerase IIalpha expression. Clinical cancer research : an official journal of the American Association for Cancer Research, 2003, Oct-15, Volume: 9, Issue:13 Topics: Adult; Aged; Antigens, Neoplasm; Antineoplastic Agents; Breast Neoplasms; Cisplatin; Cohort Studies; Disease Progression; DNA Topoisomerases, Type II; DNA-Binding Proteins; Etoposide; Female; Humans; Immunohistochemistry; Infusions, Intravenous; Middle Aged; Neoplasm Metastasis; Organophosphorus Compounds; Receptors, Estrogen; Time Factors	2003
[Simultaneous detection of both non-Hodgkin's lymphoma cells and breast cancer cells in pleural effusion--a case report]. Gan to kagaku ryoho. Cancer & chemotherapy, 2003, Volume: 30, Issue:10 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Combinations; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Mastectomy, Segmental; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Pleural Effusion; Prednisone; Tamoxifen; Tegafur; Uracil; Vincristine	2003
Inhibition of histone deacetylase increases cytotoxicity to anticancer drugs targeting DNA. Cancer research, 2003, Nov-01, Volume: 63, Issue:21 Topics: Acetylation; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; DNA Topoisomerases, Type II; DNA, Neoplasm; Drug Synergism; Enzyme Inhibitors; Etoposide; Gene Expression; Glioblastoma; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Tumor Suppressor Protein p53; Vorinostat	2003
Hemopoietic recovery and infectious complications in breast cancer and multiple myeloma after autologous CD34+ cell-selected peripheral blood progenitor cell transplantation. International journal of hematology, 2004, Volume: 79, Issue:1 Topics: Adult; Aged; Antibiotic Prophylaxis; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Follow-Up Studies; Graft Survival; Hematopoiesis; Humans; Idarubicin; Ifosfamide; Infections; Male; Middle Aged; Multiple Myeloma; Neutropenia; Peripheral Blood Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Vincristine; Whole-Body Irradiation	2004
Specific downregulation of bcl-2 and xIAP by RNAi enhances the effects of chemotherapeutic agents in MCF-7 human breast cancer cells. Cancer gene therapy, 2004, Volume: 11, Issue:5 Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Down-Regulation; Doxorubicin; Etoposide; Female; Humans; Proteins; Proto-Oncogene Proteins c-bcl-2; RNA, Small Interfering; Transfection; X-Linked Inhibitor of Apoptosis Protein	2004
IL-4 protects tumor cells from anti-CD95 and chemotherapeutic agents via up-regulation of antiapoptotic proteins. Journal of immunology (Baltimore, Md. : 1950), 2004, May-01, Volume: 172, Issue:9 Topics: Antibodies, Monoclonal; Antineoplastic Agents; Apoptosis; bcl-X Protein; Breast Neoplasms; Camptothecin; Carrier Proteins; CASP8 and FADD-Like Apoptosis Regulating Protein; Cell Line, Tumor; Cell Survival; Etoposide; fas Receptor; Female; Humans; Interleukin-4; Intracellular Signaling Peptides and Proteins; Male; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Recombinant Proteins; Up-Regulation	2004
Effect of wild-type and mutant E-cadherin on cell proliferation and responsiveness to the chemotherapeutic agents cisplatin, etoposide, and 5-fluorouracil. Oncology, 2004, Volume: 66, Issue:2 Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cadherins; Cell Division; Cell Line, Tumor; Cisplatin; Colony-Forming Units Assay; DNA Mutational Analysis; Etoposide; Female; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; Mutation; Tumor Suppressor Protein p53	2004
Tamoxifen long-term treatment in vitro alters the apoptotic response of MCF-7 breast cancer cells. Anti-cancer drugs, 2004, Volume: 15, Issue:8 Topics: Annexin A5; Apoptosis; Breast Neoplasms; Drug Administration Schedule; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Enzyme-Linked Immunosorbent Assay; ErbB Receptors; Estrogen Receptor alpha; Estrogen Receptor beta; Etoposide; Germany; Histones; Humans; Hybridization, Genetic; Oligonucleotide Array Sequence Analysis; Receptor, ErbB-2; RNA; Staining and Labeling; Tamoxifen; Time Factors; Tumor Cells, Cultured; Up-Regulation	2004
Prediction of toxicant-specific gene expression signatures after chemotherapeutic treatment of breast cell lines. Environmental health perspectives, 2004, Volume: 112, Issue:16 Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Line, Tumor; Doxorubicin; Etoposide; Female; Fluorouracil; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Inhibitory Concentration 50; Oligonucleotide Array Sequence Analysis; RNA, Messenger	2004
A new human breast carcinoma cell line resistant to DNA-damaging drugs. Alternatives to laboratory animals : ATLA, 2004, Volume: 32, Issue:4 Topics: Benzimidazoles; Breast Neoplasms; DNA; DNA Damage; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Flow Cytometry; Humans; Tumor Cells, Cultured	2004
Suppression of RAD21 gene expression decreases cell growth and enhances cytotoxicity of etoposide and bleomycin in human breast cancer cells. Molecular cancer therapeutics, 2005, Volume: 4, Issue:3 Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; Bleomycin; Breast; Breast Neoplasms; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cell Survival; DNA Damage; DNA-Binding Proteins; Dose-Response Relationship, Drug; Drug Synergism; Etoposide; Gene Expression Regulation, Neoplastic; Genetic Predisposition to Disease; Genome; Humans; Neoplasms; Nuclear Proteins; Phosphoproteins; Polymorphism, Single Nucleotide; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Time Factors; Transfection	2005
Primary small-cell carcinoma of the breast. Clinical oncology (Royal College of Radiologists (Great Britain)), 2005, Volume: 17, Issue:3 Topics: Antineoplastic Agents; Axilla; Breast Neoplasms; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Humans; Lymph Node Excision; Mastectomy, Segmental; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Postmenopause; Radiotherapy; Treatment Outcome	2005
Polyadenylate polymerase modulations in human epithelioid cervix and breast cancer cell lines, treated with etoposide or cordycepin, follow cell cycle rather than apoptosis induction. Biological chemistry, 2005, Volume: 386, Issue:5 Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Caspase 6; Caspases; Cell Cycle; Cell Line, Tumor; Deoxyadenosines; DNA Fragmentation; Etoposide; Female; Humans; Isoenzymes; Neoplasms, Glandular and Epithelial; Polynucleotide Adenylyltransferase; Time Factors; Uterine Cervical Neoplasms	2005
Transcription factor NF-kappaB differentially regulates death receptor 5 expression involving histone deacetylase 1. Molecular and cellular biology, 2005, Volume: 25, Issue:13 Topics: Apoptosis; Binding Sites; Breast Neoplasms; Cell Culture Techniques; Cell Line; Cell Line, Tumor; Chromatin Immunoprecipitation; Epidermal Growth Factor; Etoposide; Female; Gene Expression Regulation; Genes, Reporter; Histone Deacetylases; Humans; Introns; Kidney; Luciferases; Mutation; NF-kappa B; Nucleic Acid Synthesis Inhibitors; Protein Binding; Receptors, TNF-Related Apoptosis-Inducing Ligand; Receptors, Tumor Necrosis Factor; Time Factors; Tumor Suppressor Protein p53	2005
Enhanced G2-M arrest by nuclear factor-{kappa}B-dependent p21waf1/cip1 induction. Molecular cancer research : MCR, 2005, Volume: 3, Issue:6 Topics: Antibiotics, Antineoplastic; Apoptosis; Breast Neoplasms; Camptothecin; Cell Cycle Proteins; Cell Line, Tumor; Cell Survival; Cyclin-Dependent Kinase Inhibitor p21; Doxorubicin; Enzyme Inhibitors; Etoposide; Female; Flow Cytometry; G2 Phase; Humans; Mitosis; NF-kappa B; Nucleic Acid Synthesis Inhibitors; Radiation, Ionizing; RNA Interference; T-Lymphocytes; Time Factors; Tumor Necrosis Factor-alpha	2005
Vascular targeting and antiangiogenesis agents induce drug resistance effector GRP78 within the tumor microenvironment. Cancer research, 2005, Jul-01, Volume: 65, Issue:13 Topics: Angiogenesis Inhibitors; Animals; Breast Neoplasms; Disintegrins; Drug Resistance, Neoplasm; Endoplasmic Reticulum Chaperone BiP; Etoposide; Female; Glucose; Heat-Shock Proteins; Humans; Mice; Mice, Nude; Molecular Chaperones; Neovascularization, Pathologic; Oxygen; Promoter Regions, Genetic; RNA, Small Interfering; Stilbenes; Transcriptional Activation; Transfection; Xenograft Model Antitumor Assays	2005
Platinum-based chemotherapy in metastatic breast cancer: the Leicester (U.K.) experience. Clinical oncology (Royal College of Radiologists (Great Britain)), 2005, Volume: 17, Issue:4 Topics: Adult; Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Etoposide; Female; Humans; Middle Aged; Mitomycins; Neoplasm Metastasis; Neutropenia; Retrospective Studies; Salvage Therapy; Taxoids; Treatment Outcome; United Kingdom; Vinblastine	2005
Rho GDP dissociation inhibitor protects cancer cells against drug-induced apoptosis. Cancer research, 2005, Jul-15, Volume: 65, Issue:14 Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; Base Sequence; Breast Neoplasms; Caspase 3; Caspase Inhibitors; Caspases; Cell Line, Tumor; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Guanine Nucleotide Dissociation Inhibitors; Humans; Lymphoma; Molecular Sequence Data; Mutation; rac1 GTP-Binding Protein; rho Guanine Nucleotide Dissociation Inhibitor alpha; rho-Specific Guanine Nucleotide Dissociation Inhibitors; RNA Interference; RNA, Small Interfering; Transfection	2005
A small molecule Smac-mimic compound induces apoptosis and sensitizes TRAIL- and etoposide-induced apoptosis in breast cancer cells. Oncogene, 2005, Nov-10, Volume: 24, Issue:49 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Baculoviral IAP Repeat-Containing 3 Protein; Breast Neoplasms; Caspase 3; Caspases; Drug Resistance, Neoplasm; Enzyme Activation; Etoposide; Humans; Inhibitor of Apoptosis Proteins; Intracellular Signaling Peptides and Proteins; Membrane Glycoproteins; Mitochondrial Proteins; Molecular Mimicry; TNF-Related Apoptosis-Inducing Ligand; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Ubiquitin-Protein Ligases; X-Linked Inhibitor of Apoptosis Protein	2005
Gefitinib reverses chemotherapy resistance in gefitinib-insensitive multidrug resistant cancer cells expressing ATP-binding cassette family protein. Cancer research, 2005, Aug-01, Volume: 65, Issue:15 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; ATP-Binding Cassette Transporters; Breast Neoplasms; Cell Line, Tumor; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Etoposide; Gefitinib; Humans; Lung Neoplasms; Paclitaxel; Protein Kinase Inhibitors; Quinazolines; Topotecan	2005
Adenovirus-mediated human topoisomerase IIalpha gene transfer increases the sensitivity of etoposide-resistant human and mouse breast cancer cells. Acta oncologica (Stockholm, Sweden), 2005, Volume: 44, Issue:3 Topics: Adenoviridae; Animals; Antigens, Neoplasm; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; DNA Topoisomerases, Type II; DNA-Binding Proteins; Drug Resistance, Neoplasm; Etoposide; Female; Gene Expression Regulation, Enzymologic; Gene Transfer Techniques; Genetic Vectors; Humans; Isoenzymes; Leukemia; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred Strains; RNA, Messenger; Transduction, Genetic; Tumor Burden	2005
A Case of Burkitt's Lymphoma Involving Both Breasts. Breast cancer (Tokyo, Japan), 2005, Volume: 12, Issue:3 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Dexamethasone; Diagnostic Errors; Doxorubicin; Etoposide; Fatal Outcome; Female; Humans; Lymphoma, B-Cell; Peripheral Blood Stem Cell Transplantation; Prednisone; Vincristine	2005
Mutant p53 gain of function: reduction of tumor malignancy of human cancer cell lines through abrogation of mutant p53 expression. Oncogene, 2006, Jan-12, Volume: 25, Issue:2 Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; Breast Neoplasms; Cell Proliferation; Cisplatin; Colonic Neoplasms; Colony-Forming Units Assay; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Mice; Mice, Nude; Mutation; Radiation-Sensitizing Agents; Transplantation, Heterologous; Tumor Cells, Cultured; Tumor Suppressor Protein p53	2006
Cross talk between apoptosis and invasion signaling in cancer cells through caspase-3 activation. Cancer research, 2005, Oct-15, Volume: 65, Issue:20 Topics: Animals; Apoptosis; Breast Neoplasms; Caspase 3; Caspase Inhibitors; Caspases; Cell Line, Tumor; Enzyme Activation; Etoposide; Gene Silencing; Humans; Liver Neoplasms, Experimental; Neoplasm Invasiveness; Rats; Signal Transduction	2005
BRCA1 and c-Myc associate to transcriptionally repress psoriasin, a DNA damage-inducible gene. Cancer research, 2005, Nov-15, Volume: 65, Issue:22 Topics: Antineoplastic Agents, Phytogenic; BRCA1 Protein; Breast Neoplasms; Calcium-Binding Proteins; Cell Line, Tumor; DNA Damage; Drug Resistance, Neoplasm; Etoposide; Gene Expression Regulation, Neoplastic; Genes, BRCA1; Humans; Proto-Oncogene Proteins c-myc; RNA, Small Interfering; S100 Calcium Binding Protein A7; S100 Proteins; Transcription, Genetic; Transfection	2005
Survivin expression is regulated by coexpression of human epidermal growth factor receptor 2 and epidermal growth factor receptor via phosphatidylinositol 3-kinase/AKT signaling pathway in breast cancer cells. Cancer research, 2005, Dec-01, Volume: 65, Issue:23 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Apoptosis; Breast Neoplasms; Cell Line, Tumor; ErbB Receptors; Etoposide; Humans; Immunohistochemistry; Inhibitor of Apoptosis Proteins; Microtubule-Associated Proteins; Neoplasm Proteins; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Receptor, ErbB-2; Signal Transduction; Survivin; Transfection; Trastuzumab; Up-Regulation	2005
Labd-14-ene-8,13-diol (sclareol) induces cell cycle arrest and apoptosis in human breast cancer cells and enhances the activity of anticancer drugs. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2006, Volume: 60, Issue:3 Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cisplatin; Diterpenes; Dose-Response Relationship, Drug; Doxorubicin; Drug Interactions; Etoposide; Female; G1 Phase; Humans; Resting Phase, Cell Cycle; S Phase; Time Factors; Tumor Suppressor Protein p53	2006
Rare germ line CHEK2 variants identified in breast cancer families encode proteins that show impaired activation. Cancer research, 2006, Sep-15, Volume: 66, Issue:18 Topics: Amino Acid Sequence; Animals; Breast Neoplasms; Cell Line, Tumor; Checkpoint Kinase 2; Computational Biology; DNA Damage; Enzyme Activation; Etoposide; Germ-Line Mutation; Humans; Molecular Sequence Data; Mutagenesis, Site-Directed; Phosphorylation; Protein Isoforms; Protein Serine-Threonine Kinases; Sequence Alignment; Transfection	2006
(-)-Epigallocatechin gallate overcomes resistance to etoposide-induced cell death by targeting the molecular chaperone glucose-regulated protein 78. Cancer research, 2006, Sep-15, Volume: 66, Issue:18 Topics: Adenosine Triphosphatases; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Breast Neoplasms; Caspase 7; Caspase Inhibitors; Catechin; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Synergism; Endoplasmic Reticulum Chaperone BiP; Etoposide; Heat-Shock Proteins; Humans; Mice; Molecular Chaperones; Protein Conformation; Urinary Bladder Neoplasms	2006
Endonuclease G promotes cell death of non-invasive human breast cancer cells. Experimental cell research, 2006, Dec-10, Volume: 312, Issue:20 Topics: Animals; Apoptosis; Breast; Breast Neoplasms; Camptothecin; Cell Death; Cell Line, Tumor; Cell Movement; DNA Fragmentation; Endodeoxyribonucleases; Etoposide; Humans; Mice; Mice, Knockout; Transfection	2006
DNA topoisomerase IIalpha (TOP2A) inhibitors up-regulate fatty acid synthase gene expression in SK-Br3 breast cancer cells: in vitro evidence for a 'functional amplicon' involving FAS, Her-2/neu and TOP2A genes. International journal of molecular medicine, 2006, Volume: 18, Issue:6 Topics: Antibiotics, Antineoplastic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antigens, Neoplasm; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; DNA Topoisomerases, Type II; DNA-Binding Proteins; Doxorubicin; Enzyme Inhibitors; Etoposide; Fatty Acid Synthases; Female; Gene Amplification; Gene Expression Regulation, Neoplastic; Genes, erbB-2; Humans; In Vitro Techniques; Luciferases; Poly-ADP-Ribose Binding Proteins; Promoter Regions, Genetic; Topoisomerase II Inhibitors; Trastuzumab; Up-Regulation	2006
Evidence of a novel antiapoptotic factor: role of inhibitor of differentiation or DNA binding (Id-1) in anticancer drug-induced apoptosis. Cancer science, 2007, Volume: 98, Issue:3 Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carcinoma, Hepatocellular; Catechin; Cell Line, Tumor; Cell Survival; Cisplatin; Down-Regulation; Doxorubicin; Etoposide; Female; HeLa Cells; Humans; Inhibitor of Differentiation Protein 1; Liver Neoplasms; Male; Mechlorethamine; Methotrexate; Mitomycin; Nasopharyngeal Neoplasms; Paclitaxel; Prostatic Neoplasms; Vincristine	2007
Chemotherapy and zoledronate sensitize solid tumour cells to Vgamma9Vdelta2 T cell cytotoxicity. Cancer immunology, immunotherapy : CII, 2007, Volume: 56, Issue:8 Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Burkitt Lymphoma; Carcinoma; Cell Line, Tumor; Cisplatin; Colorectal Neoplasms; Concanavalin A; Cytotoxicity, Immunologic; Diphosphonates; Doxorubicin; Drug Screening Assays, Antitumor; Drug Synergism; Etoposide; Female; Genes, T-Cell Receptor delta; Genes, T-Cell Receptor gamma; Humans; Imidazoles; Interferon-gamma; Lovastatin; Lung Neoplasms; Male; Membrane Glycoproteins; Neoplasms; Perforin; Pore Forming Cytotoxic Proteins; Prostatic Neoplasms; Receptors, Antigen, T-Cell, gamma-delta; T-Lymphocyte Subsets; Urinary Bladder Neoplasms; Vincristine; Zoledronic Acid	2007
Biophysical characterization of MDR breast cancer cell lines reveals the cytoplasm is critical in determining drug sensitivity. Biochimica et biophysica acta, 2007, Volume: 1770, Issue:4 Topics: Anthracyclines; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Breast Neoplasms; Carbocyanines; Cell Line, Tumor; Cell Survival; Cisplatin; Colchicine; Cytoplasm; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Electrophoresis; Etoposide; Female; Fluorescent Dyes; Humans; Inhibitory Concentration 50; Membrane Potentials; Membrane Transport Proteins; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Paclitaxel; Phenotype	2007
Pneumatosis coli after etoposide chemotherapy for breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007, Apr-20, Volume: 25, Issue:12 Topics: Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Dose-Response Relationship, Drug; Etoposide; Female; Follow-Up Studies; Humans; Mastectomy, Modified Radical; Middle Aged; Pneumatosis Cystoides Intestinalis; Radiography, Abdominal; Risk Assessment; Severity of Illness Index	2007
Cellular FLICE-inhibitory protein regulates chemotherapy-induced apoptosis in breast cancer cells. Molecular cancer therapeutics, 2007, Volume: 6, Issue:5 Topics: Antineoplastic Agents; Blotting, Western; Breast Neoplasms; Camptothecin; CASP8 and FADD-Like Apoptosis Regulating Protein; Caspase 8; Cell Line, Tumor; Dose-Response Relationship, Drug; Down-Regulation; Etoposide; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Interferon-gamma; Irinotecan; Mitoxantrone	2007
Inducible expression of maize polyamine oxidase in the nucleus of MCF-7 human breast cancer cells confers sensitivity to etoposide. Amino acids, 2008, Volume: 34, Issue:3 Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Doxycycline; Etoposide; Gene Expression Regulation, Enzymologic; Humans; Oxidoreductases Acting on CH-NH Group Donors; Polyamine Oxidase; Polyamines; Recombinant Proteins; Zea mays	2008
The ubiquitin-conjugating enzyme E2-EPF is overexpressed in primary breast cancer and modulates sensitivity to topoisomerase II inhibition. Neoplasia (New York, N.Y.), 2007, Volume: 9, Issue:7 Topics: Breast Neoplasms; Cell Cycle; Cell Proliferation; Doxorubicin; Drug Resistance, Neoplasm; Enzyme Inhibitors; Etoposide; HeLa Cells; Humans; Receptors, Estrogen; RNA, Small Interfering; Topoisomerase II Inhibitors; Transcriptional Activation; Ubiquitin-Conjugating Enzymes; Up-Regulation	2007
Profiling of apoptotic changes in human breast cancer cells using SELDI-TOF mass spectrometry. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2007, Volume: 20, Issue:5 Topics: Apoptosis; Biomarkers; Breast Neoplasms; Caspase Inhibitors; Caspases; Cell Cycle Proteins; Cell Line, Tumor; Densitometry; Etoposide; Humans; Protease Inhibitors; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Protein Binding; Proteomics; S100 Calcium Binding Protein A6; S100 Proteins; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Time Factors; TNF-Related Apoptosis-Inducing Ligand	2007
Chemopreventive agents induce programmed death-1-ligand 1 (PD-L1) surface expression in breast cancer cells and promote PD-L1-mediated T cell apoptosis. Molecular immunology, 2008, Volume: 45, Issue:5 Topics: Antigens, CD; Antineoplastic Agents; Apoptosis; B7-H1 Antigen; Breast Neoplasms; Cell Line, Tumor; Etoposide; Female; Gene Expression Regulation; Humans; Paclitaxel; T-Lymphocytes	2008
Significance of mitochondrial calcium and nitric oxide for apoptosis of human breast cancer cells induced by tamoxifen and etoposide. International journal of molecular medicine, 2008, Volume: 21, Issue:3 Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Calcium; Cell Line, Tumor; Cytochromes c; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Membrane Potential, Mitochondrial; Mitochondria; Nitric Oxide; Tamoxifen; Time Factors; Tyrosine	2008
Polysaccharopeptide enhances the anticancer activity of doxorubicin and etoposide on human breast cancer cells ZR-75-30. International journal of oncology, 2008, Volume: 32, Issue:3 Topics: Antineoplastic Agents; Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Doxorubicin; Drug Evaluation, Preclinical; Drug Synergism; Etoposide; Female; Humans; Middle Aged; Models, Biological; Proteoglycans	2008
[Effect of neoadjuvant chemotherapy on ERCC1 gene expression in breast cancer]. Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2008, Volume: 28, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; DNA-Binding Proteins; Docetaxel; Endonucleases; Etoposide; Female; Gene Expression Regulation, Neoplastic; Humans; Middle Aged; Neoadjuvant Therapy; Reverse Transcriptase Polymerase Chain Reaction; Taxoids	2008
Primary small cell carcinoma of the breast. Breast cancer (Tokyo, Japan), 2009, Volume: 16, Issue:1 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Camptothecin; Carboplatin; Carcinoma, Small Cell; Etoposide; Fatal Outcome; Female; Humans; Irinotecan; Liver Neoplasms; Mastectomy; Middle Aged; Neoplasm Recurrence, Local; Thoracic Wall	2009
Clinical trials in cancer medicine. Australian family physician, 1980, Volume: 9, Issue:1 Topics: Adult; Antineoplastic Agents; Bleomycin; Breast Neoplasms; Clinical Trials as Topic; Doxorubicin; Etoposide; Female; Humans; Male; Methotrexate; Platinum; Tamoxifen; Teniposide; Testicular Neoplasms	1980
Mitomycin-C, VP16-213 combination as third line chemotherapy in advanced breast cancer. Cancer chemotherapy and pharmacology, 1982, Volume: 7, Issue:2-3 Topics: Adult; Breast Neoplasms; Drug Therapy, Combination; Etoposide; Female; Humans; Middle Aged; Mitomycin; Mitomycins; Podophyllotoxin	1982
VP16-213 and cyclophosphamide in advanced breast cancer. A phase II study. Cancer chemotherapy and pharmacology, 1983, Volume: 10, Issue:3 Topics: Adult; Aged; Breast Neoplasms; Cyclophosphamide; Drug Evaluation; Drug Synergism; Drug Therapy, Combination; Etoposide; Female; Humans; Middle Aged; Neoplasm Metastasis; Podophyllotoxin; Prognosis	1983
Adriamycin and VP16-213 combination treatment for breast cancer previously treated by the CMF regimen. Cancer chemotherapy and pharmacology, 1982, Volume: 7, Issue:2-3 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Resistance; Drug Therapy, Combination; Etoposide; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Neoplasm Metastasis; Podophyllotoxin	1982
VP-16 and adriamycin in patients with advanced breast cancer. American journal of clinical oncology, 1982, Volume: 5, Issue:5 Topics: Adenocarcinoma; Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dexamethasone; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Fluorouracil; Humans; Leukopenia; Male; Methotrexate; Middle Aged; Podophyllotoxin; Prednisone; Thrombocytopenia; Vincristine; Vomiting	1982
Phase II study of VP16-213 (etoposide) in refractory metastatic breast carcinoma. Cancer chemotherapy and pharmacology, 1982, Volume: 7, Issue:2-3 Topics: Adult; Aged; Breast Neoplasms; Drug Evaluation; Drug Resistance; Etoposide; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Podophyllotoxin	1982
Etoposide in the treatment of refractory breast cancer. Cancer treatment reviews, 1982, Volume: 9 Suppl Topics: Antineoplastic Agents; Breast Neoplasms; Drug Therapy, Combination; Etoposide; Female; Humans; Podophyllotoxin	1982
Evaluation of the cytotoxic activity of gemcitabine in primary cultures of tumor cells from patients with hematologic or solid tumors. Seminars in oncology, 1995, Volume: 22, Issue:4 Suppl 11 Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Breast Neoplasms; Cisplatin; Cladribine; Colorectal Neoplasms; Cytarabine; Deoxycytidine; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Gemcitabine; Humans; In Vitro Techniques; Leukemia; Lung Neoplasms; Lymphoma; Ribonucleotide Reductases; Tumor Cells, Cultured; Urogenital Neoplasms	1995
Correlation of colony-forming cells, long-term culture initiating cells and CD34+ cells in apheresis products from patients mobilized for peripheral blood progenitors with different regimens. Bone marrow transplantation, 1994, Volume: 13, Issue:4 Topics: Adult; Antigens, CD; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Blood Component Transfusion; Blood Transfusion, Autologous; Breast Neoplasms; Colony-Forming Units Assay; Cyclophosphamide; Etoposide; Female; Flow Cytometry; Granulocyte Colony-Stimulating Factor; Hematopoiesis; Hematopoietic Stem Cells; Humans; Immunologic Factors; Leukapheresis; Lymphoma, Non-Hodgkin; Middle Aged; Neutropenia; Ovarian Neoplasms	1994
Clostridium septicum abscess in hepatic metastases: successful medical management. Bone marrow transplantation, 1994, Volume: 13, Issue:4 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Carmustine; Ceftazidime; Cisplatin; Clindamycin; Clostridium Infections; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Fluorouracil; Gases; Granulocyte Colony-Stimulating Factor; Humans; Imipenem; Immunocompromised Host; Liver Abscess; Liver Neoplasms; Methotrexate; Neutropenia; Sepsis	1994
Retroviral mediated transfer of the human multidrug resistance gene (MDR-1) into hematopoietic stem cells during autologous transplantation after intensive chemotherapy for metastatic breast cancer. Human gene therapy, 1994, Volume: 5, Issue:7 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bone Marrow Transplantation; Breast Neoplasms; Carboplatin; Clinical Protocols; Drug Resistance; Etoposide; Genetic Vectors; Hematopoietic Cell Growth Factors; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Ifosfamide; Informed Consent; Interleukin-3; Interleukin-6; Mesna; Middle Aged; Neoplasm Metastasis; Paclitaxel; Pancytopenia; Recombinant Fusion Proteins; Recombinant Proteins; Retroviridae; Stem Cell Factor; Transplantation, Autologous; Vinblastine	1994
The severe combined immunodeficient-human peripheral blood stem cell (SCID-huPBSC) mouse: a xenotransplant model for huPBSC-initiated hematopoiesis. Blood, 1995, Jul-01, Volume: 86, Issue:1 Topics: Adult; Animals; Antibody Formation; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Breast Neoplasms; Cell Line; Chimera; Cisplatin; Cyclophosphamide; Epirubicin; Etoposide; Female; Fibroblasts; Fluorouracil; Graft Survival; Granulocyte Colony-Stimulating Factor; Hematopoiesis; Hematopoietic Cell Growth Factors; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Ifosfamide; Interleukin-3; Lymphoid Tissue; Male; Mice; Mice, SCID; Middle Aged; Ovarian Neoplasms; Rats; Severe Combined Immunodeficiency; Testicular Neoplasms; Transplantation, Heterologous	1995
Enrichment of bone marrow and blood progenitor (CD34+) cells by density gradients with sufficient yields for transplantation. Experimental hematology, 1995, Volume: 23, Issue:9 Topics: Antigens, CD; Antigens, CD34; Bone Marrow; Bone Marrow Cells; Breast Neoplasms; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Separation; Centrifugation, Density Gradient; Colony-Forming Units Assay; Etoposide; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Lymphocyte Depletion; Lymphoma, Non-Hodgkin; Mucins; Povidone; Reference Values; Silicon Dioxide; T-Lymphocytes	1995
A marrow harvest procedure under local anesthesia. Experimental hematology, 1995, Volume: 23, Issue:11 Topics: Anesthesia, Local; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Breast Neoplasms; Carmustine; Combined Modality Therapy; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Lung Neoplasms; Mitoxantrone; Outpatients; Pain Measurement; Thiotepa; Tissue Preservation; Transplantation, Autologous	1995
High-dose ifosfamide, carboplatin, and etoposide with autologous stem-cell support. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:7 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Parenteral Nutrition, Total	1995
Carboplatin and etoposide in metastatic breast cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 1995, Volume: 6, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Etoposide; Female; Humans	1995
O-phospho-L-tyrosine inhibits cellular growth by activating protein tyrosine phosphatases. Cancer research, 1993, Feb-01, Volume: 53, Issue:3 Topics: Breast Neoplasms; Carcinoma, Renal Cell; Cell Death; Cell Division; Doxorubicin; Enzyme Activation; Epidermal Growth Factor; ErbB Receptors; Etoposide; Humans; Kidney Neoplasms; Neoplasm Proteins; Phosphorylation; Phosphotyrosine; Protein Tyrosine Phosphatases; S Phase; Sensitivity and Specificity; Tumor Cells, Cultured; Tyrosine	1993
Role of chemotherapy and GM-CSF on hemopoietic progenitor cell mobilization in multiple myeloma. Bone marrow transplantation, 1993, Volume: 11, Issue:4 Topics: Adult; Aged; Antigens, CD; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Breast Neoplasms; Colony-Forming Units Assay; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Doxorubicin; Etoposide; Feasibility Studies; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cells; Humans; Immunologic Factors; Lymphoma; Male; Middle Aged; Multiple Myeloma; Pilot Projects; Prednisone; Recombinant Proteins; Vincristine	1993
Rapid administration of multiple cycles of high-dose myelosuppressive chemotherapy in patients with metastatic breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1993, Volume: 11, Issue:6 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Breast Neoplasms; Carboplatin; Carcinoma; Cyclophosphamide; Drug Administration Schedule; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Middle Aged	1993
Buthionine sulphoximine-mediated sensitisation of etoposide-resistant human breast cancer MCF7 cells overexpressing the multidrug resistance-associated protein involves increased drug accumulation. British journal of cancer, 1995, Volume: 71, Issue:4 Topics: Antimetabolites, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Buthionine Sulfoximine; Cell Line; Cell Survival; Drug Resistance, Multiple; Etoposide; Female; Glutathione; Humans; Kinetics; Methionine Sulfoximine; Tumor Cells, Cultured; Vincristine	1995
Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifylline. Cancer research, 1995, Apr-15, Volume: 55, Issue:8 Topics: Apoptosis; Breast Neoplasms; Cell Line; Cell Survival; Cisplatin; Clone Cells; Doxorubicin; Etoposide; G1 Phase; Gamma Rays; Genes, p53; Genes, Viral; Humans; Methyl Methanesulfonate; Oncogenes; Papillomaviridae; Pentoxifylline; Transfection; Tumor Cells, Cultured	1995
Ca2+/Mg(2+)-dependent endonuclease activation is an early event in VP-16-induced apoptosis of human breast cancer MCF7 cells in vitro. Biochimica et biophysica acta, 1995, Apr-28, Volume: 1266, Issue:2 Topics: Apoptosis; Breast Neoplasms; Calcium; DNA; Endonucleases; Enzyme Activation; Etoposide; Humans; Magnesium; Plasmids; Tumor Cells, Cultured	1995
MCF-7 human mammary adenocarcinoma cell death in vitro in response to hormone-withdrawal and DNA damage. International journal of cancer, 1995, May-16, Volume: 61, Issue:4 Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Cycle; Cell Death; Cell Division; Cell Survival; DNA Damage; DNA, Neoplasm; Estradiol; Estrogen Antagonists; Estrogens; Etoposide; Fulvestrant; Humans; Mechlorethamine; Neoplasms, Hormone-Dependent; Tumor Cells, Cultured	1995
[Comparison of the effectiveness and toxicity of parenteral and oral vepesid in the treatment of disseminated breast cancer]. Vestnik Rossiiskoi akademii meditsinskikh nauk, 1995, Issue:4 Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Epirubicin; Etoposide; Female; Humans; Injections, Intravenous; Lymphatic Metastasis; Middle Aged; Neoplasm Metastasis; Time Factors	1995
Multidrug resistance-associated protein gene overexpression and reduced drug sensitivity of topoisomerase II in a human breast carcinoma MCF7 cell line selected for etoposide resistance. Cancer research, 1994, Jan-01, Volume: 54, Issue:1 Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Carrier Proteins; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Drug Resistance; Etoposide; Female; Humans; Membrane Glycoproteins; RNA, Messenger; Teniposide; Tumor Cells, Cultured	1994
High-dose cisplatin, etoposide, and cyclophosphamide with autologous stem cell reinfusion in patients with responsive metastatic or high-risk primary breast cancer. Cancer, 1994, Jan-01, Volume: 73, Issue:1 Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Bone Marrow Transplantation; Breast Neoplasms; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Drug Administration Schedule; Etoposide; Feasibility Studies; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Middle Aged; Neoplasm Staging; Remission Induction; Risk Factors; Survival Rate; Transplantation, Autologous	1994
Etoposide for metastatic breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1994, Volume: 12, Issue:10 Topics: Breast Neoplasms; Etoposide; Humans; Neoplasm Metastasis; Remission Induction	1994
Busulfan-containing pre-transplant regimens for the treatment of solid tumors. Bone marrow transplantation, 1994, Volume: 14, Issue:3 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Busulfan; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Follow-Up Studies; Humans; Middle Aged; Neoplasms; Ovarian Neoplasms; Pilot Projects; Retrospective Studies; Sarcoma	1994
Enhanced expression of HLA-A,B,C and inducibility of TAP-1, TAP-2, and HLA-A,B,C by interferon-gamma in a multidrug-resistant small cell lung cancer line. Lymphokine and cytokine research, 1994, Volume: 13, Issue:2 Topics: ATP Binding Cassette Transporter, Subfamily B, Member 2; ATP Binding Cassette Transporter, Subfamily B, Member 3; ATP-Binding Cassette Transporters; Base Sequence; Breast Neoplasms; Carcinoma, Small Cell; Carrier Proteins; Cytotoxicity, Immunologic; DNA Primers; Drug Resistance; Etoposide; Female; Gene Expression; HLA Antigens; Humans; Interferon-gamma; Killer Cells, Lymphokine-Activated; Lung Neoplasms; Molecular Sequence Data; Ovarian Neoplasms; Recombinant Proteins; Tumor Cells, Cultured	1994
Amendment to clinical research projects. Genetic marking with retroviral vectors to study the feasibility of stem cell gene transfer and the biology of hematopoietic reconstitution after autologous transplantation in multiple myeloma, chronic myelogenous Human gene therapy, 1993, Volume: 4, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Transplantation; Breast Neoplasms; Cisplatin; Clinical Protocols; Combined Modality Therapy; Cyclophosphamide; Etoposide; Feasibility Studies; Genetic Therapy; Genetic Vectors; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Melphalan; Multiple Myeloma; Neoplasm Metastasis; Retroviridae; Transfection; Transplantation, Autologous; Whole-Body Irradiation	1993
Taxol in combination with doxorubicin or etoposide. Possible antagonism in vitro. Cancer, 1993, Nov-01, Volume: 72, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; DNA, Neoplasm; Doxorubicin; Drug Interactions; Drug Screening Assays, Antitumor; Etoposide; Female; Flow Cytometry; Humans; Lung Neoplasms; Ovarian Neoplasms; Paclitaxel; Tumor Cells, Cultured	1993
High-dose, brief duration, multiagent chemotherapy for metastatic breast cancer. Cancer, 1994, Apr-01, Volume: 73, Issue:7 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Neoplasms; Brain Neoplasms; Breast Neoplasms; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Fluorouracil; Follow-Up Studies; Hemorrhage; Humans; Leucovorin; Liver Neoplasms; Lung Neoplasms; Methotrexate; Middle Aged; Neutropenia; Remission Induction; Survival Rate; Thrombocytopenia	1994
Carboplatin and oral etoposide in the treatment of patients with advanced breast cancer refractory to anthracyclines. Tumori, 1993, Dec-31, Volume: 79, Issue:6 Topics: Administration, Oral; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Drug Resistance; Etoposide; Female; Humans; Middle Aged; Survival Analysis; Treatment Outcome	1993
Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. The EMBO journal, 1993, Volume: 12, Issue:9 Topics: Animals; Apoptosis; Breast Neoplasms; Cell Line; Cell Line, Transformed; DNA; DNA, Neoplasm; Epithelial Cells; Etoposide; Female; Genes, ras; Humans; Male; Nucleosomes; Prostatic Neoplasms; Rats; Recombinant Proteins; Transforming Growth Factor beta; Tumor Cells, Cultured	1993
[Four cases of advanced adenocarcinoma showing marked response to EAP (etoposide, ADM, CDDP) treatment]. Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:15 Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Doxorubicin; Etoposide; Female; Gallbladder Neoplasms; Humans; Male; Middle Aged; Rectal Neoplasms; Remission Induction	1993
Induction chemotherapy and intensification with autologous bone marrow reinfusion in patients with locally advanced and disseminated breast cancer. European journal of cancer (Oxford, England : 1990), 1993, Volume: 29A, Issue:5 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Prednisone; Prognosis; Remission Induction; Time Factors; Transplantation, Autologous; Vincristine	1993
The effect of hypoxia on acquired drug resistance and response to epidermal growth factor in Chinese hamster lung fibroblasts and human breast-cancer cells in vitro. International journal of cancer, 1993, Jun-19, Volume: 54, Issue:4 Topics: Animals; Breast Neoplasms; Cell Hypoxia; Cricetinae; Cricetulus; Doxorubicin; Drug Resistance; Epidermal Growth Factor; Etoposide; Fibroblasts; Humans; Lung; Tumor Cells, Cultured	1993
Dose-intensive chemotherapy with etoposide-cyclophosphamide for advanced breast cancer. North American Marrow Transplant Group. Seminars in oncology, 1996, Volume: 23, Issue:2 Suppl 4 Topics: Adult; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Interleukin-3; Middle Aged; Neoplasm Metastasis; Recombinant Proteins; Thrombocytopenia; Treatment Outcome	1996
High-dose cyclophosphamide, carboplatin, and etoposide with autologous stem cell rescue in patients with breast cancer. American journal of clinical oncology, 1996, Volume: 19, Issue:2 Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Combined Modality Therapy; Creatinine; Cyclophosphamide; Diarrhea; Disease-Free Survival; Drug Resistance, Neoplasm; Etoposide; Female; Fever; Hematopoietic Stem Cell Transplantation; Humans; Middle Aged; Nausea; Neutropenia; Remission Induction; Transplantation, Autologous; Treatment Outcome; Vomiting	1996
Multiple cycles of high dose chemotherapy supported by hematopoietic progenitor cells as treatment for patients with advanced malignancies. Cancer, 1995, Sep-01, Volume: 76, Issue:5 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Breast Neoplasms; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Leukapheresis; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Neoplasm Metastasis; Thiotepa	1995
Clinical significance of bone marrow metastases as detected using the polymerase chain reaction in patients with breast cancer undergoing high-dose chemotherapy and autologous bone marrow transplantation. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1996, Volume: 14, Issue:6 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Bone Marrow Transplantation; Breast Neoplasms; Carboplatin; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Immunohistochemistry; Keratins; Middle Aged; Polymerase Chain Reaction; Prognosis; Recurrence; Retrospective Studies; Sensitivity and Specificity	1996
Comparison of costs for infusion versus bolus chemotherapy administration: analysis of five standard chemotherapy regimens in three common tumors--Part one. Model projections for cost based on charges. Cancer, 1996, Jul-15, Volume: 78, Issue:2 Topics: Antibiotics, Antineoplastic; Antidotes; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Colonic Neoplasms; Costs and Cost Analysis; Cyclophosphamide; Disposable Equipment; Doxorubicin; Drug Costs; Etoposide; Fees, Medical; Fees, Pharmaceutical; Female; Fluorouracil; Humans; Infusions, Intravenous; Injections, Intravenous; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Models, Economic; Prednisone; Survival Rate; Vincristine	1996
Ifosfamide, carboplatin, etoposide, and paclitaxel chemotherapy: a dose-escalation study. Seminars in oncology, 1996, Volume: 23, Issue:3 Suppl 6 Topics: Adult; Aged; Alopecia; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Etoposide; Female; Fever; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Leukopenia; Male; Middle Aged; Neoplasms; Neutropenia; Paclitaxel; Pilot Projects; Remission Induction; Sarcoma; Thrombocytopenia	1996
Drug-resistant breast cancer cells frequently retain expression of a functional wild-type p53 protein. Carcinogenesis, 1996, Volume: 17, Issue:7 Topics: Amides; Antineoplastic Agents; Aspartic Acid; Blotting, Western; Breast Neoplasms; Cell Cycle; Clone Cells; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Drug Resistance, Neoplasm; Enzyme Inhibitors; Etoposide; Female; Flow Cytometry; Gene Expression; Genes, p53; Humans; Immunohistochemistry; Melphalan; Mitoxantrone; Neoplasm Proteins; Nuclear Proteins; Phosphonoacetic Acid; Polymerase Chain Reaction; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-mdm2; Pyrazoles; Ribonucleosides; Ribose; Tumor Cells, Cultured; Tumor Suppressor Protein p53	1996
Down-regulation of apoptosis-related bcl-2 but not bcl-xL or bax proteins in multidrug-resistant MCF-7/Adr human breast cancer cells. International journal of cancer, 1996, Sep-04, Volume: 67, Issue:5 Topics: Antineoplastic Agents; Apoptosis; Base Sequence; bcl-2-Associated X Protein; bcl-X Protein; Breast Neoplasms; Cyclosporine; Doxorubicin; Drug Resistance, Multiple; Etoposide; Gene Expression Regulation, Neoplastic; Humans; Molecular Sequence Data; Paclitaxel; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; RNA, Messenger; Tumor Cells, Cultured; Verapamil; Vincristine	1996
Transfection of a human topoisomerase II alpha gene into etoposide-resistant human breast tumor cells sensitizes the cells to etoposide. Oncology research, 1996, Volume: 8, Issue:3 Topics: Amsacrine; Animals; Antigens, Neoplasm; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Cycle; Cell Death; Cell Division; DNA Topoisomerases, Type II; DNA-Binding Proteins; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Isoenzymes; Mice; RNA, Messenger; Transfection; Tumor Cells, Cultured	1996
[A case of lung metastasis from breast cancer successfully treated by FLEP (5-FU leucovorin, etoposide CDDP) combined arterial infusion chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 1996, Volume: 23, Issue:11 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Drug Administration Schedule; Etoposide; Female; Fluorouracil; Humans; Infusion Pumps, Implantable; Leucovorin; Lung Neoplasms	1996
[Bilateral highly malignant centroblastic lymphoma of the breast]. RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 1996, Volume: 165, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma; Magnetic Resonance Imaging; Mammography; Middle Aged; Neoplasms, Multiple Primary; Prednisone; Stem Cell Transplantation; Tomography, X-Ray Computed; Vincristine	1996
Monitoring of tumor cell purging after highly efficient immunomagnetic selection of CD34 cells from leukapheresis products in breast cancer patients: comparison of immunocytochemical tumor cell staining and reverse transcriptase-polymerase chain reaction. Blood, 1997, Jan-01, Volume: 89, Issue:1 Topics: Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Cisplatin; DNA, Complementary; DNA, Neoplasm; Epirubicin; ErbB Receptors; Etoposide; Evaluation Studies as Topic; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Immunoenzyme Techniques; Immunomagnetic Separation; Keratins; Leukapheresis; Melphalan; Middle Aged; Neoplasm Proteins; Neoplastic Cells, Circulating; Polymerase Chain Reaction; RNA, Messenger; RNA, Neoplasm; Transplantation Conditioning	1997
Mobilization of peripheral-blood progenitor cells with high-dose etoposide and granulocyte colony-stimulating factor in patients with breast cancer, non-Hodgkin's lymphoma, and Hodgkin's disease. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1997, Volume: 15, Issue:2 Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Phytogenic; Blood Specimen Collection; Breast Neoplasms; Cryopreservation; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Hodgkin Disease; Humans; Immunophenotyping; Lymphoma, Non-Hodgkin; Male; Middle Aged	1997
Potentiation of etoposide-induced apoptosis by staurosporine in human tumor cells is associated with events downstream of DNA-protein complex formation. Cancer chemotherapy and pharmacology, 1997, Volume: 39, Issue:5 Topics: Apoptosis; Breast Neoplasms; CDC2 Protein Kinase; CDC2-CDC28 Kinases; Cell Line; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinases; DNA Replication; Dose-Response Relationship, Drug; Drug Synergism; Etoposide; Female; HeLa Cells; Humans; Kinetics; Neoplasm Proteins; Protein Serine-Threonine Kinases; Staurosporine; Tumor Cells, Cultured	1997
Effect of CD34+ selection and various schedules of stem cell reinfusion and granulocyte colony-stimulating factor priming on hematopoietic recovery after high-dose chemotherapy for breast cancer. Blood, 1997, Mar-01, Volume: 89, Issue:5 Topics: Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Breast Neoplasms; Carcinoma; Cell Separation; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Middle Aged	1997
Annamycin circumvents resistance mediated by the multidrug resistance-associated protein (MRP) in breast MCF-7 and small-cell lung UMCC-1 cancer cell lines selected for resistance to etoposide. International journal of cancer, 1997, Mar-28, Volume: 71, Issue:1 Topics: Antibiotics, Antineoplastic; ATP-Binding Cassette Transporters; Blotting, Western; Breast Neoplasms; Carcinoma, Small Cell; Cell Survival; DNA Damage; DNA Topoisomerases, Type II; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Fluorescent Antibody Technique, Indirect; Humans; Immunohistochemistry; Multidrug Resistance-Associated Proteins; Tumor Cells, Cultured	1997
Apoptosis is associated with cleavage of a 5 kDa fragment from RB which mimics dephosphorylation and modulates E2F binding. Oncogene, 1997, Mar-13, Volume: 14, Issue:10 Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carrier Proteins; Cell Cycle Proteins; Cysteine Endopeptidases; Cytarabine; DNA-Binding Proteins; E2F Transcription Factors; Etoposide; fas Receptor; Female; HL-60 Cells; Humans; Peptide Fragments; Phosphorylation; Retinoblastoma Protein; Retinoblastoma-Binding Protein 1; Transcription Factor DP1; Transcription Factors	1997
Expression of the multidrug resistance-associated protein gene in refractory lymphoma: quantitation by a validated polymerase chain reaction assay. Blood, 1997, May-15, Volume: 89, Issue:10 Topics: Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biopsy; Breast Neoplasms; Carcinoma, Small Cell; Cyclophosphamide; DNA, Neoplasm; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Gene Expression Regulation, Neoplastic; HL-60 Cells; Humans; Lung Neoplasms; Lymphoma; Neoplasm Proteins; Polymerase Chain Reaction; Prednisone; RNA, Messenger; RNA, Neoplasm; Tumor Cells, Cultured; Verapamil; Vincristine	1997
Autologous bone marrow purging by in situ IL-2 activation of endogenous killer cells. Leukemia, 1997, Volume: 11, Issue:5 Topics: Bone Marrow Purging; Bone Marrow Transplantation; Breast Neoplasms; Colony-Forming Units Assay; Cytarabine; Cytotoxicity, Immunologic; Daunorubicin; Drug Resistance, Neoplasm; Etoposide; Female; Hematopoietic Stem Cells; HL-60 Cells; Humans; Interleukin-2; Killer Cells, Lymphokine-Activated; Killer Cells, Natural; Leukemia; Lung Neoplasms; Lymphocyte Activation; Tissue Donors; Transplantation, Autologous; Transplantation, Homologous; Tumor Cells, Cultured	1997
High-dose chemotherapy and stem-cell rescue in the treatment of high-risk breast cancer: prognostic indicators of progression-free and overall survival. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1997, Volume: 15, Issue:8 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Middle Aged; Prognosis; Risk Factors; Survival Rate	1997
DNase I primary transcript is alternatively spliced in both normal and apoptotic cells: no evidence of up-regulation in apoptosis. DNA and cell biology, 1997, Volume: 16, Issue:8 Topics: 3T3 Cells; Adenocarcinoma; Alternative Splicing; Animals; Apoptosis; Breast Neoplasms; Cell Line; Deoxyribonuclease I; Etoposide; Exons; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Jurkat Cells; Liver Neoplasms, Experimental; Male; Mice; PC12 Cells; Polymerase Chain Reaction; Prostatic Neoplasms; Rats; Transcription, Genetic; Tumor Cells, Cultured; Up-Regulation	1997
Overexpression of bax sensitizes breast cancer MCF-7 cells to cisplatin and etoposide. Surgery today, 1997, Volume: 27, Issue:7 Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Breast Neoplasms; Cell Survival; Cisplatin; Enzyme-Linked Immunosorbent Assay; Etoposide; Gene Expression; Humans; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Transfection; Tumor Cells, Cultured	1997
Allogeneic transplantation after a conditioning regimen with ifosfamide, carboplatin and etoposide (ICE). Bone marrow transplantation, 1997, Volume: 20, Issue:5 Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Carboplatin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Immunosuppressive Agents; Middle Aged; Transplantation Conditioning	1997
Cellular adaptation to drug exposure: evolution of the drug-resistant phenotype. Cancer research, 1997, Nov-15, Volume: 57, Issue:22 Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; DNA Topoisomerases, Type II; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Humans; Phenotype; Phosphorylation; RNA, Messenger; Sequence Deletion; Tumor Cells, Cultured; Tumor Stem Cell Assay	1997
Basic fibroblast growth factor downregulates Bcl-2 and promotes apoptosis in MCF-7 human breast cancer cells. Experimental cell research, 1998, Jan-10, Volume: 238, Issue:1 Topics: 3T3 Cells; Animals; Apoptosis; Breast Neoplasms; Cell Adhesion; Cell Division; Clone Cells; Etoposide; Female; Fibroblast Growth Factor 2; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; Kinetics; Mice; Proto-Oncogene Proteins c-bcl-2; Tumor Cells, Cultured; Tumor Stem Cell Assay	1998
Role of the vacuolar H+-ATPase in daunorubicin distribution in etoposide-resistant MCF7 cells overexpressing the multidrug-resistance associated protein. International journal of oncology, 1998, Volume: 12, Issue:3 Topics: 4-Chloro-7-nitrobenzofurazan; Adenocarcinoma; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Cell Nucleus; Cholesterol; Cytoplasm; Daunorubicin; Drug Resistance, Multiple; Etoposide; Female; Humans; Norsteroids; Proton-Translocating ATPases; Tumor Cells, Cultured; Vacuolar Proton-Translocating ATPases; Verapamil	1998
Caspase activation in MCF7 cells responding to etoposide treatment. Molecular pharmacology, 1998, Volume: 53, Issue:3 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Breast Neoplasms; Caspase 3; Caspases; Cysteine Endopeptidases; Enzyme Activation; Etoposide; Female; Humans; Poly(ADP-ribose) Polymerases; Tumor Cells, Cultured	1998
Sequence-dependent cytotoxicity of etoposide and paclitaxel in human breast and lung cancer cell lines. Cancer chemotherapy and pharmacology, 1998, Volume: 41, Issue:6 Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Administration Schedule; Drug Interactions; Etoposide; Female; Humans; Lung Neoplasms; Paclitaxel; Tumor Cells, Cultured	1998
Induction of sensitivity to doxorubicin and etoposide by transfection of MCF-7 breast cancer cells with heregulin beta-2. Clinical cancer research : an official journal of the American Association for Cancer Research, 1998, Volume: 4, Issue:4 Topics: Antibiotics, Antineoplastic; Antigens, Neoplasm; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Carrier Proteins; Cell Cycle; DNA Topoisomerases, Type II; DNA-Binding Proteins; Doxorubicin; Enzyme Activation; Etoposide; Gene Amplification; Genes, erbB-2; Glycoproteins; Humans; Isoenzymes; Neuregulin-1; Prognosis; Promoter Regions, Genetic; Proto-Oncogene Mas; Transfection; Tumor Cells, Cultured	1998
[A case report of neoadjuvant intra-arterial injection chemotherapy combined with peripheral blood stem cell reinfusion in an advanced breast cancer patient]. Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:5 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Papillary; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Epirubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Mastectomy, Radical	1998
Growth characteristics and metastatic properties of human breast cancer xenografts in immunodeficient mice. The American journal of pathology, 1998, Volume: 152, Issue:5 Topics: Adenocarcinoma; Aged; Animals; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Etoposide; Female; Humans; Injections, Intravenous; Injections, Subcutaneous; Lymphatic Metastasis; Male; Mice; Mice, Inbred NOD; Mice, SCID; Middle Aged; Neoplasm Transplantation; Polymerase Chain Reaction; Severe Combined Immunodeficiency; Transplantation, Heterologous; Tumor Cells, Cultured	1998
High-dose cyclophosphamide, etoposide and carboplatin with autologous bone marrow support for metastatic breast cancer: long-term results. Bone marrow transplantation, 1998, Volume: 21, Issue:8 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Carboplatin; Cyclophosphamide; Etoposide; Humans; Middle Aged; Neoplasm Metastasis; Survival Rate; Transplantation, Autologous	1998
Therapy-related leukemia and myelodysplasia following oral administration of etoposide for recurrent breast cancer. International journal of oncology, 1998, Volume: 13, Issue:1 Topics: Administration, Oral; Antineoplastic Agents, Phytogenic; Biomarkers, Tumor; Breast Neoplasms; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Middle Aged; Myelodysplastic Syndromes; Neoplasms, Second Primary; Recurrence; Risk Factors	1998
Swelling-activated chloride currents in a drug-sensitive cell line and a P glycoprotein-expressing derivative are underlied by channels with the same pharmacological properties. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 1998, Volume: 8, Issue:5 Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Cell Size; Chloride Channels; Colchicine; Cytochalasin D; Cytoskeleton; Electrophysiology; Etoposide; Humans; Hypertonic Solutions; Hypotonic Solutions; Meglumine; Nitrobenzenes; Tumor Cells, Cultured; Verapamil; Vinblastine	1998
Cyclic AMP-dependent protein kinase type I is involved in hypersensitivity of human breast cells to topoisomerase II inhibitors. Clinical cancer research : an official journal of the American Association for Cancer Research, 1995, Volume: 1, Issue:1 Topics: Amsacrine; Bleomycin; Breast Neoplasms; Cell Division; Cell Survival; Cyclic AMP-Dependent Protein Kinase Type II; Cyclic AMP-Dependent Protein Kinases; DNA Topoisomerases, Type II; Etoposide; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Genes, ras; Humans; Recombinant Proteins; Teniposide; Topoisomerase II Inhibitors; Transfection; Transforming Growth Factor alpha; Tumor Cells, Cultured	1995
In vitro evaluation of synergism or antagonism with combinations of new cytotoxic agents. Anti-cancer drugs, 1998, Volume: 9, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Deoxycytidine; Dose-Response Relationship, Drug; Drug Synergism; Etoposide; Gemcitabine; Humans; Male; Paclitaxel; Prostatic Neoplasms; Sarcoma; Tumor Cells, Cultured; Vinblastine; Vinorelbine	1998
1,25-Dihydroxyvitamin D3 enhances the susceptibility of breast cancer cells to doxorubicin-induced oxidative damage. Cancer research, 1999, Feb-15, Volume: 59, Issue:4 Topics: Antineoplastic Agents; Breast Neoplasms; Calcitriol; Dose-Response Relationship, Drug; Doxorubicin; Drug Synergism; Etoposide; Female; Humans; Reactive Oxygen Species; Superoxide Dismutase; Topoisomerase II Inhibitors; Tumor Cells, Cultured; Vitamin K	1999
Etoposide enhances the lethal effect of radiation on breast cancer cells with less damage to mammary gland cells. Cancer chemotherapy and pharmacology, 1999, Volume: 43, Issue:4 Topics: Breast; Breast Neoplasms; Cell Survival; Cells, Cultured; Dose-Response Relationship, Radiation; Etoposide; Female; Humans; Menopause; Premenopause; Radiation-Sensitizing Agents; Tumor Cells, Cultured	1999
Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers. Oncogene, 1999, Apr-01, Volume: 18, Issue:13 Topics: Adenocarcinoma; Animals; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Breast Neoplasms; Cell Cycle; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Screening Assays, Antitumor; Drug Synergism; Etoposide; Female; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; Immunization, Passive; Mice; Mice, Nude; Neoplasm Proteins; Neoplasm Transplantation; Neoplasms, Hormone-Dependent; Paclitaxel; Phosphorylation; Protein Processing, Post-Translational; Receptor, ErbB-2; Recombinant Proteins; Thiotepa; Topoisomerase II Inhibitors; Transplantation, Heterologous; Trastuzumab; Treatment Outcome; Vinblastine	1999
Dose-intensive chemotherapy for breast cancer with brain metastases: a case series. American journal of clinical oncology, 1999, Volume: 22, Issue:4 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Carboplatin; Carmustine; Cisplatin; Cyclophosphamide; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Middle Aged; Neoplasm Metastasis; Remission Induction; Survival Analysis; Thiotepa	1999
Front-line chemotherapy with cisplatin and etoposide for patients with brain metastases from breast carcinoma, nonsmall cell lung carcinoma, or malignant melanoma. A prospective study. Cancer, 1999, Sep-01, Volume: 86, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cranial Irradiation; Etoposide; Humans; Lung Neoplasms; Melanoma; Prospective Studies; Skin Neoplasms; Survival Analysis	1999
Differential effects of chemotherapeutic agents on the Bcl-2/Bax apoptosis pathway in human breast cancer cell line MCF-7. Breast cancer research and treatment, 1999, Volume: 55, Issue:1 Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Breast Neoplasms; Camptothecin; Doxorubicin; Etoposide; Female; Humans; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured	1999
Regulation of BAX and BCL-2 expression in breast cancer cells by chemotherapy. Breast cancer research and treatment, 1999, Volume: 55, Issue:2 Topics: Adenocarcinoma; Annexin A5; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Breast Neoplasms; Cell Cycle; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Synergism; Estrogens; Etoposide; Female; Gene Expression Regulation, Neoplastic; Genes, bcl-2; Humans; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Tumor Cells, Cultured	1999
Safety and efficacy of a continuous infusion, patient controlled anti-emetic pump to facilitate outpatient administration of high-dose chemotherapy. Bone marrow transplantation, 1999, Volume: 24, Issue:5 Topics: Adult; Ambulatory Care; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Carmustine; Cyclophosphamide; Cytarabine; Dexamethasone; Diphenhydramine; Etoposide; Evaluation Studies as Topic; Female; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Infusion Pumps; Infusions, Intravenous; Lorazepam; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multiple Myeloma; Nausea; Patient Acceptance of Health Care; Prospective Studies; Safety; Self Care; Thiotepa; Vomiting	1999
Adenovirus-mediated human topoisomerase IIalpha gene transfer increases the sensitivity of etoposide-resistant human breast cancer cells. Cancer research, 1999, Sep-15, Volume: 59, Issue:18 Topics: Adenoviridae; Antigens, Neoplasm; Breast Neoplasms; Cell Survival; DNA Topoisomerases, Type II; DNA-Binding Proteins; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Female; Genetic Vectors; Humans; Isoenzymes; Neoplasm Proteins; Recombinant Proteins; RNA, Messenger; Transcription, Genetic; Transfection	1999
Schedule-dependent interactions between paclitaxel and etoposide in human carcinoma cell lines in vitro. Cancer chemotherapy and pharmacology, 1999, Volume: 44, Issue:5 Topics: Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Cell Division; Colonic Neoplasms; Dose-Response Relationship, Drug; Drug Interactions; Drug Screening Assays, Antitumor; Etoposide; Female; Humans; Lung Neoplasms; Ovarian Neoplasms; Paclitaxel; Time Factors; Tumor Cells, Cultured	1999
Overexpression of basic fibroblast growth factor (FGF-2) downregulates Bcl-2 and promotes apoptosis in MCF-7 human breast cancer cells. Breast cancer research and treatment, 1999, Volume: 56, Issue:2 Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Breast Neoplasms; Down-Regulation; Epithelial Cells; Etoposide; Fibroblast Growth Factor 2; Fluorouracil; Humans; Neoplastic Stem Cells; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Tumor Cells, Cultured	1999
p53 regulates the expression of the tumor suppressor gene maspin. The Journal of biological chemistry, 2000, Mar-03, Volume: 275, Issue:9 Topics: Adenoviridae; Antineoplastic Agents; Breast Neoplasms; DNA Damage; DNA-Binding Proteins; Etoposide; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Humans; Male; Neoplasm Metastasis; Promoter Regions, Genetic; Prostatic Neoplasms; Proteins; RNA, Messenger; Serpins; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Ultraviolet Rays	2000
Resistance to taxanes is induced by c-erbB-2 overexpression in human MCF-10A mammary epithelial cells and is blocked by combined treatment with an antisense oligonucleotide targeting type I protein kinase A. International journal of cancer, 2000, Mar-01, Volume: 85, Issue:5 Topics: Antineoplastic Agents; Breast; Breast Neoplasms; Carboplatin; Cell Division; Cell Line; Cell Line, Transformed; Cell Survival; Cisplatin; Cyclic AMP-Dependent Protein Kinase Type II; Cyclic AMP-Dependent Protein Kinases; Docetaxel; Doxorubicin; Epithelial Cells; Etoposide; Female; Genes, erbB-2; Humans; Oligodeoxyribonucleotides, Antisense; Paclitaxel; Receptor, ErbB-2; Taxoids; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Topotecan; Tumor Cells, Cultured	2000
Regulation of cellular glutathione modulates nuclear accumulation of daunorubicin in human MCF7 cells overexpressing multidrug resistance associated protein. European journal of cancer (Oxford, England : 1990), 2000, Volume: 36, Issue:3 Topics: Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cassette Transporters; Breast Neoplasms; Buthionine Sulfoximine; Cell Nucleus; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Enzyme Inhibitors; Etoposide; Female; Flow Cytometry; Glutathione; Glutathione Synthase; Humans; Microscopy, Confocal; Multidrug Resistance-Associated Proteins; Reverse Transcriptase Polymerase Chain Reaction; Spectrometry, Fluorescence; Tumor Cells, Cultured	2000
Depletion of cellular glutathione by conditions used for the passaging of adherent cultured cells. Toxicology letters, 2000, May-19, Volume: 115, Issue:2 Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Hepatocellular; Cell Communication; Cell Culture Techniques; Cell Death; Etoposide; Female; Glutathione; Humans; Hydrogen Peroxide; Liver Neoplasms; Oxidants; Rats; Toxicity Tests; Tumor Cells, Cultured	2000
High-dose chemotherapy and stem cell transplantation for patients with stage IV breast cancer without clinically evident disease: correlation of CD34+ selection to clinical outcome. Bone marrow transplantation, 2000, Volume: 25, Issue:10 Topics: Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Cell Separation; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Middle Aged; Mitoxantrone; Survival Analysis; Thiotepa; Treatment Outcome	2000
Role of multidrug resistance P-glycoprotein in the secretion of aldosterone by human adrenal NCI-H295 cells. American journal of physiology. Cell physiology, 2000, Volume: 278, Issue:6 Topics: Adrenal Glands; Aldosterone; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Cell Line; Cell Membrane; Drug Resistance, Multiple; Etoposide; Female; Glomerular Mesangium; Humans; Oligodeoxyribonucleotides, Antisense; Reverse Transcriptase Polymerase Chain Reaction; Rhodamine 123; Transcription, Genetic; Transfection; Tumor Cells, Cultured	2000
Coordinated regulation of two TRAIL-R2/KILLER/DR5 mRNA isoforms by DNA damaging agents, serum and 17beta-estradiol in human breast cancer cells. Breast cancer research and treatment, 2000, Volume: 61, Issue:1 Topics: Antineoplastic Agents; Base Sequence; Breast Neoplasms; Camptothecin; DNA Damage; Doxorubicin; Estradiol; Etoposide; Female; Gene Expression Regulation, Neoplastic; Gene Library; Humans; Molecular Sequence Data; Protein Isoforms; Receptors, TNF-Related Apoptosis-Inducing Ligand; Receptors, Tumor Necrosis Factor; RNA, Messenger; Serum Albumin, Bovine; Tumor Cells, Cultured	2000
Serum ICAM-1 concentrations following conventional dose consolidation chemotherapy for acute myeloid leukemia and after high dose chemotherapy with autologous haematopoietic stem cell rescue. International journal of oncology, 2000, Volume: 17, Issue:3 Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Breast Neoplasms; Combined Modality Therapy; Cytarabine; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Intercellular Adhesion Molecule-1; Leukemia, Myeloid; Leukocyte Count; Male; Middle Aged; Neoplasm Proteins; Neutropenia; Neutrophils; Recombinant Proteins; Solubility	2000
Expression of CD11b/CD18 on neutrophils after consolidation chemotherapy for acute myeloid leukemia and after high dose chemotherapy with autologous haematopoietic stem cell transplantation. International journal of oncology, 2000, Volume: 17, Issue:3 Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Breast Neoplasms; CD18 Antigens; Combined Modality Therapy; Cytarabine; Etoposide; Female; Filgrastim; Gene Expression Regulation, Leukemic; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid; Macrophage-1 Antigen; Male; Melphalan; Middle Aged; Neoplasm Proteins; Neutropenia; Recombinant Proteins; Remission Induction	2000
Myeloid differentiation and maturation of SCF+IL-3+IL-11 expanded AC133+/CD34+ cells selected from high-risk breast cancer patients. Neoplasma, 2000, Volume: 47, Issue:2 Topics: AC133 Antigen; Adult; Antigens, CD; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Etoposide; Female; Glycoproteins; Granulocyte Colony-Stimulating Factor; Hematopoietic Cell Growth Factors; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cells; Humans; Interleukin-11; Interleukin-3; Leukapheresis; Middle Aged; Peptides; Recombinant Proteins; Stem Cell Factor	2000
Mobilization and transplantation of peripheral blood stem cells. Stem cells (Dayton, Ohio), 1998, Volume: 16 Suppl 1 Topics: Antigens, CD34; Blood Transfusion; Bone Marrow Transplantation; Breast Neoplasms; Cyclophosphamide; Cytokines; Erythrocytes; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Leukapheresis; Leukocyte Count; Lymphoma, Non-Hodgkin; Paclitaxel; Platelet Transfusion; Regression Analysis; Retrospective Studies; Transplantation, Autologous	1998
Caspase-8/FLICE functions as an executioner caspase in anticancer drug-induced apoptosis. Oncogene, 2000, Sep-21, Volume: 19, Issue:40 Topics: Adenocarcinoma; Amino Acid Chloromethyl Ketones; Antineoplastic Agents; Apoptosis; bcl-X Protein; BH3 Interacting Domain Death Agonist Protein; Breast Neoplasms; Carrier Proteins; CASP8 and FADD-Like Apoptosis Regulating Protein; Caspase 3; Caspase 8; Caspase 9; Caspases; Cysteine Proteinase Inhibitors; Enzyme Activation; Enzyme Precursors; Etoposide; fas Receptor; Humans; Intracellular Signaling Peptides and Proteins; Jurkat Cells; Mitochondria; Mitomycin; Neoplasm Proteins; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-bcl-2; Tumor Cells, Cultured	2000
Reconstitution of caspase 3 sensitizes MCF-7 breast cancer cells to doxorubicin- and etoposide-induced apoptosis. Cancer research, 2001, Jan-01, Volume: 61, Issue:1 Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; Breast Neoplasms; Caspase 3; Caspases; Cell Nucleus; DNA Fragmentation; Doxorubicin; Drug Screening Assays, Antitumor; Enzyme Activation; Etoposide; Humans; Inhibitory Concentration 50; Tumor Cells, Cultured	2001
The small heat shock protein alpha B-crystallin negatively regulates cytochrome c- and caspase-8-dependent activation of caspase-3 by inhibiting its autoproteolytic maturation. The Journal of biological chemistry, 2001, May-11, Volume: 276, Issue:19 Topics: Apoptosis; Breast Neoplasms; Caspase 3; Caspase 8; Caspase 9; Caspases; Crystallins; Cytochrome c Group; Enzyme Activation; Etoposide; Female; Heat-Shock Proteins; Humans; Kinetics; Myocardium; Recombinant Proteins; Transfection; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha	2001
Selection of candidates for oral etoposide salvage chemotherapy in heavily pretreated breast cancer patients. Anti-cancer drugs, 2001, Volume: 12, Issue:3 Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Disease Progression; Etoposide; Female; Humans; Middle Aged; Patient Selection; Salvage Therapy; Survival Analysis; Treatment Outcome	2001
Induction of topoisomerase II activity after ErbB2 activation is associated with a differential response to breast cancer chemotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research, 2001, Volume: 7, Issue:6 Topics: 3T3 Cells; Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Blotting, Western; Breast Neoplasms; Cell Cycle; Cell Nucleus; Cyclophosphamide; DNA; DNA Topoisomerases, Type II; Doxorubicin; Enzyme Activation; Epidermal Growth Factor; Etoposide; Female; Humans; Mice; Nucleic Acid Synthesis Inhibitors; Protein Binding; Receptor, ErbB-2; Signal Transduction; Time Factors; Transfection; Tumor Cells, Cultured	2001
Expression of drug resistance genes in VP-16 and mAMSA-selected human carcinoma cells. Japanese journal of cancer research : Gann, 2001, Volume: 92, Issue:7 Topics: Amsacrine; Anion Transport Proteins; Antigens, Neoplasm; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Blotting, Northern; Breast Neoplasms; Carcinoma; Carrier Proteins; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; DNA-Binding Proteins; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Etoposide; Humans; Isoenzymes; Multidrug Resistance-Associated Proteins; Tumor Cells, Cultured	2001
Hypophosphorylation of topoisomerase IIalpha in etoposide (VP-16)-resistant human carcinoma cell lines associated with carboxy-terminal truncation. Japanese journal of cancer research : Gann, 2001, Volume: 92, Issue:7 Topics: Alternative Splicing; Antigens, Neoplasm; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Carcinoma; DNA Topoisomerases, Type II; DNA-Binding Proteins; Drug Resistance, Neoplasm; Etoposide; Exons; Humans; Isoenzymes; Phosphorylation; Structure-Activity Relationship; Tumor Cells, Cultured	2001
Ionizing radiation but not anticancer drugs causes cell cycle arrest and failure to activate the mitochondrial death pathway in MCF-7 breast carcinoma cells. Oncogene, 2001, Aug-16, Volume: 20, Issue:36 Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carcinoma; Carrier Proteins; Caspase 3; Caspase 9; Caspases; Cell Cycle; DNA Damage; DNA Fragmentation; DNA, Neoplasm; Doxorubicin; Etoposide; Female; HeLa Cells; Humans; Microfilament Proteins; Mitochondria; Radiation, Ionizing; Transformation, Genetic; Tumor Cells, Cultured	2001
University of Washington high-dose cyclophosphamide, mitoxantrone, and etoposide experience in metastatic breast cancer: unexpected cardiac toxicity. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Sep-15, Volume: 19, Issue:18 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials, Phase II as Topic; Cyclophosphamide; Etoposide; Female; Heart Diseases; Humans; Medical Audit; Middle Aged; Mitoxantrone; Retraction of Publication as Topic; Scientific Misconduct; South Africa; Washington	2001
Altered topoisomerase IIalpha and multidrug resistance-associated protein levels during drug selection: adaptations to increasing drug pressure. Japanese journal of cancer research : Gann, 2001, Volume: 92, Issue:9 Topics: Amsacrine; Antigens, Neoplasm; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Carcinoma; Clone Cells; DNA Topoisomerases, Type II; DNA-Binding Proteins; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Enzyme Induction; Enzyme Inhibitors; Etoposide; Female; Humans; Mitoxantrone; Neoplasm Proteins; Nucleic Acid Synthesis Inhibitors; RNA, Messenger; RNA, Neoplasm; Selection, Genetic; Topoisomerase II Inhibitors; Tumor Cells, Cultured; Tumor Stem Cell Assay; Vincristine	2001
Characterization of fortilin, a novel antiapoptotic protein. The Journal of biological chemistry, 2001, Dec-14, Volume: 276, Issue:50 Topics: Amino Acid Sequence; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Biomarkers, Tumor; Blotting, Northern; Blotting, Western; Breast Neoplasms; Caspase 3; Caspases; Cell Death; Cell Line; Cloning, Molecular; Coumarins; DNA, Complementary; Dose-Response Relationship, Drug; Enzyme Inhibitors; Etoposide; HeLa Cells; Humans; Immunohistochemistry; Molecular Sequence Data; Neoplasm Proteins; Nuclear Proteins; Nucleic Acid Synthesis Inhibitors; Oligopeptides; Proto-Oncogene Proteins c-bcl-2; Recombinant Fusion Proteins; Sequence Homology, Amino Acid; Time Factors; Tissue Distribution; Tumor Cells, Cultured; Tumor Protein, Translationally-Controlled 1; Two-Hybrid System Techniques	2001
Incidence of mutation and deletion in topoisomerase II alpha mRNA of etoposide and mAMSA-resistant cell lines. Japanese journal of cancer research : Gann, 2001, Volume: 92, Issue:10 Topics: Amsacrine; Antigens, Neoplasm; Antineoplastic Agents; Breast Neoplasms; DNA Mutational Analysis; DNA Topoisomerases, Type II; DNA-Binding Proteins; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Mutation; Nuclease Protection Assays; Ribonucleases; RNA, Neoplasm; Sequence Deletion; Tumor Cells, Cultured	2001
Sustained complete remission following a combination of very low intensity chemotherapy with rituximab in an elderly patient with Burkitt's lymphoma. Haematologica, 2002, Volume: 87, Issue:1 Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Burkitt Lymphoma; Carcinoma, Intraductal, Noninfiltrating; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Immunotherapy; Mastectomy, Segmental; Neoplasms, Multiple Primary; Orbital Neoplasms; Prednisone; Radiotherapy, Adjuvant; Remission Induction; Rituximab; Salvage Therapy; Vincristine	2002
TRAIL and inhibitors of apoptosis are opposing determinants for NF-kappaB-dependent, genotoxin-induced apoptosis of cancer cells. Oncogene, 2002, Jan-10, Volume: 21, Issue:2 Topics: Apoptosis; Apoptosis Regulatory Proteins; Breast Neoplasms; Carcinoma, Squamous Cell; Cloning, Molecular; DNA Fingerprinting; DNA-Binding Proteins; Dose-Response Relationship, Drug; Etoposide; Female; Gene Expression Regulation, Neoplastic; Humans; I-kappa B Proteins; Kinetics; Lung Neoplasms; Membrane Glycoproteins; NF-kappa B; NF-KappaB Inhibitor alpha; Recombinant Proteins; TNF-Related Apoptosis-Inducing Ligand; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha	2002
Subnuclear distribution of topoisomerase I is linked to ongoing transcription and p53 status. Proceedings of the National Academy of Sciences of the United States of America, 2002, Feb-05, Volume: 99, Issue:3 Topics: Adenocarcinoma; Binding Sites; Breast Neoplasms; Cell Nucleolus; Cell Nucleus; DNA Topoisomerases, Type I; Etoposide; Female; Genes, p53; Humans; Peptide Fragments; Polymerase Chain Reaction; Recombinant Fusion Proteins; Transcription, Genetic; Tumor Cells, Cultured; Tumor Suppressor Protein p53	2002
[Globalization of anti-cancer therapies]. Gan to kagaku ryoho. Cancer & chemotherapy, 2002, Volume: 29, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Camptothecin; Carboplatin; Cisplatin; Colorectal Neoplasms; Etoposide; Female; Humans; Irinotecan; Lung Neoplasms; Male; Neoplasms; Ovarian Neoplasms; Paclitaxel; Prostatic Neoplasms; Stomach Neoplasms	2002
[Chemotherapy-associated myelosuppression in gynecological oncology]. Gynakologisch-geburtshilfliche Rundschau, 2001, Volume: 41, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Cobalt Radioisotopes; Combined Modality Therapy; Cyclophosphamide; Data Interpretation, Statistical; Etoposide; Female; Fluorouracil; Hematopoiesis; Humans; Leukopoiesis; Lymph Node Excision; Lymphatic Metastasis; Mastectomy, Segmental; Methotrexate; Middle Aged; Ovarian Neoplasms; Platelet Count; Radioisotope Teletherapy; Radiotherapy Dosage	2001
DNA damage is able to induce senescence in tumor cells in vitro and in vivo. Cancer research, 2002, Mar-15, Volume: 62, Issue:6 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; beta-Galactosidase; Breast Neoplasms; Camptothecin; Cell Cycle; Cellular Senescence; Cyclin-Dependent Kinase Inhibitor p16; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; DNA Damage; Etoposide; Humans; Irinotecan; Neoadjuvant Therapy; Tumor Suppressor Protein p53	2002
Inhibition of protein synthesis in apoptosis: differential requirements by the tumor necrosis factor alpha family and a DNA-damaging agent for caspases and the double-stranded RNA-dependent protein kinase. Cancer research, 2002, Apr-15, Volume: 62, Issue:8 Topics: Adaptor Proteins, Signal Transducing; Animals; Apoptosis; Apoptosis Regulatory Proteins; Breast Neoplasms; Carrier Proteins; Caspase Inhibitors; Caspases; Cell Cycle Proteins; DNA Damage; Down-Regulation; eIF-2 Kinase; Etoposide; Eukaryotic Initiation Factor-2; Eukaryotic Initiation Factor-4E; Eukaryotic Initiation Factors; Fibroblasts; Humans; Membrane Glycoproteins; Mice; Peptide Initiation Factors; Phosphoproteins; Phosphorylation; Protein Biosynthesis; Protein Synthesis Inhibitors; TNF-Related Apoptosis-Inducing Ligand; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha	2002
Modulation by D,L-buthionine-S,R-sulphoximine of etoposide cytotoxicity on human non-small cell lung, ovarian and breast carcinoma cell lines. European journal of cancer (Oxford, England : 1990), 1992, Volume: 28A, Issue:8-9 Topics: Antimetabolites, Antineoplastic; Breast Neoplasms; Buthionine Sulfoximine; Carcinoma, Non-Small-Cell Lung; Cisplatin; Doxorubicin; Drug Synergism; Etoposide; Female; Glutathione; Humans; Lung Neoplasms; Methionine Sulfoximine; Ovarian Neoplasms; Tumor Cells, Cultured; Verapamil	1992
Reduced intracellular drug accumulation in the absence of P-glycoprotein (mdr1) overexpression in mitoxantrone-resistant human MCF-7 breast cancer cells. Cancer research, 1992, Nov-15, Volume: 52, Issue:22 Topics: Adenosine Triphosphate; Antibodies; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Western; Breast Neoplasms; Cell Membrane Permeability; Cross Reactions; DNA Topoisomerases, Type II; Doxorubicin; Drug Resistance; Etoposide; Gene Expression; Humans; Intracellular Fluid; Membrane Glycoproteins; Membrane Proteins; Mitoxantrone; Tumor Cells, Cultured; Verapamil	1992
Bone marrow purging in patients with refractory cancer. Progress in clinical and biological research, 1992, Volume: 377 Topics: Adolescent; Adult; Bone Marrow Purging; Bone Marrow Transplantation; Breast Neoplasms; Child; Child, Preschool; Colony-Forming Units Assay; Etoposide; Female; Hematopoietic Stem Cells; Humans; In Vitro Techniques; Leukemia; Lymphoma; Male; Methylprednisolone; Middle Aged; Neoplasms; Transplantation, Autologous	1992
High-dose hydroxyurea in autologous bone marrow transplantation: a promising "new" agent. Seminars in oncology, 1992, Volume: 19, Issue:3 Suppl 9 Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Carmustine; Chemotherapy, Adjuvant; Cyclophosphamide; Drug Administration Schedule; Etoposide; Humans; Hydroxyurea; Lymphoma, Non-Hodgkin; Middle Aged; Remission Induction; Survival Rate; Thiotepa	1992
[Remarkable effect of the combination therapy of etoposide, epiadriamycin, and CDDP (EAP) in the treatment of metachronous lung metastases of breast cancer--a case report]. Gan to kagaku ryoho. Cancer & chemotherapy, 1991, Volume: 18, Issue:14 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Cisplatin; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Mastectomy, Radical; Remission Induction	1991
[5'-deoxy-5-fluorouridine (5'-DFUR), mitomycin C (MMC), etoposide and medroxy progesterone acetate (MPA) in a previously treated patient with advanced breast cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1991, Volume: 18, Issue:1 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Etoposide; Female; Floxuridine; Humans; Liver Neoplasms; Lymphatic Metastasis; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Mitomycin; Mitomycins; Remission Induction	1991
Infusion of floxuridine plus etoposide plus cisplatin in human malignancies. European journal of cancer (Oxford, England : 1990), 1991, Volume: 27, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Diarrhea; Drug Evaluation; Etoposide; Female; Floxuridine; Gastrointestinal Neoplasms; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Risk Factors; Stomatitis; Thrombocytopenia	1991
A lack of detectable modification of topoisomerase II activity in a series of human tumor cell lines expressing only low levels of etoposide resistance. International journal of cancer, 1991, Apr-01, Volume: 47, Issue:6 Topics: Amsacrine; Breast Neoplasms; Cell Line; Cell Nucleus; DNA Damage; DNA Topoisomerases, Type II; DNA, Neoplasm; Drug Resistance; Etoposide; Female; Humans; Immunoblotting	1991
Tyrosinase-induced free radical formation from VP-16,213: relationship to cytotoxicity. Free radical research communications, 1990, Volume: 10, Issue:4-5 Topics: Animals; Breast Neoplasms; Electron Spin Resonance Spectroscopy; Etoposide; Free Radicals; Humans; Melanoma, Experimental; Mice; Monophenol Monooxygenase; Phenylthiourea; Tumor Cells, Cultured	1990
P-glycoprotein-independent mechanism of resistance to VP-16 in multidrug-resistant tumor cell lines: pharmacokinetic and photoaffinity labeling studies. Molecular pharmacology, 1990, Volume: 37, Issue:6 Topics: Affinity Labels; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azides; Binding, Competitive; Breast Neoplasms; Cricetinae; Cricetulus; Dactinomycin; Doxorubicin; Drug Resistance; Etoposide; Humans; Membrane Glycoproteins; Neoplasm Proteins; Tumor Cells, Cultured; Verapamil; Vinblastine; Vindesine	1990
Ifosfamide/etoposide and mesna uroprotection in advanced breast cancer. Cancer chemotherapy and pharmacology, 1990, Volume: 26 Suppl Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Etoposide; Female; Humans; Ifosfamide; Mesna; Middle Aged	1990
A phase II study of mitoxantrone, etoposide, and thiotepa with autologous marrow support for patients with relapsed breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1990, Volume: 8, Issue:11 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Combined Modality Therapy; Drug Evaluation; Etoposide; Female; Humans; Infusions, Intravenous; Middle Aged; Mitoxantrone; Neoplasm Metastasis; Neoplasm Recurrence, Local; Survival Rate; Thiotepa; Transplantation, Autologous	1990
[High-dose cyclophosphamide, thio-TEPA, etoposide with autologous bone marrow transplantation for refractory cancers]. Gan to kagaku ryoho. Cancer & chemotherapy, 1990, Volume: 17, Issue:11 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Drug Resistance; Etoposide; Female; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Thiotepa	1990
Structure-activity relations, cytotoxicity and topoisomerase II dependent cleavage induced by pendulum ring analogues of etoposide. European journal of cancer (Oxford, England : 1990), 1990, Volume: 26, Issue:5 Topics: Breast Neoplasms; Cell Survival; DNA Damage; DNA Topoisomerases, Type II; DNA, Neoplasm; Etoposide; Female; Humans; Structure-Activity Relationship; Tumor Cells, Cultured	1990
Nasopharyngeal rhabdomyosarcoma presenting as a breast mass. Pediatric hematology and oncology, 1990, Volume: 7, Issue:3 Topics: Adolescent; Breast Neoplasms; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Humans; Nasopharyngeal Neoplasms; Rhabdomyosarcoma; Tomography, X-Ray Computed; Vincristine	1990
Combination therapy with platinum and etoposide of brain metastases from breast carcinoma. Cancer investigation, 1990, Volume: 8, Issue:3-4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Breast Neoplasms; Drug Evaluation; Etoposide; Female; Humans; Leukopenia; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Platinum; Regression Analysis; Remission Induction	1990
Evaluation of the continuous infusion of etoposide plus cisplatin in metastatic breast cancer. A collaborative North Central Cancer Treatment Group/Mayo Clinic phase II study. Cancer, 1990, Feb-01, Volume: 65, Issue:3 Topics: Acute Kidney Injury; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Drug Evaluation; Etoposide; Female; Humans; Infusions, Intravenous; Middle Aged; Neoplasm Metastasis; Prospective Studies	1990
Doxorubicin and etoposide in the treatment of advanced measurable breast cancer. Oncology, 1990, Volume: 47, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Doxorubicin; Etoposide; Female; Humans; Middle Aged; Survival Rate	1990
Combination chemotherapy with oral etoposide plus intravenous cyclophosphamide in liver metastases of breast cancer. American journal of clinical oncology, 1990, Volume: 13, Issue:2 Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Drug Synergism; Etoposide; Female; Humans; Injections, Intravenous; Liver Neoplasms; Middle Aged; Remission Induction	1990
Subpopulation analysis of drug-induced cell-cycle delay in human tumor cells using 90 degrees light scatter. Cytometry, 1988, Volume: 9, Issue:4 Topics: Breast Neoplasms; Cell Cycle; Cell Separation; Demecolcine; DNA, Neoplasm; Etoposide; Flow Cytometry; Humans; Light; Microscopy, Fluorescence; Mitosis; Mitotic Index; Scattering, Radiation; Staining and Labeling; Tumor Cells, Cultured; Vincristine	1988
Etoposide and mitomycin-C in pretreated metastatic breast cancer. Tumori, 1989, Oct-31, Volume: 75, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Etoposide; Female; Follow-Up Studies; Humans; Middle Aged; Mitomycin; Mitomycins; Neoplasm Metastasis	1989
Mitogen-induced topoisomerase II synthesis precedes DNA synthesis in human breast cancer cells. Biochemical and biophysical research communications, 1989, Apr-14, Volume: 160, Issue:1 Topics: Amsacrine; Blotting, Western; Breast Neoplasms; Cross-Linking Reagents; DNA; DNA Topoisomerases, Type II; DNA, Neoplasm; Estrogens; Etoposide; Humans; Tumor Cells, Cultured	1989
Cystosarcoma phyllodes. Effective therapy with cisplatin and etoposide chemotherapy. Cancer, 1989, Jun-01, Volume: 63, Issue:11 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Combined Modality Therapy; Etoposide; Female; Humans; Phyllodes Tumor; Radiography	1989
Oestrogen potentiates topoisomerase-II-mediated cytotoxicity in an activated subpopulation of human breast cancer cells: implications for cytotoxic drug resistance in solid tumours. International journal of cancer, 1989, Sep-15, Volume: 44, Issue:3 Topics: Breast Neoplasms; Cell Cycle; DNA Topoisomerases, Type II; Drug Resistance; Estrogens; Etoposide; Female; Flow Cytometry; Humans; Immunohistochemistry; Neoplastic Stem Cells; Tumor Cells, Cultured	1989
Role of differential drug uptake, efflux, and binding of etoposide in sensitive and resistant human tumor cell lines: implications for the mechanisms of drug resistance. Molecular pharmacology, 1989, Volume: 35, Issue:3 Topics: Adenosine Triphosphate; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azides; Breast Neoplasms; Dose-Response Relationship, Drug; Drug Resistance; Etoposide; Female; Humans; Leukemia, Promyelocytic, Acute; Membrane Glycoproteins; Sodium Azide; Tumor Cells, Cultured; Vincristine	1989
Differential cytotoxic activity of chemotherapy agents on colony-forming cells from human tumors and normal bone marrow in vitro. Experimental hematology, 1985, Volume: 13 Suppl 16 Topics: Antineoplastic Agents; Bleomycin; Breast Neoplasms; Cell Survival; Cells, Cultured; Cisplatin; Doxorubicin; Etoposide; Fluorouracil; Hematopoietic Stem Cells; Humans; Lung Neoplasms; Melanoma; Neoplastic Stem Cells; Sarcoma; Stem Cells	1985
Differential increases in glutathione S-transferase activities in a range of multidrug-resistant human tumor cell lines. Cancer communications, 1989, Volume: 1, Issue:6 Topics: Antineoplastic Agents; Blotting, Northern; Blotting, Western; Breast Neoplasms; Doxorubicin; Drug Resistance; Etoposide; Glutathione; Glutathione Peroxidase; Glutathione Transferase; Humans; In Vitro Techniques; Mitoxantrone; Tumor Cells, Cultured; Vincristine	1989
Phase II study with etoposide in previously untreated advanced breast cancer. Cancer chemotherapy and pharmacology, 1989, Volume: 24, Issue:4 Topics: Adult; Aged; Alopecia; Breast Neoplasms; Drug Administration Schedule; Drug Evaluation; Drug Tolerance; Etoposide; Female; Humans; Injections, Intravenous; Leukopenia; Middle Aged; Pilot Projects; Platelet Count; Remission Induction	1989
Estrogen-induced potentiation of DNA damage and cytotoxicity in human breast cancer cells treated with topoisomerase II-interactive antitumor drugs. Cancer research, 1988, Jan-15, Volume: 48, Issue:2 Topics: Amsacrine; Breast Neoplasms; Cell Survival; DNA Damage; DNA Repair; DNA Topoisomerases, Type II; Doxorubicin; Drug Synergism; Estrogens; Etoposide; Female; Humans; Mitoxantrone; Tumor Cells, Cultured	1988
Iron-dependent hydroxyl radical formation and DNA damage from a novel metabolite of the clinically active antitumor drug VP-16. FEBS letters, 1988, Jan-25, Volume: 227, Issue:2 Topics: Breast Neoplasms; Cell Line; Cell Survival; DNA Damage; Drug Screening Assays, Antitumor; Electron Spin Resonance Spectroscopy; Etoposide; Female; Ferric Compounds; Free Radicals; Glutathione; Humans; Hydrogen Peroxide; Hydroxides; Hydroxyl Radical	1988
Pilot study of a continuous five-day intravenous infusion of etoposide concomitant with cisplatin in selected patients with advanced cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1988, Volume: 6, Issue:7 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Etoposide; Female; Histiocytoma, Benign Fibrous; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Pilot Projects; Stomach Neoplasms; Tongue Neoplasms	1988
DNA strand breaks produced by etoposide (VP-16,213) in sensitive and resistant human breast tumor cells: implications for the mechanism of action. Cancer research, 1988, Sep-15, Volume: 48, Issue:18 Topics: Breast Neoplasms; Cell Line; DNA Damage; DNA Topoisomerases, Type II; DNA, Neoplasm; Drug Resistance; Etoposide; Female; Humans; Time Factors	1988
[Efficacy of etoposide in bone metastasis of breast cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1989, Volume: 16, Issue:2 Topics: Bone Neoplasms; Breast Neoplasms; Etoposide; Female; Humans; Middle Aged; Radiography	1989
[A case report of advanced breast cancer effectively treated with etoposide, adriamycin and cis-platinum combination therapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 1988, Volume: 15, Issue:10 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Combined Modality Therapy; Doxorubicin; Etoposide; Female; Humans; Lymphatic Metastasis; Mastectomy, Extended Radical; Middle Aged; Postoperative Care	1988
Sequential multiagent chemotherapy incorporating cisplatin, doxorubicin, and cyclophosphamide in the treatment of metastatic breast cancer. Cancer, 1988, Nov-15, Volume: 62, Issue:10 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Fluorouracil; Follow-Up Studies; Humans; Menopause; Methotrexate; Middle Aged; Neoplasm Metastasis; Receptors, Estrogen	1988
Cisplatin and etoposide in chemotherapy-refractory advanced breast cancer. Tumori, 1988, Apr-30, Volume: 74, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Drug Evaluation; Etoposide; Female; Humans; Leukopenia; Middle Aged; Nausea; Vomiting	1988
Characterisation of VP-16-induced DNA cleavage in oestrogen-stimulated human breast cancer cells. British journal of cancer, 1988, Volume: 57, Issue:5 Topics: Breast Neoplasms; Cell Division; Chromatin; DNA Damage; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Synergism; Estradiol; Etoposide; Female; Humans; In Vitro Techniques; Time Factors; Tumor Cells, Cultured	1988
Platinum and etoposide in chemotherapy refractory metastatic breast cancer. A phase II trial of the Italian Oncology Group for Clinical Research (G.O.I.R.C.). European journal of cancer & clinical oncology, 1986, Volume: 22, Issue:7 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Drug Evaluation; Etoposide; Female; Humans; Middle Aged; Neoplasm Transplantation	1986